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ABSTRACT
The basic helix-loop-helix (bHLH) proteins are intimately assoc iated with deve lopmental
events such as cell differentiation and lineage commitment. The HLH domain in the bHLH
motif is responsible for dimerization whereas the basic reg ion mediates sequence specific DNA
binding. Human DEC, mouse STRA and rat SHARP proteins rep resent a new c lass of bHLH
proteins. In each species, two members are identified wi th a sequence identi ty of>90% in the
bHLH regio n and - 40% in the total protein, respectively. Based on sequence alignment and
domain analysis, DEC/STRA/SHARP proteins show hi gh s imilarities (- 40%) to Drosoph ila
Hairy and E(spl) as well as the mammalian homologues (e.g., HES) in the bHLH domain.
However, they lack the C-terminal WRPW motif which is present at all other Ha iry/E(spl)/Hes
proteins and mediates transcription repression. These structural d ifferences distinguish
DEC/STRA/SHARPs from other bHLH proteins and indicate that they have dist inct biological
functions. The purpose of this dissertation is to elucidate the oncogenic roles of DEC I and
determine the mo lecul ar actions of DEC I on transcription regulation.

Expression measurments demonstrate that DEC I is abundantly exp ressed in cancer tissues but
not in adjacent nonmal tiss ues.

In stable transfectants, DEC I inhibits cell proliferation,

antago ni zes serum deprivation-induced apoptos is, and selectively decreases the activities of
several major caspases. Western blotting ana lyses identify that antiapoptotic protein survivin is
a fu nctional mediator responsible for DEC I-directed antiapoptotic activity. DEC I and survivin

exhibit a paralleled expression pattern in paired tumor-normal tissues.

In co-transfection

experiments, DEC I stimulates the survivin promoter, and this mechanism relies on the physical
interactions with Sp I sites in the proximal promoter. In contrast, DEC I and its structurall y
related protein DEC2 show an inverted expression pattern in paired tumor-normal tiss ues.
Forced expression of DEC I causes proportional decreases in the expression of DEC2 in stable
transfectants. Co-transfection with DEC I represses the activity of a DEC2 promoter reporter
by as much as 90%. The DEC I mediated transcription repression is achieved by direct binding
to the E-box element in the proximal promoter of DEC2. The established activation of the
survivi n promoter provides a molecular explanation for its oncogenic involvement, and the

differential activities toward DEC2 and survivin promoters establish that DEC I can act as a
repressor or an activator depending on the genomic context of a target gene.
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INTRODUCTION
Gene expression within eukaryot ic cells is primarily regulated at transcription level. The
transcription of genes is contro lled by complex interactions between transcripti on faclors and

their corresponding DNA sequences in target genes. Transcription factors have two functiona l
domains: one for sequence-specific DNA binding and one for transcription activation
(Brivanlou et al, 2002). In some cases this dual requirement is shared between partner proteins,
hence the site-specific DNA binding domain and transcription activatio n domain occur on
separate proteins. Based on the structural features of the DNA binding domain, transcription
factors fa ll into four major structu ral families: (I) Helix-turn-helix; (2) Zinc finger; (3) Leucine
zipper; and (4) Helix-loop-helix.

Helix-loop-helix transcription factors
Helix-loop-helix (HLH) transcription factors play important roles in a wide array of
developmental processes such as myogenesis (MyoD/E4 7) (Weintraub et al, 1991; Zhuang et al,
1994), neurogenesis (NeuroD, Ashaete-scute/Daughterless) (Villares et al, 1987; Caudy et al,
1988), hematopoiesis and sex determ ination (E 12/Da/ESC) (C hen et al, 1990; Benton et al,
1993). Other functions of HLH proteins include regulation of cell proliferation and apoptos is
(Myc/Max) (Morgenbesser et al, 1995; Bissonnette et al, 1994), phospholipid/pigment metabolism (Ino2/Delila) (Zhao et al, 1993 ; Goodrich et al, 1992) and xenobiotic response
(AHR/ARNT) (Hirose et al, 1996; Burbach et al, 1992). HLH proteins are divided into two
broad functiona l groups based upon their tissue distribut ions (Murre et al, 1994, 1992). Class I

HLH proteins, also known as E proteins like E12 and E47, have a ubiquitous expression pattern
and are ca pable of forming either homo- or hetero-dimers. Class II HLH proteins such as MyoD
and NeuroD exhibit a tissue-restricted expression pattern and usually form hetero-dimers wi th
class I HLH proteins. Other classification systems have also been proposed based on the
structural domains or evolutionary relationship (Atchley and Fitch, 1997; Massari and Murre,
2000).

I . Structure and DNA binding activity of HLH proteins
Structurally, all helix-loop-hel ix proteins possess a HLH motif which comprises two highly
conserved helical segments (heli x I and helix 2) of hydrophobic residues separated by a
non-conserved sequence of variable length (the loop). The loop contains a stretch of amino
acids unfavorable for helix formation. The HLH domain is usually adjacent to a short region of
bas ic resid ues that constitute the seq uence-specific DNA binding interface (Ellenberger, 1994).
Therefore, Helix-loop-helix proteins are also referred to as basic helix-loop-helix (bHLH)
proteins.

X-ray structures of many bHLH proteins have confirmed the belief that bHLH

proteins bind DNA as dimers in which the conserved HLH domain mediates dimerization and
the basic region defines the DNA binding sequence (Ferre et al, 1993, 1994; Ma et al , 1994).
The basic region, immediately N-terminal to the first hel ix, consists of a cluster of I 0-20
hydrophilic residues rich in lysine and arginine and binds to the major groove of the DNA in the
X-ray structure.
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The response DNA element recognized by bHLH proteins is usually shon palindromic
sequence CANNTG where N represents any base, most commonl y either CG or GC. CANNTG,
also known as E-box, is found in promoter and enhancer elements that regu late large numbers
of pancreatic-, lymphoid- and muscle-specific genes (linlewood and Evan, 1998). As shown by
X-ray structure, each monomer of the bHLH protein binds one half-site of the E-box.
Oligonucleotides flanking the core E-box sequence also contribute, at least in part, to the
specific interactions between the E-box and bHLH proteins. Although most ofbHLH proteins
are ab le to bind the E-box, there are some exceptions. Some bHLH proteins that have
pra line-containing basic regions have higher affin ity toward another hexamer core sequence,
CACNAG, also known as N-box (Akazawa et al, 1992). AHR-ARNT comp lex, known to
activate xenobiotic gene transcriptions, usually binds to the dioxin response element
TNGCGTG. (Wu and whitlock, 1993; Basci et al, 1995).

2. Transcription regulation by HLH proteins.
After binding to DNA, the HLH protein can either act ivate or repress transcription.
I l Activation of transcription.
A prototypical example of transcription activator is the E protein, including E2A (E47 and El2},
E2-2, and HEB (Henthorn et al, 1990). As described previously, E proteins are ubiquitously
expressed and capable of fanning homo-dimers or hetero-dimers with class II HLH proteins.
Two transactivati on domains, AD I and AD2, have been mapped to the N-terminal regions in

E2A and HEB proteins (Aronheim et al, 1993; Massari et al, 1996). Amino acid substitutions in
conserved hydrophobic residues within these motifs abolish transactivation activity. Removal
of the N-terminal tranactivation domains of E2A abrogates its inducing abi lity on
B-lineage-specific gene expressions in macrophage cells (Kee and Murre, 1998). Recent
reports have demonstrated that transcription coactivators, p300 and/or CBP, interact with E
proteins when bound to DNA (Eckner et al, 1996). The recruitment of p300/CBP is mediated by
either direct interaction (Figure I A) or indirect interaction. (Figure I B). P300/CBP have been
shown to contain histone acetyltransferase (HAT), an enzyme involved in chromatin
modification (Bannister and Kouzarides, 1996).

A
Activation

B

c
Activation

E-box

Figure 1. Models for transcription activation by E proteins

4

More recently, stud ies reports that LDFS, a conserved motif located in th e ADI domain in E
protein, is capable of interacting wi th a nuclear protein complex, termed SAGA (Figu re I C)
(Massari et al, 1999). SAGA has intrinsic HAT act ivity. The components of SAGA are highly
conserved from yeast to mammals. This includes a subset of the TATA bind ing
protein-associated factors (TAFs), the HAT Gcn5, the Ada and Spt proteins, and Tral (Grant et
al, I 998a, I 998b; Ogryzko et al, 1998). Amino acid subst itutio ns of the conserved residues
within A DI domain abo lish the SAGA binding in vitro and transcription activation in vivo
(Massari et al, 1999). Moreove r, AD I lost the transactivition acti vity in yeast strains lacki ng
functional SAGA complex. Both p300/C BP and SAGA co mplex have HAT activities.
Transcription activatio n in eukaryotes is strong ly promoted by histo ne acetylati on. Hence, the
E proteins act ivate transcription through interacting with protein complexes that have HAT
activity.

2) Repression of transcri ption.

Over the last few years, considerable progress has been made toward understanding the
repressive act ivi ti es of Drosoph ila hairy and Enh ancer-of-split proteins (Fisher and Caudy,
1998; Parkhurst, 1998). These proteins co ntain a tand em arrangement of the bHLH domain and
an adjace nt seq uence known as the Orange doma in, so we refer to these proteins as
bHLH-Orange or bHLH-0 proteins. The hairy-related proteins contain proline residue with in
their basic domain and prefer binding to N-box as a homo-dimer or hetero-dimer. Once bound

to DNA , these proteins recruit a co-repressor known as Groucho ( Figure2 A). The interaction
with Groucho is mediated through a 4-amino ac id motif, WRPW (Trp-Arg-Pro-Trp), present at
the C terminus of all hairy-related proteins. A more recent study demonstrates that Groucho can
functionally interact with Rpd3 (Chen, 1999), a hi stone deacetylase (HDAC). This findin g
raises the possible mechanism that Groucho represses the transcription through recruiting
chromatin modification enzyme.

A

Repression

B

No DNA binding

Figure 2. Models for transcription repression by HLH proteins

Another example of negative regulation on transcripti on by HLH protein is dominant negative
effect. Id and emc proteins represent a class of HLH proteins that have distinct structural
features (Benezra et al, 1990; Ellis et al, 1990). These proteins contain a HLH domain but lack
the adjacent basic domain necessary for DNA binding. Heterodimeri zati on wi th these proteins
results in a HLH dimer that is incapable of bind ing to DNA (Figure2 B). Thus far, four Id
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proteins (ldl to ld4) have been identified. All of them share a homologous HLH region and
have similar affinities to various E proteins (Langlands et al, 1997). E proteins play important
roles in cell differentiation and activate transcription through homo or hetero-dimer formation.
Id proteins dimerize with E proteins and attenuate their function as transcription activators. For

example, Id I inhibits muscle differentiation by dimerizing with E 12 protein and prevent it from
forming active myogenic MyoD/E 12 hetero-dimer (Neuhold and Wold, 1993).

3. Dimerization partners are important fo r the functions of HLH proteins
Given the fact that some HLH proteins are active as hetero-dimers, the availability of each
dimerization partner is clearly an important factor in dictating which particular dimer will form.
Although some HLH proteins (like E proteins) are able to form functional homo-dimers, their
activities can be modulated through hetero-dimerization with other partners. Consistent with
this, many HLH proteins show strict spatial and temporal expressions during cell
differentiation. Therefore, patterns of expression of HLH proteins are critical in maintenance of
cell lineages and decision of cell fates.

Myc/Max/Mad proteins give a good example in understanding how HLH proteins exhibit their
biological act ivities through dimerizing with different partners (Figure 3). The Myc family of
proteins has been shown to regulate a wide range of processes, including oncogenic
transformation, apoptosis and cell cycle progression. Previous studies indicate that c-Myc

protein level correlates with cell proliferative state (Evan and Littlewood, 1993). Thus, c-Myc
is always expressed in mature, proliferative cells. Withdrawal of growth factors triggers rapid
and synchronous down-regulation of c-Myc protein level in cells, resulting in growth arrest.
The biological activity of c-Myc is through dimerizing with another bHLH protein, Max
(Amati et al, 1993 ). The Max/Myc dimer binds to classic E-box CACGTG, leading to
transcription activation.

Studies demonstrate that c-Myc interacts with protein complex

involved in chromatin modification. A SWl-SNF chromatin remodeling complex, hSNFS(lni I),
interacts with the bHLH-LZ domain of c-Myc (C heng et al, 1999). TRAPP, related to Tral that
is present in several HAT complexes, interacts with N terminus of c-Myc (McMa hon et al,
1998). These findings suggest that c-Myc activates transcription, at least in part, by recruiting
chromatin remodeling complex. c-Myc has a very short half-life of both mRNA and protein
whe reas Max protein is extremely stable. Max protein level is invariant throughout the cell
cycles. Furthermore, Max can form homo-dimers and bind to the same E-box sequence
CACGTG as Max/Myc heterodimer does. But Max homo-dimer does not show any activities
on transcription regulation in vitro (Kretzner et al , 1992). Taken together, the ratio ofMax/Myc
versus Max/Max is thus critical to determine the Myc activity within cells.

In addition to Myc proteins, four other proteins, Mad I, Mad3, Mad4 and Mxi I, also form
hetero-d imers with Max. These dimers recognize the same E-box CACGTG as Mad/Myc or
Mad/Mad dimer does. Unlike Max/Myc whic h actives transcription, or Max/Max which is

transcription silent, Mad and Mxi I actively repress transcription in reporter assay (Aye r et al,
1993). Mad proteins can directly interact with mammalian homologs of the yeast repressor
Sin3 through the N-terminal Mad repression domain (SID) (Ayer et al, 1995). Sin is identified
as a component of a protein complex that includes nuclear receptor co-repressors, N-CoR and
HDAC (alland et al, 1997). Therefore, Max/Mad represses transcription through interacting
with a protein complex containing HDAC activity. Mad proteins have been shown to exhibit
growth inhibitory activity, wh ich is opposite to Myc's funct ion. Both Mad and Mxi I are able to
suppress co-transformation of rat embryo cells by c-Myc and activate ras alleles (Lahoz et al,
1994; Koskine et al, 1995). Opposite expression panerns of Mad and Myc proteins are
observed in differentiated cells and tissues whe re Max remains relatively constant. All these
data suggest that activity of genes responsible to these bHLH transcription factors can be
simply modulated by changes in the ratio of Myc versus Mad (or Mxi I).
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Figure 3 The Myc network
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DEC/STRA/SHARP helix-loop-helix transcription factors
Human DEC! (differentially expressed in chondrocytes), mouse STRA 13 (stimulated with
retinoi c acid), and rat SHARP2 (split and hairy related protein) represent a structurall y d istinct
class of bHLH proteins and are identified independentl y by three research groups. Shen et al
(1997) identifies Bt2cA MP-inducible gene, DEC! , from primary culture of human embryonic
chondrocytes. Boudjelal et al ( 1997) demonstrates that STRA 13 is induced by stimulation of
embryonal carc inoma cells (P 19) with retin oic acid.

bHLH

Orange

h. DEC2

482

h. DEC!

412

h. HES- I

280
WRPW

D. Hairy

337

D. E(spl)m3

Figure 4. Schematic representation of the structures ofDEC2 and related bHLH proteins.
Percentages indicate amino ac id identity in the bHLH region or the Orange domain betwee n the
respective proteins and DEC2. The number of am ino acids are sho wn on the ri ght. h. human; D.
Drosophila.

Rossner et al ( 1997) identifies SHARP2 in an effon to identify new bHLH proteins in
differentiated rat neurons and find that it is distantly related to Drosophila enhancer-of-split and
hai ry gene family. Human, mouse and rat DEC2 are subsequently identified by Fujimoto et al
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(2001). DEC2 proteins have >90% identity to DECl /STRA 13/SHARP2 in the bHLH regions
and -40% identity in the total proteins (Figure 4).

Protein sequence alignment reveals that DEC/STRA/SHARPs show higher similarities (-40%)
to Drosophila Hai ry and E(spl) as well as the mammalian homologues (e.g., HES) in the bHLH
domain (Figure 4) (Giebel et al, 1997; Poortinga et al, 1998; Fisher et al, 1996). Simi lar to
Hairy/E(spl)/Hes, DEC/STRA/SHARPs contain an orange doma in just C-term inal to the
bHLH domain and a proline residue in the basic region. However, the proline residue is located
2 ami no ac id residues more N-te rminal (Figure 5). Beside bHLH domain and orange domain,

Basic domain
Hesl
Hes2
Hess
E (spl) M3
E(spl)M7
Hairy
Dpn
DECl
DEC2

28
7
10

5
7
25
34
46
48

PKTASEHRKS
VEDAADVRKN
MLSPKEKNRL
MSKTYQYRKV
MSKTYQYRKV
ETPLKSDRRS
GLSKAELRKT
SEDSKETYKL
RDDTKDTYKL

SKPI MEKRRR
LKPLLEKRRR
RKPVVEKMRR
MKPLLERKRR
MKPLLERKRR
NKPI MEKRRR
NKPIMEKRRR
PHRLIEKKRR
PHRLIEKKRR

ARINESLSOL
ARINESLSQL
DRINSSIEQL
ARINKCLDDL
ARINKCLDEL
ARINNCLNEL
ARINHCLNEL
DRINECIAQL
DRINECIAQL

57
36
39
34
36
54
63
75
77

Figure 5. The basic regions of Hairy/E(spl)/Hes proteins and DEC proteins. The basic domains

of representative proteins are aligned. The conserved residues are emphasized in bold type.
Notably, proline residues in DEC proteins are located more N-te rmi nal. The regions of the
basic domains are indicated by residue numbers adjace nt to the sequence.

DEC/STRA/SHARPs do not show similarity to any known proteins; especially, they lack the
C-terminal WRPW motif which is present at all other Hairy/E(spl)/Hes proteins and mediates
transcription repression. These structural differences di stinguish DEC/STRA/SHARPs from

12

other bHLH proteins and indicate that they have distinct biological functions.

I. Transcriptional regu lation mediated by DEC/STRA/SHARPs

Although DEC/STRA/SHARPs lack the WRPW domain which is required for transcription
repression in Hairy/E(sp l)/Hes proteins, they are still found to act as transcription repressors in
different cell systems. STRA 13 is found to repress its own promoter and c-myc promoter
reporter genes (Sun and Taneja, 2000). Both repressions require the c-terminal regio n which
interacts with HDAC-Sin3A co-repressor complex as well as basal transcription factors
TATA-binding protein (TBP), TFllD and TFllB (Boudjelal, 1997). STRA 13 represses its own
promoter through an HDAC-dependent pathway and can be abrogated by trichostatin (TSA), a
speci fi c HDAC inhibitor. c-Myc repress ion by STRA 13 is HDAC-independent and in volves
interaction with basal transcription facto r TFllB. Thus, STRA 13 represses transcription
through either interacting with histone deacetylase or affecting basal transcription machinery.

Most bHLH proteins bind DNA as either hetero- or homo-dimers to E-box. Hairy/E(spl)/Hes
proteins which have proline-contain ing basic regions prefer binding to the N-box. Like
Hairy/E(spl)/Hes, DEC/STRA/SHARPs also contain a proline residue at basic region.
However, several groups demonstrate that DEC/STRA/SHARPs bind to E-Box CACGTG as
homo-dime rs (Zawel et al, 2002; St-Pierre et al, 2002). Whether DEC/STRA/SHARPs bind to
N-box remains to be clarified.

13

2. Expression regulation of DEC/STRA/SHARPs
Both DECl /STRA 13/SHARP2 and DEC2 are shown to be ubiquitously expressed but have
different expression patterns. Many stimuli have been shown to rapidly induce the mRNA
levels of DECl /STRA13/SHARP2 within one hour in different cultured cell systems. These
stimuli include: nerve growth factor (NGF), kainic acid (Rossner et al, 1997), platele-derived
growth factor (PDGF), transforming growth factor-P (TGF-P) (Zawel et al, 2002), parathyroid
hormone (PTH), and cyclic adenosine monophosphate (cAMP) (Shen et al, 200 I, 2002). Most
of these hormones and growth factors modulate proliferation and differentiation via changes of
the intracellular cAMP, a secondary messenger. Furthermore, Teramoto et al (200 I) located two
consensus sequences for the cAMP-responsive element in the promoter reg ion of DEC I gene.
All these findings suggest that DECl /STRAl3/SHARP2 is a direct target ofcAMP in a wide
types of cells. Some other stimuli, like retinoic acid (Boudjelal et al, 1997), TSA and serum
starvation, start to increase DEC I expression at 6 hours and the high level of DEC I is sustained
for more than 24 hours. This data indicated that there might be a different signaling pathway
responsible for DEC I induction.

Another pathway that regulates the transcription of DEC/STRA/SHARP proteins is through
hypoxia-inducible

factor-I

(H IF-1 ),

a

transcription

activator.

The

induction

of

DEC/STRA/SHARP proteins by hypoxia has been demonstrated by many groups (lvanova et al,
200 1; Yun et al, 2002). HIF-1 , usually exists as an hetero-dimerofHIF-lnand HIF-IP, is a key
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player in regulati ng 0 2 homeostasis. Under normoxia, HIF-lc:t interacts with von
Hippel-Lindau tumor suppresso r protein (pYHL) and undergoes proteosome mediated
degradation. Under hypoxia, HIF-1 a becomes stabilized and trans located into nucleus, where it
heterodimerizes with HIF-113 and binds to hypoxia response element (HRE) to in itiate
transc ri ption of target genes. Functional HREs that bind to HI F- l a in electropho retic mobility
shift assay are fo und in the promoter regions of both DEC I and DEC2 (Miyazaki et al, 2002).
Disruption of these HREs abrogates the induction activity of HI F- l c:t in reporter assay.
Moreover, DEC I/STRA 13 is shown to be down-regulated by pYHL (lvanova et al, 200 1). The
increase ofDECI/STRAl 3 mRNA occurs in wild-type MEF cells but not in HIF-la-/- MEF
cells. All these data demonstrate that DECl /STRA 13 is the direct target gene regulated by
HIF-lc:t.

In add ition to transcription regu latio n, STRA 13 is also found to be regul ated by protein
degradation (lvanova et al, 200 I). The yeast two-hybrid screening reveals that human
ubiquitin-conjugating enzyme (UBC9) interacts with the c-terminus of STRA 13 protein.
Co-expression of STRA 13 an d UBC9 increases ubiquitination of STRA 13 and shortens its
half-li fe. Proteasome inhibitor treatment accumu lates STRA 13 and blocks its degradation.
These results suggest that STRA 13 is degradated through ub iquit in-dependent proteasome
pathway.
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Overall, the regulati on of DEC/STRA/SHARP proteins is either through transcription
activat ion by cA MP and HIF- la. or through protein degradation pathway assoc iated with
UBC9/ubiquitin.

3. Biological functions
Although DEC/STRA/SHARP proteins are regulated by hypoxia and some environmental
sti muli, their biological roles are poorly defined. Distin ct tiss ue distribution patterns indicate
that these proteins are important in cell differentiation. In P1 9 em bryonal carcinoma cell lines,
overexpression of STRA 13 results in neuron al differentiation, while wild-type P 19 cells only
undergo mesodermal/endodermal differentiation (Boudjelal et al, 1997). Two rat SHARP
proteins have been shown to play roles in terminal neuronal differentiation and adapti ve
changes to environmental stimuli (Rossner et al, 1997). Human DEC I is found to promote
chondrocyte d ifferen ti ati on both at the earl y and terminal stages (S hen et al, 2002).

In addition to neuronal and chondrocyte differentiation, STRA 13 has been found to regulate
lymphocyte acti vation . STRA 13 is highly expressed in unstimulated, rest ing B cells and is
strongly repressed during B cells act ivatio n as well as a va riety of stimuli that activate B cells
(Seimiya et al, 2002). Forced expression of STRA 13 in B cells delays the cell cycle progression
into S phase. This data suggests that STRA 13 is a negative regul ator of B cell acti vation by
affecti ng cell cycle progression. In contrast, STRA 13 plays a different role in T cell
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development (Sun et al, 200 1). Up-regulation of STRA 13 is found upon activation of CD4+ T
cells. STRA 13 knockout mice exhibit defects in several phases of T cell activation. These
defects include reduced cytockine production like IL-2, IFN-y and IL-4; impaired
differentiation of T cells into effector cells; and ineffective el imination of activated T and B
cells.

More recently, DEC I and DEC2 have been found to function as regu lators of the mammalian
molecular clock (Honma et al, 2002). The circadian rh)'lhms of mammals are regulated by four
clock-gene fam ilies that form a transcription-translation feedback loop. C lock and Bmal I bind
to the E-box elements in the promoter region of Per as a hetero-dimer and activate its
transcription. The Per protein, in turn, acts with Cry protein and represses its own transcription.
Like all these four gene families, DEC! and DEC2 are expressed in the suprechiasmic nucleus
of the hypothalamus in a circadian fashion. Gel mobility shift assay and luciferase assay
demonstrated that DEC I and DEC2 bind to the proximal E-box elements in Per promoter and
strongly repress the transcription of Per. Yeast two-hybr id assay reveals that both DEC I and
DEC2 bind stereo-specifically to Bmal I. Thus, DEC proteins repress the Per transcription
through competition fo r E-box with Clock/Bmal I and/or interaction with Bmal 1.
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STATEMENT OF PURPOSE
The basic hel ix-loop-helix (bHLH) proteins belong to a fami ly of well-characterized transcription factors that are in volved in cell differentiation, xenobiotic response and oncogenesis.

Human DEC, mouse STRA and rat SHARP represent a new and structurall y distinct class of
bHLH proteins. In each species, two related members are identified with sequence identity of
>90% in the bHLH regions and -40% in the total proteins. The bHLH proteins contain two
functional domains: helix-loop-helix (HLH) domain and the adjacent basic domain. The HLH
doma in is responsible for the dimerization whereas the positively charged basic region
mediates

sequence-specific

DNA

binding.

Based

on

the

sequence

al ignment,

DEC/STRA/SHARP proteins closely resemble Drosophila Hairy and E(spl) as well as the
mammalian homologues (e.g. , HES). In addition to the bHLH domain, these proteins contain
an orange domain wh ich is approximate 30 amino acids closer to the C-terminus and is thought
to

mediate

transcription

rep ression.

Beside

bHLH

domain

and

orange

domain,

DEC/STRA/SHARP proteins do not show sim ilarity to any known proteins. Especially, they
lack the C-termi nal WRPW domain which is present at all other Hairy/E(Sp l)/Hes proteins and
recruits the transcription co-repressor Groucho. These structural differences indicate that

DEC/STRA/SHARP may have distinct biological functions and unique mechanisms on
transcription regulation.
In an effort to identify genes that are differentially expressed in colon carcinoma and the
adjacent normal tissue, we performed cDNA subtraction assays and found that DEC I ge ne was
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abundantly expressed in colon carcinoma but not in the adjacent normal tissue. High expression
level of DEC I is not only observed in colon carcinoma tissue, but in many other cancer tissues
as well. Some detrimental conditions, like hypoxia and treatment with cytotoxic stimuli,
markedly induce the expression of DEC I in many cell lines. Cells that lack the functional
tumor suppressor gene VHL (Von Hippel-Lindau) express higher levels of DEC!. All these
observations suggest that DEC I is involved in oncogenesis. However, little is known about the
functions of DEC I in oncogenesis. The studies performed in manuscript I aimed to determine
whether DEC! plays a role in oncogenesis. To test this possibility, stable transfectants were
prepared in which DEC I can be inducibly expressed by tetracycline. These stable transfectants
are used to test the effects of DEC! on proliferation and apo ptosis, two events involved in
oncogenesis. The studies described in manuscript II aim to extend the studies of manuscript I
and to determine the signaling pathways that lead to antagonism of apoptosis.

Transcription regulation by the bHLH proteins is primarily mediated by binding to cis-acting
DNA elements present in the target genes via the basic region in the bHLH sequence. These
DNA elements contain core sequences CANNTG or CANNAG, which are commonly referred
to as E-box or N-box, respectivel y. Generally, praline-containing basic regions have higher
affinity toward the N-box whereas the basic regions without a praline preferentially recognize
the E-box. DEC I contains a praline residue at its basic domain. A recent study shows that
mouse STRA 13 binds to typical E-box sequence CACGTG. DEC I and DEC2 have been shown
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to have different tissue distributions. E-box elements are located in the promoter regions of
both DEC I and DEC2. So we hypothesized that DEC I and DEC2 are mutually regu lated. The
studies performed on manuscript Ill are to determine the molecular actions of DECI on the
transcription regulation of DEC2. To test this, a genomic fragment of the DEC2 promoter
which harbors two proximal E-box elements is inserted into a luciferase reporter. Deletion and
site-d irected substitution mutants of both DEC2 reporters and DEC I constructs are generated
to test the requirement of E-box and structural domains of DEC I on transcription regulation of
DEC2. Electrophoretic mobility sh ift assay is used to test the DNA-protein interact ions.

In general, the studies described in this dissertation establish the oncogenic roles of DEC I and
elucidate the s ignal ing pathway leading to this function . The studies on transcription
regulations mediated by DEC I provide molecular mechanisms that expand our basic
understandings of DEC I functioning as a transcription factor.

20

REFERENCE
Akazawa, C., Sasai , Y., Nakan ishi , S., and Kagemaya, R. (1992) Molecular characterization of
a rat negati ve regulator with a basic helix-loop-helix structure predominantly expressed in the
developing nervous system. J Biol. Chem. 267, 2 1879-2 1885.
Alland L., Muhle R., Hou H., Jr., Potes J., Ch in L., Schreiber-Agus N ., and DePinho R.A. (1997)
Role for N-CoR and histone deacetylase in Sin3-mediated transcript ional repression. Nature
387, 49-55.
Amati B., Brooks M.W., Levy N., Littlewood T.D., Evan G.J., and Land H. ( 1993) Oncogenic
activity of the c-Myc protein requires dimerization with Max. Cell 72, 233-245.
Aronheim A, Shiran R., Rosen A., and Walker M.D. ( 1993) The E2A gene product contains
two separable and functionall y distinct transcription activation domains. Proc. Natl. Acad. Sci.
USA 90, 8063 -8067.
Atchley, W.R., and Fitch, W.M. (1997) A natural classification of the basic helix-loop-heli x
class of transcription factors. Proc. Natl. Acad. Sci. USA 94, 5172-5176.
Ayer D. E., Kretzner L., and Eisenman R.N. ( 1993) Mad: a heterodimeric partner for Max that
antagonizes Myc transcriptional activity. Cell 72, 211-222.
Ayer D.E., Lawrence Q., and Eisenman R.N. ( 1995) Mad-Max transcriptional repression is
mediated by ternary complex format ion with mammalian homologs of yeast repressor Sin3.
Cell 80, 767-776.
Bacsi, S.G., Reisz Porszasz, S., and Hankinson, 0., ( 1995) Orientation of the heterodimeric aryl
hydrocarbon (dioxin) receptor complex on its asy mmetric DNA recognition sequence. Mo/.
Pharmacol. 41, 432-438.
Bannister A., and Kouzarides T. ( 1996) The CBP co-activatior is a histone acetyltransferase.
Nature 384, 641 -643.
Benezra R., Davis R.L., Lockshon D., Turner D.L., and Weintraub H. ( 1990) The protein Id : a
negative regulator of helix-loop-helix DNA binding proteins. Cell 61 , 49-59.
Benton, B.K., Reid, M.S., and Okayama, H. (1993) A sch izosaccharomyces pombe gene that
promotes sexual differentiation encodes a helix-loop-helix protein with homology to myo D.
EMBOJ 12, 135-143.

21

Bissonnette, R.P. , McGahon, A., Mahboubi, A., and Green, D.R. ( 1994) Functional myc-max
heterodimer is required fo r activation-induced apoptosis in T cell hybridomas. J. Exp. Med. 180,
2413-24 18.
Boudjelal , M. , Taneja, R. , Matsubara, S., Bouillet, P. , Dolle, P., and Chambon, P. (1997)
Overexpression of Strat 13 , a novel retinoic acid-inducible gene of the bas ic helix-loop-helix
family, inhibits mesodermal and promotes neuronal differentiation of Pl9 cells. Genes Dev. 11 ,
2052-2065.
Brivanlou A.H., Darnell J.E. (2002) Signal transduction and the control of gene expression.

Science 29S, 8 I 3-8 I 8.
Burbach, K. , Poland, A. , and Bradfield, C.A. (1992) Cloning of the Ah-receptor cDNA reveals
a di stinctive ligand-activated tra nscription factor. Proc. Natl. A cad. Sci. USA 89, 8185-8 I 89.
Caudy, M., Vassin, H., Brand, M., Tuma, R., Jan, L. Y., and Jan. Y.N. (I 988) Daughterless, a
drosophila gene essential for both neurogenesis and sex determination, has sequence
similarities to myc and the achaete-scute complex. Cell SS, 1061-1067.
Chen G, Fernandez J., Mische S., and Courey A. (1999) A functional interaction between the
hi stone deacetylase Rpd3 and the corepresso r Groucho in Drosophila development. Genes Dev.
13, 22 I 8-2230.
Chen Q., Cheng J.T., Tasi L.H. , Schneider N., Buchanan g ., Carroll A., Cri st W. , Ozanne B. ,
Sici liano M.J. , and Baer R. (1990) The tal gene undergoes chromosone trans locatioin in T cell
leukemia and potentially encodes a helix-loop-helix protein . EMBO J. 9, 415-424.
Cheng S. W., Davies K.P., Yung E., Beltran R.J ., Yu J., and Kalpana G V. ( I 999) c-MYC
interacts with INI l/hSNF5 and requires the SWl/SNF complex for transactivation functi on.

Nat. Genet. 22, I 02- I 05.
Eckner R. , Yao T.P., Oldread E., and Livingston D. ( 1996) interaction and functional
col laborat ion ofp300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev.

10, 2478-2490
Ellenberger, T. (I 994) Getting a grip on DNA recognition, stuctures of the bas ic reg ion leucine
zipper, and the basic region helix-loop-helix DNA-binding domains. Curr Opin. Cell. Biol. 4,
12-2 1.

22

Ellis H.M., Spann D.R., and Posakony J.W. (1990) Extramacrochaetae, a negative regu lator of
sensory organ deve lopment in Drosophila, defines a new class of helix-loop-helix proteins.

Ce/1 61, 27-38.
Evan GI. and Littlewood T.D. ( 1993) The role ofc-myc in cell growth. Cu" Opin. Genet. Dev.
3, 44-49.
Ferre D.A., Pognonec P., Roeder R.G. and Burley S.K. ( 1994) Structure and funct ion of the
b/HLH/Z domain of USF. EMBO J. 13, 180-189.
Ferre D.A ., Prendergast G.C., Ziff E.B. and Burley S.K. (1993) Recogn ition by Max of its
cognate DNA through a dimeric b/HLH/Z domain. Nature 363, 38-45 .
Fisher A.L., and Caudy M. ( 1998) Groucho proteins: transcriptional co-repressors for specific
subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes Dev. 12,
1931 -1 940.
Fisher, A.L., Ohsako, S. And Caudy, M. ( 1996) The WRPW motif of the hairy basis
helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and
protein-protein interaction domain. Mo/. Cell. Biol. 16, 2670-2676.
Fujimoto, K., Shen, M., Noshiro, M., Matsu bara, K., Shingu, S., Honda, K., Yoshida, E.,
Suardita, K., Matsuda, Y., and Kato, Y. (200 I ) Molecular cloning and characterization of DEC2,
a new member of basic helix-loop-helix proteins. Biochem. Biophys. Re. Commun s. 280,
164- 17 1.
Giebel, B., and Campos-Ortega, J.A. (1997) Functional dissection of the drosophila enhancer
of split protein, a suppressor of neurogenesis. Proc. Natl. A cad. Sci. USA 94, 6250-6254.
Goodrich, J. , Carpenter, R., and Cohen, E.S. (1992) A common gene regulates pigmentation
pattern in diverse plant species. Ce// 68, 955-964 .
Grant P., Schieltz D., Pray-Grant M., Steger D. , Reese J., Yates Ill , and Workman J. (1998) a
subset of TA Fils are integral components of the SAGA complex reauired for nucleosomal
acetylation and transcription stimulation. Ce/1 94 , 45-53.
Grant P., Schieltz D., Pray-Grant M., Yates 111 , and Workman J. ( 1998) The ATM-re lated
cofactor Tra I is a component of the purified SAGA complex. Mo/. Ce/12, 863-867.
Henthorn P., Kiledjian M., and Kadesch T. (1990) Two distinct transcription factors that bind

23

the immunoglobulin enhancer µE5hcE2 motif. Science 247, 467-470.
Hirose, K., Morita, M., Ema, M., Mimura, J., Hamada, H., Fujii, H., Saijo, Y. , Gotoh, 0.,
Sogawa, K., and Fujii-Kuriyama, Y. (1996) cDNA cloning and tissue-specific expression ofa
novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl
hydrocarbon receptor nuclear translocator (Arnt). Mo/. Cell Biol. 16, 1706-1713.
Honma S. , Kawamoto T., Takagi Y., Fujimoto K., Sato F., Noshiro M., Kato Y., and Honma K.
DEC I and DEC2 are regulators of the mammalian molecular clock. Nature 419, 841-844.
lvanova, A.V., Ivanov, S.V., Danilkovitch-Miagkova, A., and Lerman, M.I. (2001) Regulation
of STRA 13 by the van Hippel-Lindau tumor suppressor protein, hypoxia, and the
UBC9/ubiquitin proteasome degradation pathway. J. Biol. Chem. 276, 15306-15315.
Kee, B., and Murre C. (1998) Induction of early B cell factor (EBF) and multiple Bl ineage
genes by the basic helix-loop-helix transcription factor El2. J. Exp. Med. 188, 699-713.
Koskinen P.J., Ayer D.E., and Eisenman R.N. (1995) Repression ofMyc-Ras cotransformation
by Mad is mediated by multiple protein-protein interactions. Cell. Growth. Diffe' 6, 623-629.
Kretzner L., Blackwood E.M., and Eisenman R.N. (1992) Myc and Max proteins possess
distinct transcriptional activities. Nature 359, 426-429.
Lahoz E.G., Xu L., Schreiber-Agus N., and DePinho R.A. (1994) Suppression of Myc, but not
EI a, transformation acitivity by Max-associated proteins, Mad and Mxi I. Proc. Natl. A cad. Sci.

USA 91, 5503-5507.
Langlands K. , Yin X., Anand G., and Prochownik E.V. (1997) Differential interactioins ofld
proteins with basic-helix-loop-helix transcriptioin factors. J. Biol. Chem. 272, 19785-19793.
Littlewood, T.D., and Evan, G. I. ( 1998) Helix-loop-helix transcription factors, Oxford
University Press, pp 1-48.
Ma P.C.M., Rould M.A., Weintraub H., and Pabo C.0. (1994) Crystal structure ofMyoD bHLH
domain DNA complex: perspectives on DNA recognition and implications for transcriptional
activation. Cell 77, 451-459.
Massari , M. E., and Murre C. (2000) Helix-loop-helix proteins: Regulators of transcription in
eucaryotic organisms. Mo/. Cell. Biol. 20, 429-440.
Massari M., Grant P. , Pray-Grant M., Berger S., Workman J., and Murre C. ( 1999) A conserved

24

motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment
of the SAGA complex. Mo/. Cell 4, 63-73.
Massari M. , Jennings P., and Murre C. ( 1996) The AD I transactivation domain of E2A contains
a highly conserved helix which is required for its activity in both saccharomyces cerevisiae and
mammalian cells. Mo/. Cell. Biol. 16, 121-129.
McMahon S.B. , Van Buskirk H.A. , Dugan K.A., Copeland T.D., and Cole M.D. (1998) The
novel ATM-related protein TRRAP is essential cofactor for the c-Myc and E2F oncoproteins.
Cell 94, 363-374.
Miyazaki K., Kawamoto T., Tanimoto K., Nishiyama M., Honda H., and Kato Y. (2002)
Ident ification of functional hypoxia response elements in the promoter region of the DEC I and
DEC2 genes. J. Biol. Chem. 277, 47014-47021.
Morgenbesser, S.D., Schreiber Agus, N. , Bidder, M., Mahon., K.A., Overbeek, P.A., Horner, J.,
and DePinho, R.A. (1995) Contrasting roles for c-myc and 1-myc in the regulation of cellular
growth and differentiation in vivo. EMBO J. 14, 743-756.
Murre, C., Bain, G., Dijk, M.A. V., Engel, I. , Furnari, B.A ., Massari, M.E., Matthews, J.K.,
Quong, M.W., Rivera, R.R., and Stuiver, M.H. (1994) Structure and function of
helix-loop-helix proteins. Biochim. Biophys. Acta 1218, 129-135.
Murre, C., and Baltimore, D. (1992) The helix-loop-helix motif: structure and function, Cold
Spring Harbor Laboratory Press, Plainview, N.Y.
Neuhold L.A., and Wold b. ( 1993) HLH forced dimers: tethering Myo D to E47 generates a
dominant positive myogenic factor insulated from negative regulation by Id. Cell 74,
1033-1042.
Ogryzko V., Kotani T., Zhang X., Schlitz R., Howard T., Yang X., Howard B., Qin J. , and
Nakatani Y. ( 1998) Histone-like TAFs within the PCAF histone acetylase complex. Cell 87,
953-959.
Parkhurst S.M. (1998) Groucho: making its Marx as a transcriptional co-repressor. Trends
Genet. 14, 130-132.
Pooninga, G., Watanabe, M., and Parkhurst, S.M . (1998) Drosophila CtBP: a hairy-interacting
protein required fo r embryonic segmentation and hairy-mediated transcriptional repression.
EMBO J. 17, 2067-2078.

25

Rossner, M.J ., Dorr, J., Gass, P., Schwab, M.H., and Nave, K.A. (1997) SHARPs: mammalian
enhancer-of-split and hairy-related proteins coupled to neuronal stimulation. Mo/. Cell.

Neurosci. 9, 460-475.
Seimiya M., Bahar R. , Wang Y., Kawamura K. , Tada Y., Okada S., Hatano M., Tokuhisa T.,
Saisho H., Watanabe T., Tagawa M .. , and 0-Wang J. (2002) Clast5/Stral3 is a negati ve
regulatorofB lymphocyte activation. Biochem .. Biophys.. Res .. Commun. . 292, 121-127.
Shen M .. , Kawamoto T., Teramoto M., Makihira S., Fujimoto K., Yan W., Noshiro M. , and
Kato Y. (2001) Induction of basic helix-loop-helix protein DEC! (BHLHB2)/Stra l 3/Sharp2 in
response to the cyclic adenosine monophosphate pathway. Eu' J. Cell. Biol. 80, 329-334.
Shen, M., Kawamoto, T., Yan, W., Nakamasu, K., Tamagami, M., Koyano, Y., Noshiro, M., and

Kato, Y. (1997) Molecular characterization of the novel basic helix-loop-heli x protein DECI
expressed in differentiated human embryo chondrocytes. Biochem .. Biophys .. Res .. Commun. .
236, 294-298.
Shen M., Yoshida E., Yan W., Kawamoto t. , Suardita K., Koyano Y., Fujimoto K. , Noshiro M.,
and Kato Y. (2002) Basic helix-loop-helix protein DEC I promotes chondrocyte differentiation
at the early and terminal stages. J. Biol. Chem. 277, 50112-50120.
St-Pierre B., Flock G., Zacksenhaus E., and Egan S.E. (2002) Stra 13 homodimers repress
transcription through class B E-box elements. J. Biol. Chem. 277, 46544-46551.
Sun H. , Lu B., Li R. , Flavell R.A., and Taneja R. (200 I) Defect ive T cell activation and
autoimmune di sorder in Stra 13-deficient mice. Nat. fmmunol. 2, 1040-1047.
Sun, H ., and Taneja R. (2000) Stra I 3expression is associated with growth arrest and represses
transcription through histone deacetylase (HDAC)-dependent and HDAC-independent
mechan isms. Proc. Natl. Acad. Sci. USA 97, 4058-4063.
Teramoto M, Nakamasu K, Noshiro M, Matsuda Y, Gotoh 0 , Shen M, Tsutsumi S, Kawamoto
T, Iwamoto Y, Kato Y. (2001 ) Gene structure and chromosomal location of a human bHLH
transcriptional factor DECI x Stral3 x SHARP-2/BHLHB2. J. Biochem. (Tokyo) 29, 391-396.
Villares, R., and Cabrera, C.V. (1987) The achaet-scute gene complex of D. Melanogaster:
conserved domains in a subset of genes required for neurogenesis and their homology to myc.

Cell SO, 415-424.

26

Weintraub, H., Davis, R., Tapscon, S., Thayer, M., Krause, M., Benezra, R. Blackwell, T.K.,
Turner, D., Rupp, R., Hollenberg, S., Zhuang, Y., and Lassar, A. ( 1991) The MyoD gene family:
nodal point during specification of the muscle cell lineage. Science 251, 761-766.
Wu, L., and Whitlock, J.P.J. (1993) Mechanism of dioxin action: receptor-enhancer interactions
in intact cells. Nucleic Acids Res. 21, 119-125.
Yun

z.,

Maecker H.L., Johnson R.S., and Giaccia A.J . (2002) Inhibition of PPARy2 gene

expression by the HIF-1-regualted gene DECl /Str13: a mechanism for regu lation of
adipogenesis by hypox ia. Dev. Ce/1 2, 331-341.
Zawel L., Yu J., Torrance C.J ., Markowitz S., Kinzler K. W., Vogelstein B., and Zhou S. (2002)
DEC I is a downstream target of TGF-P with sequence-specific transcriptional repressor
activities. Proc. Natl. Acad. Sci. USA 99, 2848-2853.
Zhao, G.Q., Zhao, Q., Zhou, X., Manei, M.G., and de Crombrugghe, B. ( 1993) TFEC, a basic
helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent
transcription activation. Mo/. Cell Biol. 13, 4505-4512.
Zhuang, Y., Soriano, P., and Weintraub, H. (1994) The helix-loop-helix E2A is required for B
cell fonnation. Ce/179, 875-884.

27

MANUSCRIPT I
DECJ /STRA 13/SHARP2 IS ABUNDANTLY EXPRESSED JN COLON
CARCINOMA, ANTAGONIZES SERUM DEPRIVATION INDUCED APOPTOS IS AND
SELECTIVELY INHIBITS
THE ACTIVATION OF PROCASPASES

ABSTRACT

The basic helix-loop-helix (bHLH) proteins are intimately associated with developmental
events such as cell differentiation and lineage commitment. The HLH domain in the bHLH
motif is responsible for dimerization whereas the basic region mediates DNA binding. Based
on sequence alignment and domain ana lysis, DEC/STRA/SHARPs represent a new class of
bHLH proteins. This report describes the functional characterization of DECI (Qifferentially
i<xpressed in fhondrocytes). Subtractive experiments and blotting ana lyses demonstrated that
DEC I was highly expressed in colon carcinomas but not in the adjacent normal tissues. Several
cell cycle blockers markedly induced DEC I expression.

Stable transfectants with a

tetracycline inducible co nstruct demonstrated that DEC I caused proliferation inhibition,
antagonized serum deprivation-induced apoptosis, and se lectively inhibited the activation of
procaspases.

These

activities

were

highly

correlated

with

the

abundance

of

tetracycline-induced DECI. Stable transfectants expressing a mutant DECJ (lacking the DNA
binding domain) exhibited neither proliferation inhibition nor apoptotic antagonism,
suggesting that DNA binding is required for these actions.
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Enzymatic assays and

immunoblotting analyses demonstrated that induction of DEC! by tetracycline markedly
decreased the activation of procaspase 3, 7, and 9 but not 8. The selecti ve suppress ion on the
acti vation of pro-caspases 3, 7 and 9 over 8 suggests that DEC I-mediated antiapoptosis is
achieved by blocking apoptotic pathways initiated through the mitochondria.

The data

functiona ll y distinguish DEC! from other bHLH proteins and directly link this fac tor to
oncogenesis.
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INTRODUCTION
The basic helix-loop-he lix (bHLH) proteins belong to a family of transcription factors
(Littlewood and Evan, 1998). These proteins are known to play important roles in myogenesis
(MyoD/E47) (Weintraub et al, 1991 ), neurogenesis (NeuroD) (Villares and Cabrera, 1987), cell
proliferation and differentiation (Myc/Max) (Bissonnette et al, 1994), sex detennination
(E 12/Da/ESC) (Cronmiller et al, 1988), regulation of immunoglobu lin genes (TFECffFE3)
(Beckmann et al , 1990), phospholipid metabolism (lno2/Delila) (Nikoloff et al, 1992) and
xenobiotic response (AHR/ARNT) (Hirose et al, 1996). The bHLH proteins are structurally
featured by their bHLH motif(Littlewood and Evan, 1998). The bHLH motif is divided into
two functional domains: the helix-loop-helix (HLH) domain and an adjacent basic region. The
HLH domain, consisting oftwo-amph ipathic CL-helices connected by a nonconserved loop ofa
varying length, is responsible for the dimerization between HLH proteins. The basic region,
just N-terminal to the first helix, consists of a cluster of 10-20 amino acids rich in lysine and
arginine residues and mediates sequence-specific DNA binding (Littlewood and Evan, 1998;
Massari and Murre, 2000; Murre et al, 1994).

Human DEC, mouse STRA and rat SHARP represent a new and structurally distinct class of
bHLH proteins (Boudjelal et al, 1997; Fujimoto et al, 2001; Rossner et al, 1997; Shen et al,
1997). In each species, two related members are identified with a sequence identity of>90% in
the bHLH reg ion and -50% in total. Based on sequence alignment, DEC/STRA/ SHARPs

30

closely resemble Drosophila Hairy and E(spl) as well as the mamma lian homologues (e.g.,
HES) (Fisher et al, 1996; Biebel and Campos-Ortega, 1997; Poortinga et a l, 1998). They share
the highest sequence identity (-40%) in the bHLH domain. The basic reg ion contains a praline
residue usually located in repressive bHLH proteins (Littlewood and Evan, 1998).

Like

Hairy/E(spl)/Hes, DEC/STRA/SHARPs contain an orange domain, wh ich is approximate 30
amino acids away from the second helix of the bHLH motif and is thought to mediate local
repression ofbHLH activators. In contrast to Hairy/E(Spl)/Hes proteins, DEC/STRA/SHARPs
Jack the C-terminal WRPW motif. Through this sequence, Hairy/E(spl)/Hes recruit a
corepressor known as Groucho to the transcription regulatory complex (F isher et al, 1996;
Chen et al, 1999).

Recruitment of Groucho is responsible for a vast array of biological

activities of Hairy/E(spl)/Hes proteins including cellular differentiation and lineage
commitment (Fisher et al, 1996; Chen et al, 1999; Hojo et al, 2000; Ohtsuka et al, 2001).

Lack of the functiona lly important WRPW motif suggests that DEC/STRA/SHARPs have
rather distinct biological functions and do so through different mechanisms. In a cultured cell
system, mouse STRA 13 has been shown to promote neuronal but repress mesodennal and
endodermal differentiation (Boudjelal et al, 1997). NIH 3T3 cells transfected with STRA 13
exhibit a reduction in colony forming numbers compared with cells transfected with an empty
vector (Sun and Taneja, 2000).

Disruption of STRA 13 gene results in defective T cell

activation and the genesis of autoimmune disorders in aging mice (Sun et al, 200 I). Two rat
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SHARP proteins have distinct tissue distributions but both are present in a su bset of mature
neurons and drastica ll y induced by neurotrophins and glutamatergic neurotransmission
(Rossner et al, 1997), suggesting that the rat proteins are involved in the regu lation of terminal
differentiation and in the adapti ve changes to environmental stimuli . Both mouse STRA 13 and
rat SHARP! are shown to cause transcriptional repression (S un and Taneja, 2000;
Garriga-Canul et al, 2001). Human DEC ! is present in a wide range of tissues including some
oftumortissues and tumor-derived cell lines (Fujimoto et al, 200 1; Shen et al, 1997; lvanova et
al, 2001 ; Zawel et al, 2002). Absence of the vo n Hippel-Lindau tumor supp ressor proteins
up-regulates the expression of DEC I gene (lvanova et al, 200 I). These findings suggest that
DEC I has both physiological and oncogenic significance.

Th is report describes the functional characterization of DEC I. Subtractive experiments with
matched samples demonstrate that DEC I is highly expressed in colon carcinomas but not in the
adjacent normal tissues. DEC I expression is markedl y induced by several growth arrest factors.
Stable transfectants demonstrate that DEC I causes a nutrient-dependent proliferation
inhibition, antagonizes serum deprivation-induced apoptos is and selectively inhibits the
activat ion of procaspases. In contrast, stable transfectants expressing a mutant DEC I (lacking
the DNA binding dom ain) show neither proliferation inhibition nor apoptot ic antagonism,
suggesti ng that DNA binding is req uired for these actions.
characteri ze DECJ and directly link this factor to oncogenesis.
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These findings functionally

MATERIALS AND METHODS

Chemicals and supplies
Hydroxyurea, nocodazole and amino acid deficient media were purchased from Sigma. The
goat anti-rabbit-lgG conjugated with alkaline phosphatase or horseradish peroxidase and ECL
substrate were from Pierce.

Substrates for caspases were from Biomol.

Antibodies

recognizing cleaved procaspases were from Cell Signaling. DMEM medium and PCR reagents
were from Gibco. Unless otherwise indicated, all other reagents were purchased from Fisher
Scientific.

A cDNA encoding the full-length DEC I was isolated by a cDNA-trapping method (Hu and Yan,
1999). In order to establish stable transfectants, several DEC I constructs were prepared with
the tetracycline inducible pcDNA4ffO vector.

These constructs included DEC I-sense,

DEC 1-antisense and DEC I-mutant. The constructs were prepared by a PCR-based method
with the DEC I cDNA as the template. The primers used for PCR amplification were extended
to include appropriate endonuclease sites to faci litate cloning. DEC I-sense insert (the entire
coding sequence) was generated with primers S-1 (ccggaattcATCCAGACGCTCCGCTAGTG)
and A-1 (ctgctctagaGCAGGAAGTAGCGAGGAAGG) whereas DECl-antisense insert was
generated with primers S-1 and A-2 (acttaagcttGGTAGGAAGTAGCGAGGAAGG). Primers
A-1 and A-2 contained the same sequence but different endonuclease sites, which enabled the
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PCR-generated fragments to be ligated into the vector in sense or antisense orientation.
DEC I-mutant insert was generated by two steps of PCR. The N-terminal fragment was
generated wi th primers S-1 and A-3 (CTCGTTAATCCGGTCACGCTCCTTGCTCTCGCTCCG) whe reas the C-terminal fragment was generated with primers S-2 (CGGAGCGAGAGCAAGGAGCGTGACCGGATTAACGAG) and A-1. These two fragments were then annealed
through the fusion primers A-3 and S-2, and the missing strands were subsequently filled. The
resultant sequence, lacking the region encoding the DNA binding domain, was then amplified
again wi th primers S-1 and A- 1, and subcloned into the pcDNA4ffO vector. The resultant
constructs were subjected to sequencing analyses.

Tissue co llection and processing

Samples were collected from patients who underwent subtotal colon resection fo r histologically confirm-ed colonic ade nocarcinoma. A total of four samples were co llected. The age of
the patients was between 4 1 and62 with two male and two female. The size of tumors was - 5
cm in diameter and located at the sigmoid or left colon . The degree of differen tiation of tumors
was moderate as determined by patho-logical examination. Samples were freshly processed fo r
RNA isolation and protein extraction. Total RNA was isolated with a Tri-reagent as described
previously (Zhang et a l, 1999).

For the preparation of protein extracts, tissues were

homogenized in lysis buffer (20 mM Tris-HCI, pH 7.4, 1% Triton X-1 00, 1% sodium deoxycholate, 0.1 % SDS, 0.2 mM PMSF and I mM DTT). The homogenates were centri fuged at
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12,000 g for 30 min to remove any insoluble precipitates. As controls, specimens from the
adjacent, grossly normal tissues were sim ilarly processed. Use of human tissues was approved
by the Institutional Review Board.

PCR-select cDNA subtraction
Differential expression of genes between colon carcinomas and the adjacent normal tissues was
studied by PCR-select cDNA subtraction with a PCR-select cDNA kit (Clontech). PolyA(+)
RNA was isolated by two cyc les of oligo(dT)-ce llulose column chromatography. The poly A(+)
RNA from fou r individual cancer tissues was pooled, so was the polyA(+) RNA from the
adjacent normal tissues. First strand cDNA was synthesized with AMY reverse transcriptase
and the second-strand synthesis was completed wit h RNase H and DNA polymerase I. The
collection of cDNAs from both tester (cancer) and driver (normal) was blunted by Rsa I
digestion. The tester cDNAs (tumor tissue) were then divided into two portions, which were
ligated to adaptor I and adapto r 2R, respectively. Tester cDNAs ligated to each adaptor were
separately mixed with the driver cDNAs to remove sequences present in both tumor and normal
tissues. The reactions were then combined to allow remaining single stranded cDNAs to
hybr idize. The hybridized duplexes wi th one strand having adaptor I and the other having
adaptor 2 represented the sequences with a higher abundance in tumor tissue than the adjacent
normal tissues because only the cDNAs from the tumor tissues were ligated to these adaptors.
After fi lling the missing strand of the adaptors, these sequences were amplified by PCR with
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nested primers, which were designed to effectively amplify the hetero-adaptor sequences. The
enriched, different ially expressed sequences were purified and ligated into the pTarget vecto r
(Promega). The resultant clones were isolated and subjected to sequencing analysis.

Subcellular localization of DEC I
Cells (human embryonic kidney 293T) were plated in 35 mm culture dish in DMEM medium
supplemented with I 0% feta l calf serum at a density of 3 x Io' cells per dish. On day 2 when
the cells reached -70% confluence, cells we re transfected with DECI or the corresponding
empty plasmid for 4 hr with Lipofectamine (Gibco). Thereafter, the media were replaced with
fres h media. The transfected cells were cultured for an additional 48 hr. Cells were washed
once with PBS and scraped from the dish in PBS. Cells were pelleted by centrifugation at 3000
g and rapidly resuspended in three pellet volumes of homogenization buffer (JO mM HEPES,
pH 7.9, 1.5 mM MgCI,, 10 mM KCI). The resuspended cells were then subjected to a glass
Dounce homogenizer for ten strokes.

The cytoplasm and nucleus were separated by

centri fugat ion at 3,000 g for 15 min, and the nuclear pellets were resuspended in lys is buffer
(homogenization buffer plus 0.5% Triton-JOO and 0.5% SOS). Cell fractions were analyzed for
DEC I abundance.

Stable transfection
Stable transfection was conducted with T-Rex-293 cell line, wh ich was derived from the human
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embryonic kidney 293 cells. This line had been stably transfected with the pcDNA6ffR
plasmid, which encoded the tetracycline repressor and allowed the inserted sequence to be
inducibly expressed by tetracycline. The T-Rex 293 cells were seeded at 50% confluence and
cultured overnight.

Transfection was conducted with DEC I-sense, DEC 1-antisense or

DEC I-mutant (I µg) for 4 hr by Lipofectamine. Transfected cells were cultured in full media
for 24 hr, then split into fresh media. The split cells were seeded to I 0% confluence and
cu ltured in media containing both Zeocin™ (300 µg/ml) and blasticidin (5 µg/ml) to select
stable transfectants of pcDNA4ffO-DECI and maintain the integration of the pcDNA6ffR
construct, respectively. Positive foc i resistant to both antibiotics were picked up and expanded.
The induced expression of DEC I was determined by Western analyses.

Proliferation assay
Stable transfectants expressing sense, antisense or mutant DEC I were seeded in a 96-well plate
( 12,500/per well) and cu ltured in DMEM media supplemented with fetal bovine serum (0-10%)
in the presence or absence of tetracycline (0-1 µg/ml) . Afte r an incubation at 37°C for 48 hr in a
humidified atmosphere with 5% C0 2, the proliferation rate was determined with the CellTiter
kit (Promega) by measuring formazan formation converted from tetrazolium at 570 nm. The
background value of the seeding cells was also determined and subtracted.

DNA Fragmentation
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Stable transfectants (-80% confluence) were subj ected to apoptotic induction by culturing in
serum-free media in the presence or absence of tetracycline ( I µ g/ml ). After a 48-hr incubation,
cel ls ( I x 106) were collected, washed with PBS and lysed with lys is buffer (5 mM Tris-HCI,
pH 8.0, 20 mM EDTA , 0.5% Triton-100, 0.1% SOS). The high molecular we ight DNA was
removed by centrifugation at 14,000 g for 30 min. The supernatants were then sequential ly
extracted wi th equal vo lu mes of a mi x of phenol :chloroform: isoamyl alcohol (25:24: I) and
chloroform. The soluble DNA was preci pitated with 2.2 vo lumes of ethanol in the presence of
0.5 M NaC l. The DNA was resuspended with TE and treated wit h DNase-free RNase (0. 1
DNA fragmentation was analyzed by agarose

µ g/µ I) for 3 hr at 30°C to remove RNA.

electrophoresis ( 1.5%). Cell lysates were also prepared and analyzed for the expression of
DEC I . In order to quantitati vely specify the degree of DNA fragmentat ion as a function of the
expression levels of DEC I, same experiments (the sense line only) were conducted but various
concentrations (0- 1 ftg/ml) of tetracycli ne were added to proportionally increase the induction
of DEC I.

Caspase acti vity
Caspase

activities

were

determined

wi th

colorimetric substrates.

Ac-DEVD-pNA,

Ac-IETD-pNA and Ac-LEHD-pNA were used for caspase 317, 8 and 9, respective ly. Stable
transfectants were seeded at a --60% confluence in 6-we ll plates. After cells reached - 80%
con fluence, the media were replaced with serum-free media and cultured in the presence or
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absence of tetracyc line(! µg/ml ) for 48 hr. Cells were then harvested, washed with PBS and
Jysed on ice for 30 min in lysis buffer ( I 00 µI/per well). The Jys is buffer contained I 0 mM
Tris-HCI, pH 8.0, I 0 mM EDTA , 0.5% Triton X- I 00, 0. I mM PMSF, I mM OTT, pepstatin ( I 0
µg/m l} and leupeptin (I 0 µg/ml). The lysates were then subjected to centrifugation at I 0,000 g
for I min at 4°C. To determine caspase activity, JOO µ I supernatant (I mg/ml) was mixed with
I 00 µI reaction buffer [20 mM Tris-HCI, pH 7.4, 4 mM EDTA, 0.2% CHAPS, 0. 1 mM PMSF,
I mM OTT, pepstatin ( I 0 µ g/ml) and leupeptin ( 10 µ g/ml)). To the mix, co lorimetric substrate
was added at a final concentration of200 µM. After a 2-hr incubati on at 37°C, the amount of
released p-nitroanilide was determined by measuring the abso rbance at 4 10 nm, and the relative
activity was calculated.

Nort hern and Western analyses were conducted as described previously (Zhu et al, 2000; Yan et
al, 1995). Preparation of an antibody against a peptide (CSQALKPIPPLNLETKD) derived
from DEC I was described elsewhere (Zhu et al, 1999). Protein concentrat ion was determined
with BCA assay (Pierce).

Data are presented as mean ± SD of at least three separate

experiments, except where results of blots are shown in which case a representative experiment

is depicted in the figures. Comparisons between two values are made with Student's t test at a
va lue of P < 0.05.
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RESULTS
Molecular cloning and tumor-related expression of DEC I
In an effort to identify genes that are differentia lly expressed between colon carcinomas and the
adjacent normal tissues, we performed cDNA subtractive experi men ts. Four matched samples
were used. One of the genes identified encoded a bHLH protein. A full-length cDNA encoding
this protein was isolated from a liver library by a cDNA-trapping procedure as described
previously (Hu and Yan, 1999). The cDNA was 3,361 nucleotides long inc luding a 179-bp
polyA tail. A lign ment analysis revealed that this cDNA had a 98% sequence identity with
DEC 1, a gene that was identified from differentiated embryo chond rocytes (Shen et al, 1997).
Most of the nucleotide substitutions were in the 3' non-translation region, and none of the
substitutions in the coding region caused amino acid substitut ions.

We next exam ined the abundance of DEC I in colon carcinomas and the adjacent no rmal tissues
by Northern and Western analyses. As shown in Figure 1-1 A, without exception, DEC 1 gene
was expressed abundant ly in the colon adenocarcinomas, but on ly little or very low levels of
DEC I mRNA were detected in the adjacent normal tissues (>20 folds based on densitometrical
analys is). Consistent with the mRNA data, DEC I protein was detected only in the cancerous
but not in the adjacent normal tissues. As a contro l for specificity of the antibody, transfection
experiments were conducted. Cytoplasm ic and nuclear fractions were prepa red from cells
transfected with DEC 1 or the corresponding empty SPORT plasmid. As shown in Figure 1-1 B,
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Figure 1-1. Expression ofDECl in colon carcinoma and the adjacent normal tissues
Total RNA (I 0 µg) from colon carcinoma and the adjacent normal tissues was subjected to
agarose electrophoresis and transferred to a Nytran nylon membrane. The blots were detected
with

32

P labeled probes from cDNA encoding DECI. To normalize the abundance of 28S

rRNA , the same membrane was reprobed with a [32 P]ATP labeled oligonucleotide hybridizing
28S rRNA. For Western blotting analysis, homogenates (I 0 µg) from colon adenocarcinoma
and the adjace nt tissues were subjected to SOS-PAGE. The immunoblot was incubated with
the antibody against DEC I.

The primary antibody was then located by alkaline

phosphatase-conjugated goat anti-rabbit IgG. (8) Specificity of the prepared antibody. The
plasmids harboring the DEC! cDNA (transfected) or no insert (control) were used to transfect
293T cells and the subcellular fractions were prepared as described in the Materials and
Methods.

The fractions (5 µg) were subjected to SOS-PAGE and analyzed for DEC I

expression (Right).
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this antibody detected a protein with a molecu lar weight of - 52 kDa, which is consistent with
the cDNA-based calculated molecular weight. This protein was present only in the nuclear
fraction of the DEC I transfected cells (transfected) not in the empty vector-transfected cells
(contro l), suggesting that this antibody is highly specific and DEC I is a nuclear protein (Figu re
1-28).

Effects of cell confluence and cycle blockers on DEC I expression
Given the fact that DEC I is abundantly expressed in tumor but not in the adjacent normal
tissues, its expression is likel y linked to cell proliferation state and cycle progression. In order
to test this possibility, the expression of DEC I was first studied as a function of cell confluence.
OLD cells, a colon carcinoma-derived cell line, were seeded in a 12-well cu lture plate at
various densities (1-8 x 10'). On day 3 whe n we lls with the top three seeding densities we re
confluent or post-confluent, cells we re harvested. At this time, the cells at the two lowest
seeding densities were still rap idly proliferating. Total RNA and cell lysates were prepared and
ana lyzed for the expression of DEC I. As shown in Figure 1-2A, confluent and post-confluent
cells (seeded at hi gher densities) expressed high levels of DEC I, whereas cells in proliferative
states (seeded at lower densities) expressed little DEC I. It should be emphasized that the same
amount ( I 0 µg) of total protein was used for each sample. Consistent with the protein data,
DEC I mRNA levels were drastically elevated in the confluent and post-confluent cells.
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Figure 1-2. Regulation of DECI expression by cell cycle blockers
The abundance of DECI mRNA and proteins was determined by Northern and Western
analyses with JO µg of total RNA and JO µg of cell lysates, respectively. (A) Expression of
DEC I as a function of cell confluence. OLD cells were seeded in a 12-well culture plate at
various densities ( J-8 x JO'). On day 3, total RNA and lysates were prepared and analyzed for
the expression of DEC I. (B) Effects of cell cycle blockers on DEC I expression. Cells were
seeded at a 30% con.fluence. After a 12-hr incubation, media were replaced with cycle block
media (Go block, 0.1 % serum; 0 1 block, amino acid deficient media; S block, 3 mM
hydroxyurea; and 0 2 block, 500 ng/ml nocodazole). After a 30 hr-incubation, lysates were
prepared and analyzed for DEC! expression. (C) Time course ofhydroxyurea and nocodazole
on DEC I expression. Cells were treated as described in section B and harvested al indicated
times, and lysates were analyzed by Western blot. Data are presented as representative results
obtained in al least three independent experiments.
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Confluent and post-confluent cells tend to have better cell-cell contact and usually undergo
growth arrest with less number of cells continuing cycle progression.

Therefore,

confluence-induced expression of DEC! is likely due to cell contact, growth arrest or both. In
order to test these possibilities, cells were cultured at subconfluence in the presence of cell

cycle blockers. For 0 0 block, cells were cultured in normal growth media but supplemented
with only 0.1% serum. For 0 1 block, cells were cultured in amino acid deficient media (no
methionine and isoleucine).
containing hydroxyurea.

For S block, cells were cultured in nonnal growth media

For G2 block, cells were cultured in nom1a l growth medium

containing nocodazole. Cells were cultured in the cycle block media for 30 hr, and lysates (10
µg of total protein) were prepared and analyzed for the levels of DEC I. As shown in Figure
1-28, both hydroxyurea and nocodazole were shown to markedly induce DEC!. TI1e time
course study showed that the induction was observed as early as 6 hr after treatment (Figure
1-2C) and reached the maximum 30 hr after treatment.

It should be noted that similar

experiments were conducted with T-Rex 293 cells. These cells expressed markedly lower
levels of DEC! and the induction was not evident (data not shown).

Cell growth rate as a function of DEC I expression
The cell cycle arrest-related expression of DEC! suggests that this protein slows cell cycle
progress, thus, has proliferation-inhibitory effects. In order to test this possibility, constructs
DEC I-sense, DEC 1-antisense or DEC I-mutant (Figure 1-3A) was used to stably transfect
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Figure 1-3. Establishment of DEC! stable transfectants
(A) Diagrammatic presentation of constructs encoding sense, antisense and mutant DEC!. (B)
Tetracycline induced expression of DEC! in stable transfectants. The transfected cells were
cultured in the presence or absence of tetracycline (Tet, I µg/ml) for 24 hr, and lysates were
analyzed for the abundance of DEC I (5 µg protein). (C) Concentration-dependent induction of
DEC! by tetracycline. Stable transfectant expressing the sense DEC! was cultured in media
containing tetracycline (0- 1 µg/ml) for 24 hr. DEC I induction was analyzed as described in
section B. The Figure shows representative results.
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T-Rex 293 cells, which allowed the inserted gene to be inducibly regulated by tetracycline. As
shown in Figure 1-38, addition of tetracycline caused a robust expression of the sense and

mutant DEC!.

The mutant, lacking the DNA binding domain, had a slightly faster

electrophoretic mobility.

No DEC! was detected in cells transfected with the antisense

construct whether or not tetracycline was added to the media. In addition, the induction by
tetracycline occurred in a concentration-dependent manner (Figure 1-3C).

In order to detem1ine the effects of DEC I on cell proliferation, the stable transfectants

expressing sense, antisense or mutant DEC I were cultured in the presence or absence of
tetracycline. After a 48 hr-incubation, the proliferation rate was determined. As shown in

Figure l-4A, the sense but not the antisense or mutant lines exhibited a significant proliferation
inhibition.

Such an inhibitory effect was correlated well with the amount of semm

supplemented in the media (Figure 1-48). The serum-related inhibition was more evident in
cells seeded at higher densities (data not shown). Furthennore, the inhibition activity was
correlated well with the abundance of induced DEC! (Figure 1-4C).

DEC I antagonizes apoptosis during serum-deprivation
In some cases, highly proliferative cells tend to be susceptible to detrimental conditions
whereas the opposite is tme with quiescent or slow proliferative cells. In order to test whether
DEC I was antiapoptotic, DEC! stable transfectants were cultured in serum-free media. After a
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Figure 1-4. Effects of DEC ! on cell proliferation
Stable transfectants were plated in 96-well plates ( 12,500/well) and cultured in the presence or
absence of tetracycli ne (Tet, I µg/ml) for 48 hr. The proliferation rate was detennined with a
Cel!Titer kit by measuring the absorbance at 570 nm (Promega). To precisely reflect the

proliferation rate, control plates were seeded as same as experiment plates but the absorbance
was detennined 4 hr after seeding. Data are expressed by subtracting the absorbance from the
control plates. (A) Proliferation rate of sense, antisense and mutant lines cultured with or
without tetracycline (I µg/m l). (B) Proliferation rate as a function of serum concentrations. (C)
Proliferation rate as a function of tetracycline concentrations. Results were obtained in at least
three independent experiments.
tetracycline.

*Significantly different from cells cultured without
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48-hr incubation, the morphological changes were studied microscopically. When cultured in
the presence of tetracycline, the sense line displayed an appearance of normal cells (Figure
I-SA , top left). However, the same line, when cultured without tetracycline, underwent rapidly

apoptotic changes including condensed nuclei, blebbing of plasma membrane, decreased cell
size and fom1ation of aggregates (Figure I-SA, top right).

In contrast, the mutant line

underwent apoptotic changes whether or not tetracycline was added to the media (Figure I-SA,
middle). Similarly to the mutant line, tl1e antisense line underwent a cell dying process (Figure
I-SA bottom). Jn contrast to the apoptotic appearance seen with the mutant line, the changes of
the antisense line were associated by excess granule deposit, enlarged cell body, shrank cell
processes and lack of clear cell border. ln addition, the contact among the processes between
two cells was markedly reduced compared with the sense line cultured in the presence of
tetracycline (Figure I-SA).
In order to link the morphological changes to DNA fragmentation, another hall-marker for cell

apoptosis, stable transfectants were subjected to serum deprivation in the presence or absence
of tetracycline. After a 48-hr incubation, soluble DNA was isolated and analyzed by agarose
gel electrophoresis. As shown in Figure 1-S8, no DNA laddering was detected in the sense line
when cultured in the presence of tetracycline. In contrast, the antisense and mutant lines or the

sense line cultured without tetracycline had extensive DNA ladders. DNA laddering in the
sense line was inversely correlated with the abundance of tetracycline-induced DEC I (Figure
l-S8).

so

(

Figure 1-5. Antagonistic effects of DEC J on serum deprivation-induced cytotoxicity
(A) Morphological assessment of DECl-mediated protection against serum deprivation.
Stable transfectants expressing sense, antisense or mutant DEC I were plated at -40%
confluence and grown in full-media in the presence or absence of tetracycline (Tel, I µg/ml).
After a 12 hr-incubation, the cells were then cultured in serum free media (tetracycline was kept
the same). After a 48 hr-incubation, morphological changes were assessed (100 x). (B) Effects
of DEC! on DNA fragmentation in serum-deprivation induced apoptosis. Stable transfectanls
were grown in full-media in the presence or absence of I µg/ml tetracycline until reachi ng
-80% confluence. The media were then replaced by serum free media (tetracycline was kept
the same). After a 48 hr-incubation, DNA fragmentation was analyzed by agarose
electrophoresis (1.5%). Cell lysates (5 µg) were also prepared from the same cells and
analyzed for the expression of DEC I.
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Selective inhibition of DEC I on the activation of procaspases-317. 8 and 9
Caspases are a group of cycteinyl aspartate-specific proteases that are known lo be activated
during apoptotic process (Cryns and Yuan, 1998; Luscher and Eisenman, 1990). Next we
examined whether expression of DEC I caused changes on the activity of caspases-3/7, 8 and 9.
Stable transfectants underwent serum deprivation in the presence or absence of tetracycline.

Cell lysates were prepared and assayed for the activity of caspases-3/7, 8 and 9. As shown in
Figure l-6A, when cultured in the presence of tetracycline, the sense line showed a marked
decrease on the activity of caspases-3/7 and 9 but not 8. The decrease on caspase-3/7 activity
was more profound than that on caspase-9.

In both cases, the decreases were inversely

correlated with the abundance of induced DEC!. In contrast, the antisense and mutant lines
exhibited little changes on the caspase activity whether or not tetracycline was added (data
shown only on caspase-3/7) (Figure 1-6B).

Although caspases show a preference for peptidyl substrates, they are not very specific. In
order to further establish the selectivity of DEC! on the activation of several procaspases,
immunoblotting analyses were performed with antibodies specific to cleaved procaspase 3, 7, 8
or 9. As shown in Figure 1-6C, when cultured in the presence of tetracycline, the sense line
showed a marked decrease on the levels of cleaved procaspases3, 7 and 9. In contrast, little
changes were detected on the levels of cleaved procaspase 8. These results are consistent with
the data from enzymatic assays (Figure 1-6A) and provide further evidence that DEC!
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Figure 1-6.

Effects of DEC J on the activity and protein levels of caspases-317,

8 and 9
Stable transfectants were cultured in full media in the presence or absence of tetracycline (0- 1
µg/ml) overnight and then subjected to serum deprivation for 48 hr. Lysates were prepared and
assayed for caspase activity or immunoblotting analyses. (A) The dependence of suppressed
activation ofprocaspases-317, 8 and 9 on the induced DECI in the sense line (the activity was
recorded as a percentage oftliat when cells were cultured without tetracycline). (B) Relative
activity of caspase-3/7 in stable transfectants expressing sense, antisense or mutant line upon

serum deprivation. (C) Re lative abundance of caspase 3, 7, 8 and 9. Lysates (50 µg) from the
stable transfected sense line cultured in the absence or presence of tetracycline (I µg/ml) during
semm starvation were analyzed by Western blotting with antibodies specific to cleaved
procaspase 3, 7, 8 or 9. The blots were developed by chemiluminescent substrate.
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selectively suppresses the activation of procaspases.

The selective suppression on the

activation of pro-caspases 3, 7 and 9 over 8 suggests that DECl-mediated antiapoptosis is
achieved by blocking apoptotic pathways initiated through the mitochondria although the
precise mechanism remains to be detennined.

It should be noted that little changes were

observed on the expression levels of all four procaspases (inactive fonns) whether or not
tetracycline was added (data not shown).
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DISCUSSION

Human DEC proteins, along with mouse STRA and rat SHARP, represent a new class ofbHLH
transcription factors (Boudjelal et al, 1997; Fujimoto et al , 2001; Rossner et al, 1997; Shen et al ,
1997). This report describes the functional characterization of DEC I. Subtractive experiments
with matched samples, followed by Northern and Western analyses, demonstrate that DEC! is
highly expressed in the tumor but not in the adjacent nonnaJ tissues. DEC I expression is
markedly induced by several growth arrest factors. DEC! causes a nutrient-dependent
proliferation inhibition, antagonizes serum deprivation-induced apoptosis and selectively

inhibits the activation ofprocaspases. Stable transfectants expressing a mutant DEC! (lacking
the DNA binding domain) show neither proliferation inhibition nor apoptotic antagonism,
suggesting that DNA binding is required for these actions. These findings functionally
characterize DEC! and directly link this factor to oncogenesis.

The proliferation inhibition and anti-apoptosis distinguish DEC! from other bHLH proteins,
particularly those that have oncogenic significance. The myc oncoproteins exhibit intrinsically
growth-promoting activity (Luscher and Eisenman, 1990; Packham and Cleveland, 1995).
Experimentally enforced c-myc expression inhibits differentiation and induces cell

proliferation. lnstead of suppressing apoptosis, overexpression ofmyc proteins induces it (Penn
et al, 1990). The TALI protein, while absence in normal adult T lymphocytes, is constitutively
expressed in >60% of T-cell acute lymphoblastic leukemia. In contrast to DEC!, ectopic
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expression of TALI promotes cell proliferation and facilitates p53-mediated apoptosis
(Condorelli et al, 1997). Twist, another bHLH protein involved in developing oncogenic
phenotypes, promotes both proliferation and survival (Maestro et al, 1999).

ID proteins,

lacking the DNA binding domain, heterodimerize with many other bHLH proteins, therefore,
act as dominant negative regulators and have a broad spectrum of biological activities (Norton,
2000).

Similar to myc protein, fD proteins are proliferation-promoting and pro-apoptotic

(Norton, 2000; Kim et al, 1999; Wice and Dordon, 1998).

The proliferation inhibition and antiapoptosis by DEC! are likely to be active events through
direct DNA binding. In this report, we demonstrate that only the sense but not the mutant line
showed proliferation inhibition and antiapoptotic effect. The inability of the mutant to confer
both activities was unlikely due to the lack of appropriate localization in the nucleus. Studies
with del etion mutants located the nuclear targeting sequence of DEC I in the C-tem1inal region
rather than the N-terminus where the bHLH motif is present (lvanova et al, 2001). In addition,
the mutant line was shown to repress E47-mediated transcription activity toward an E-box

reporter in a tetracycline-dependent manner (data not shown), suggesting that the mutant line
produced biologically active proteins. Consistent witl1 these observations, previous study with
mouse STRA 13 has shown that the middle section of this protein has transcription repressive
activity (Boudjelal et al, 1997). The repressive activities of STRA 13 are achieved through
recmiting co-repressor HDAC l or interacting with basal transcription factor TFlfB (Sun and
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Taneja, 2000). These findings suggest that DECI exerts its biological activities through
DNA-binding dependent and independent mechanisms. It should be emphasized that STRA 13
and DECI share the DNA binding domain, however, mouse STRAl3, purified or nuclear
extracts from STRA 13-transfected cells, has no binding activity toward any known consensus
N- or E-box sequences (Boudjelal et al, 1997) whereas a OST fusion protein containing the
N-terminal 122 residues of DECI is recently report to bind to E-box and related to sequence
(Zawel et al, 2002).

Proliferation inhibition by DEC I is consistent with the observations that DECI gene is
up-regulated by agents that cause growth arrest. However, some cycle blockers show only
minimal effects on DECI induction. For example, deficient medium exhibited potent inhibitory
activities on cell proliferation but little changes on the levels of DEC! were detected (Figure
1-2B). Agents with a similar cycle block activity show differential effects on DEC I induction.
For example, cAMP, hypoxia and amino acid deficient media are all known to arrest cells at GI
and delay G l/S transition. Only the first two factors were shown to drastically induce DEC I
(Ivanova et al, 2001; Shen et al, 2001 , Figure l-2B). Generally a sustained induction by cAMP,
hydroxyurea and nocodazole was observed as early as 6 hr after treatment (Shen et al , 2001,
Figure 1-2). Cycle synchronization normally takes - 24 hr. Such a rapid induction of DEC I by
cycle blockers suggests that the induction of DEC I is not due to cycle arrest rather than a prior
change to such an event. This notion is supported by the fact that DEC I acts as suppressor on
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cell proliferation (Figure 1-4). It should be noted that induction of DEC! likely provides a
cytoprotective role as confluent cells usually experience nutrient depletion and cell cycle
blockers are generally cytotoxic.

Antiapoptotic activity of DEC I links directly tl1is factor to oncogenesis although it is
physiologically important as well. DEC I is expressed in a wide range of adult tissues and rat
SHARPs exhibit an onset of expression as early as the end of embryonic development (E20),
suggesting that DEC/STRA/SHAR.Ps play a physiological role. In this report, we demonstrate
that DEC I was abundantly expressed in colon carcinoma but not in the adjacent nonnal tissues,
suggesting that deregulated expression of DEC! is responsible for its oncogenic potential.
DEC I -mediated antiapoptotic action against serum deprivation is particularly relevant to tl1e
survival of tumors. Many cancer tissues particularly solid tumors are poorly vascularized,

which resembles the condition of serum starvation (Naek et al, 2000; Vaupel et al, 2001; Yu et
al, 2001). Poor vascularization leads to hypoxia, and survival of hypoxia is an important
mechanism of tumor expansion. Interestingly hypoxia drasticall y induces the expression of
DEC! and the induction is abolished by van Hippel-Lindau tumor-suppressor protein (lvanova
et al, 2001), a factor that regulates activity of the hypoxia-inducible factor (HIF-1). The HIF-1
deficient tumors, altl10ugh reduced vascularization, exhibit a higher expansion rate than HfF-1
expressing tumors (Naek et al, 2000; Vaupel et al, 2001 ; Yu et al, 2001 ). However, it remains to
be established whether HLF-1 deficient tumors express high levels of DEC! and whether DEC!
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expression is a contributing factor to the faster expansion of HIF-1 deficient tumors.

It is interesting to notice that the stable transfectant expressing antisense DEC I was
morphologically different from the mutant line upon semm starvation (Figure I-SA). Instead
of classical apoptotic changes such as decreased cell size, the antisense line maintained the
overall shape of the cells. DNA fragmentation displayed similar changes between mutant and
antisense lines (Figure 1-5), suggesting tliat these cells undergo apoptosis to a comparable
extent. The morphological difference, however, was likely due to the difference on the levels
of endogenous DEC 1. No endogenous expression of DEC 1 was detected under the conditions

employed, and the effectiveness of antisense sequence on blocking the endogenous expression,
therefore, remains to be established.

However, it is conceivable that the antisense line

expressed less endogenous DEC 1 than the sense or mutant line. It should be pointed out that the
inserted DEC 1 sequence was inducibly regulated by tetracycline, but the absence of this
antibiotic did not completely eliminate constitutive expression of the transgene. Therefore, the

endogenous DECI expression in the antisense line, even cultured in the absence of tetracycline,
was likely to be suppressed. We tested several lines for each type of stably transfected cells and
same results were consistently obtained, excluding the possibility that the difference in the
location of the transgene inserted in the genome was responsible for the morphological
difference upon apoptotic induction.
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In conclusion, we demonstrate that DECI causes proliferation inhibition, antagonizes
apoptosis induced by serum deprivation, and selectively inhibits the activation ofprocaspases 3,

7, 8 and 9. These activities are highly correlated with the abundance of tetracycline-induced
DEC!. Both proliferation inhibition and antiapoptotic effect require the presence of the DNA
binding domain. DECI is present in a wide range of adult tissues, and we demonstrate that this
gene is abundantly expressed in colon carcinoma but not in the adjacent nonnal tissues. These

findings together suggest that DEC I is physiologically important and plays an oncogenic role
when its expression is ectopic and deregulated. DEC/STRNSHARPs are structurally distinct
bHLH proteins. The data presented in this report functionally distinguish them from other
bHLH proteins as well.
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MANUSCRIPT II

THE EXPRESS ION OF ANTIAPOPTOTIC PROTEIN SURYIVIN IS
TRANSCRIPTIONALLY UPREGULATED BY DECI PRIMARILY THROUGH
MULTIPLE SP I BINDING SITES IN THE PROXIMAL PROMOTER

1

ABSTRACT

Human DEC, mouse STRA and rat SHARP proteins constitute a new and structurally distinct
class of the basic helix-loop-helix (bHLH) proteins. DEC! is abundantly expressed in tumors
and protects against apoptosis accompanied by decreased caspase activities. In tl1is study, we
report that DEC! transcriptionally upregulates the expression of survivin, an antiapoptotic
protein that interferes with the processing and catalysis of caspases.

In paired tumor-nom1al

tissues, survivin and DEC! exhibited a paralleled expression pattern. Tetracycline-induced
expression of transfected DEC! caused proportional increases on the levels of survivin. In
co-transfection assays, DEC! activated a survivin promoter reporter (5-fold) but repressed a
DEC2 promoter reporter (>90%). In contrast to the repression, the activation was delayed and
varied depending on serum concentrations and cycle blockers. In addition, the C-tem1inal 65

residues were required to maximize the activation but not repression. Studies with deletion and
substituted mutants located, in the proximal promoter, two Sp I sites that supported the
DEC I-mediated activity. Both DECI and Sp! were involved in the binding of these Sp! sites.
DEC! has been implicated in oncogenic process and is generally considered to be
transcriptionally repressive. The established activation of the survivin promoter provides a
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molecular explanation for its oncogenic involvement and represents the first example that

DEC I and other members in this class can act as transcription activators depending on the
genomic context of a target gene.
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INTRODUCTION

Human DEC, mouse STRA and rat SHARP constitute a new and structurall y distinct class of
bHLH proteins (Shen et al., 1997; Rossner et al., 1997; Boudjelal et al., 1997). In each species,
two members are identified with a sequence identity of >90% in the bHLl-1 region and -40% in
total proteins, respectively. These transcription factors are involved in various cellular events

such as cell proliferation, differentiation (Boudjelal et al., 1997; Sun and Taneja, 2000),
maturation of lymphocytes (Sun et al., 2001), regulation of molecular clock (Honma et al.,
2002) and lipid metabolism (Yun et al., 2002).

Transfection with DEC I causes marked

decreases in cell proliferation, and the decreased proliferation is proportionally correlated with
the levels of DEC! (Li et al., 2003). Chondrogenic cells expressing high levels of DEC!
undergo rapid phenotypic changes toward terminal differentiation in response to mitogenic

stimuli (Shen et al., 2002). Consistent with the promotion of chondrocyte differentiation,
STRA 13 promotes neuronal but represses mesodermal and endodennal differentiation
(Boudjelal et al., 1997), and Sl-IARPs are abundantly expressed in a subset of mature neurons
(Rossner et al. , 1997). STRA 13 deficient mice, although surviving to adu lthood, develop
autoinunune diseases accompanied by accumulation of spontaneously activated T and B cells

(Sun et al., 2001). Furthem10re, the mouse proteins are found to interact directly with clock
Bmall protein and regulate the expression of biological clock regulator Per (Honma et al.,
2002).
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Another notable characteristic of DEC/STRA/SHARPs is that their expression is rapid ly
induced in response to various types of detrimental stimuli.

ln rats that undergo seizure

induction by kainic acid, the levels of mRNA encoding SHARP I or 2 are sharply elevated
witl1in I h (Rossner et al., 1997). Similarly, the expression of DEC! is rapid ly increased in
response to hypoxia, a condition that close ly mimics the microenvironment of tumors

(Miyazaki et al., 2002; lvanova et al., 2001). These findings link these transcription factors,
particularly their elevated expression, to oncogenesis. Several lines of evidence support this
possibility. First, expression of DEC! appears to be deregulated in several tumor tissues. In
paired samples from the colon, lung and kidney, DEC ! is abunda ntl y expressed in the carcinomas but not in the adjacent nom1al tissues (Li et al., 2003). High levels of DEC I mRNA
are also detected in an array of cancer cell lines from a wide range of organs (Ivanova et al.,
2001). Cells that lack the functional tumor suppressor VHL (von Hippel-Lindau) express
higher levels of DEC! (Ivanova et al., 2001). Second, DECI is antiapoptotic apparently
through reducing caspase activities (Li et al., 2002). Forced expression of DEC I effectively
antagon izes apoptosis induced by serum starvation and causes a marked decrease on the

activi ty ofcaspases-3/7 and 9 but not 8. In addition, a DEC! mutant, lacking the DNA binding
domain, shows neither antiapoptotic activity nor inhibitory effects on caspases (Li et al., 2002).

Caspases are cycteinyl aspartate-specific proteases and exist in normal cells as inactive forms,
so called procaspases (Cryns and Yuan, 1998; Budihardjo et al., 1999). Upon apoptotic stimuli,
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procaspases undergo proteolytic processing in a cascading activation manner, which resu lts in
the forn1ation of active caspases. There are two major activation pathways: the cell surface

death receptor pathway and the mitochondrial patl1way (Budihardjo et al., 1999). For example,
binding ofFasL to its receptor results in the formation of the death-inducing signaling complex,
which recruits and subsequent ly activates the upstream procaspase such as procaspase-8

(Ashkenazi and Dixit, I999).

ln contrast, the mitochondrial pathway is initiated by

intracellular death signals, leading to the formation of apoptotic protein complexes (Green and
Reed, 1999). The complexes initiate the activation cascade from procapase-9 to down-stream
targets such as procaspase-3. Caspase activation, altl10ugh following a sequential cascade, is
regulated by several families of proteins. The inhibitor of apoptosis (IAP) family of proteins
emerges as one of the major classes of proteins that negatively regulate apoptosis. Several lAP
proteins are found to interact directly with and inhibit tl1e activity of caspases (Yang and Li,
2000; Miller, 1999; Lacasse et al., 1998; Kasof and Gomes, 2001 ; Reed, 2001).

Jn this study, we report that DEC 1 is a transcription activator of survivin, a member of the !AP
family. In the paired tumor-normal tissues, survivin and DEC! exhibited a paralleled expression pattern.

In co-transfection assays, DECI activated a survivin promoter reporter but

repressed a DEC2 promoter reporter. Jn contrast to the repression, the activation was delayed
and depended on serum concentrations and cycle phase. Studies with deletion and substituted
mutants located, in the proximal promoter, two Sp I sites that supported the DEC !-mediated
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activity. Both DEC! and Spl were involved in the binding of these Sp! sites. TI1e reported
activation of the survivin promoter provides a molecular explanation for the oncogenic

involvement of DEC! and represents the first example that DEC! and other members in this

class can act as transcription activators depending on the genomic context of a target gene.
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MATERIALS AND METHODS

Chemicals and supplies
Hydroxyurea, mimosine, nocodazole, tetracycline, thymidine, and anti-FLAG antibody were
purchased from Sigma.

Propidium iodide was from BD Biosciences. Antibodies against

procaspases and XlAP were from Cell Signaling. Antibody against Sp 1 was purchased from
Geneka Biotechnology. Antibodies agai nst clAP-1, clAP-2 and survivin were from Santa Cruz.
Goat anti-rabbit-lgG conjugated wi th alka line phosphatase or horseradish peroxidase and ECL
substrate we re from Pierce.

DMEM media and LipofectAM!NE were from lnvitrogen.

Dual-Luciferase Reporter reagent and DNA binding buffer were from Promega.

Unless

0U1erwise indicated, all other reagents were purchased from Fisher Scientific.

Tissue collection and processing
Samples were collected from patients who underwent surgical resection for histologicall y
confirmed adenocarcinoma. As paired controls, specimens from the adjacen t, grossly nom1al
tissues were harvested. The samples (3 or 4 pairs/each organ) were collected from the colon,
kidney, and lung with four pairs from each organ. The age of the patients was between 23 and
68 with seven male and five fema le. The size of tumors was generally 2-5 cm in diameter, and
U1e degree of differentiation of tumors was moderate or poor as determined by pathological
examination. Samples were freshly processed for RNA isolation and protein extraction. Total
RNA was isolated with a Tri-reagent as described previously (Xie et al., 2003).
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For the

preparation of protein extracts, tissues were homogenized in lysis buffer (20 mM Tris-HCI, pH
7.4, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SOS, 0.2 mM PMSF and I mM OTT).
The homogenates were centrifuged at 12,000 g for 30 min to remove any insoluble precipitates.
The protocol of using human pathological tissues was reviewed by the Institutional Review

Board.

Reverse transcription coupled polymerase chain reaction (RT-PCRl
RT-PCR experiments were performed with a Them10Script I kit.

Total RNA (2 µg) was

subjected to the synthesis of the first strand cDNA with an oligo(dT) primer and a
ThennoScript reverse transcriptase. The reactions were incubated initially at 50°C for 30 min,

and then at 60°C for 60 min after additional reverse transcriptase was added. The cDNAs were
then subjected to PCR amplification with cycling parameters as follows: 95°C for 30s, 52°C for
30s and 68°C for 30 or 40s for a total of 32 cycles. The primers for DEC! amplification were:

5 '-GTCTGTGAGTCACTCTTCAG-3', 5 ' -GAGTCTAGTTCTGTTTGAAGG-3 '; the primers
for survivin amplification were: 5'-TCAAGGACCACCGCATCTCTAC-3 ', 5'-GCACTTTCTTCGCAGTTTCC-3 ' ; and the primers for 13-actin amplification were: 5'-GTACCCTGGCATTGCCGACAGGATG-3', 5'-CGCAACTAAGTCATAGTCCGCCTA-3'. The PCRamplified products were analyzed by agarose gel electrophoresis.

Expression constructs for DEC I and mutants as well as the DEC2 promoter reporter
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(pDEC2-luc) were described previously (Li et al., 2002; 2003).

Survivin promoter reporters

were prepared witl1 the pGL3-basic luciferase vector (Promega). Deletion mutants of survivin
reporters were generated by PCR with the pSurvivin-6270 serving as the template. Preparation
and characterization of the pSurvivin-6270 reporter were described elsewhere (Li and Altieri,
1999). Substitution mutants (pSurvivin240-M and pSurvivin 154-M) were also prepared with
PCR with primers containing multiple nucleotide substitutions. The sequences of the primers
to introduce substitutions are : 5'-CTACGCGTAATAAGGAACGAGCTGGTGATGTATCGCTGGGTGCACCGCG-3' (for pSurvivin240-M), and 5'-CTACGCGTCCCGGCACACCCCTAGTTATCAAGTTTCTACTCCCAGAAGGC-3' (for pSurvivinl54-M).

All mutated

constructs were subjected to sequencing analysis to confirm the desired mutation being made
without secondary mutations.

Co-transfection experiment
Co-transfection experiments were perfom1ed with DEC! stable transfected or the parent line
(293T). The preparation and characterization of DEC! stable transfectants were described
previously (Li et al., 2002). Cells were plated in 24-well plates in DMEM media supplemented
with I 0% fetal bovine serum at a density of 1.6 x Io' cells per well.

Transfection was

conducted by lipofection with LipofectAMINE according to the manufacturer's instruction.
Transfection mixtures contained DEC! or a mutant construct (100 ng), reporter plasmid (100
ng) and the pRL-TK Ren ilia plasmid (I ng). If DEC! stable line was used, DEC! or its mutant
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construct was omitted from the transfection mixture. The transfected cells were cu ltured for an

additional 24 h, washed once with PBS and resuspended in passive lysis buffer (Promega). The
lysed cells were subjected to 2 cycles of freezing/thawing. The reporter enzyme activities were
assayed with a Dual-Luciferase Reporter Assay System. This system contained two substrates,

which were used to determine the activity of two luciferases sequentially. The firefly luciferase
activity, which represented the reporter gene activity, was initiated by mixing an aliquot of

lysates (20 µI) with Luciferase Assay Reagent II. Then the firefly luminescence was quenched
and tl1e Renilla luminescence was simultaneously activated by adding Stop & Glo Reagent to
the sample we lls.

The firefly luminescence signal was normalized based on the Renil/a

luminescence signal. In a case that the reading on the luciferase activity was too high, the
lysates were diluted and luciferase activities were then detem1ined to minimize the interference

on the reading of the Renilla luciferase activity.

Some co-transfection experiments were performed in media containing a speci fie cell cycle

blocker.

In addition to serum starvation, four commonly used blockers were included:

hydroxyurea (3 mM), minosine (0.4 mM), thymidine (2 mM) and nocodazole (0.5 µg/ml).
These blockers are known to arrest cells at GI, late GI, Sand G2/M, respectively. The blockers
were added 3 h after the cells were transfected. The treated cells were cultured for additional 30
h. Some ce lls were lysed and ana lyzed for reporter activities, whereas others were harvested,

ethanol-fixed, stained by propidium iodide and analyzed for cell cycles (BD FACSCaliber).
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Electrophoretic mobility shift assay CEMSA)
DEC I stable transfected cells (293T) were cultured in the presence or absence of tetracycline(!
µg/ml) for 36 hand nuclear extracts were prepared with a nuclear extraction kit (Active Motif).
Nuclear proteins (JO

~tg)

were incubated with radiolabeled double-stranded oligonucleotides

(Table I) in a final volume of 10 µI containing IX DNA binding buffer. For competition experiments, nuclear extracts were first incubated with excess cold probe (50x) and then mixed with
the radiolabeled probe. Oligonucleotides with a disrupted Sp I site were also used in the
competition assays. For super-shift assays, an anti-DEC I or anti-Sp I antibody was added
eitl1er before or after the nuclear extracts were incubated with the radiolabeled probe. The
protein-DNA complexes were resolved in 6% PAGE and visualized by autoradiography.

Other analyses
Western analyses were conducted as described previously (Xie et al., 2002). The anti-DEC I
antibody against the C-tern1inal peptide was described elsewhere (Li et al. , 2002). Protein
concentration was detern1ined with BCA assay (Pierce) with bovine serum albumin as the
standard. Data are presented as mean ± SD of at least four separate experiments, except where
results of blots are shown in which case a representative experiment is depicted in the figures.
Comparison between two values were made with Student 's t test atp < 0.05.

77

RESULTS
DEC I selectively increases the expression of survivin among IAP proteins
Overexpression of DEC 1 results in decreased activites of caspases-3, 7 and 9, but not caspase 8.
To detem1ine if DEC 1 selectively represses the expression of procaspases, stable transfected
lines inducibly expressing DEC! or the DNA binding mutant (DECl-M) were cultured in the
presence or absence of tetracycline to modulate the expression of DEC! and DECl-M, and the
levels of procaspases-3 and 8 were determined. As expected, addition of tetracycline caused a
robust expression of DEC! and DEC l-M (the mutant has a slightly higher electrophoretic
mobility) (Figure 2-lA). In contrary to the hypothesis, however, neither DEC! nor DECl-M
caused any changes on the levels of procaspase-3 or 8 (Figure 2-1 A). Three clonal lines for

each type of stable transfectants were tested, and consistent observations were made.

The inability of DEC ! to alter the expression of the procaspases suggests that DEC! decreases
the activity of the caspases through inhibiting the activation ofprocaspases. Several classes of
proteins, notably the inhibitor of apoptosis (!AP) fanlily (Yang and Li, 2000; Miller, 1999),

have been shown to interfere with the processing and catalysis of several caspases. We next
examined whether DEC! up-regulates the expression of !AP proteins.

DEC! stable line

underwent serum starvation for 36 h in the presence or absence of tetracycline, and cell lysates
were collected and analyzed for the abundance of several major IAP proteins including cJAP-1 ,
c!AP-2, XlAP, and survivin. Addition of tetracycline caused a robust induction oftransfected
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Figure 2-1. Expression of procaspases and inhibitor of apoptosis proteins in DEC ! stable
transfected lines
(A) Abundance of and procaspases-3 and 8 in DEC! and DECl-M stable lines as a function of

induced expression a/DEC! Stable transfected cells by DEC ! or DECI-M (lacking the DNA
binding domain) were seeded in 6-well plate. After reaching - 80% confluence, cells were
treated with tetracycline ( I µg/ml) for 36 h. Cell Iysates (5 µg) were subjected to SOS-PAGE.
The immunoblot was incubated with an antibody against procaspases-3, 8 or DEC!. The
primary antibody was then located by horseradish peroxidase-conjugated goat anti-rabbit lgG
and visualized with chemiluminescent substrate. (8) Abundance of /AP proteins in DEC!
stable lines as a function ofinduced expression ofDEC I Stable transfected cells by DEC! were
seeded in 6-well plate. After reaching - 80% confluence, cells were treated with tetracycline (I
µg/ml) for 24 h. Cell lysates (5 µg) were subjected to SOS-PAGE. The inununoblot was
incubated with an antibody against !AP proteins, DEC! or [3-actin. The blots were detected as
describe above. Three clonal lines were used for each type of stable lines, and consistent results

were obtained.
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DEC! (Figure 2-18). However, only survivin was markedly increased in tetracycline-treated
cells, suggesting that DEC I is a selective regulator on tl1e expression among !AP genes (Figure
2-18).

DEC! and survivin show a paralleled expression pattern
In order to further establish the connection that DEC! up-regulates the expression ofsurvivin,

two additional experiments were perfonned: survivin induction was monitored as a function of
DEC! levels, and expression patterns of DEC! and survivin were determined among paired
tumor-normal tissues from the kidney and lw1g. The DEC I stable line was cultured in media
containing tetracycline at various concentrations (0-1 µg/ml) and the levels of DEC I and

survivin were monitored.

Consistent with the notion that DEC I up-regulates survivin,

tetracycline-induced expression of DEC! proportionally increased the levels of survivin

(Figure 2-2A). In order to detennine whether the correlative expression pattem occurs in vivo,
samples from paired tumor-normal tissues were analyzed for the abundance of DEC I and
survivin. As shown in Figure 2-28, both DEC! and survivin were expressed markedly higher
in the carcinomas tl1an the adjacent normal tissues. Such a tumor-related increase was also
detected by RT-PCR on both DEC! and survivin (Figure 2-2C), suggesting that
DECJ-mediated induction ofsurvivin is achieved by increasing the levels ofsurvivin mRNA.
In summary, the paralleled expression pattern in tumor-nom1al samples and the inducible
expression of survivin by DEC! in the DEC! stable line support the notion that DEC! is an

activator on the expression of survivin.

80

(

Figure 2-2. Induction of survivin by DEC ! and abundance of survivin in paired tumor
and normal tissues from the kidney and lung
(A) lnducrion ofsurvivin is proporrionallycorrelaredwirh rhe levels ofDEC I DECI stable cells

were seeded in 6-well plate.

After reaching -80% confluence, cells were treated with

tetracycline at various concentrations (0-1 µg/ml) for 36 h. Cell lysates (5 µg) were analyzed
for the expression of survivin, DEC I and j}-actin. (B) Paralleled expression of DEC! and
sun,ivin in paired tumor and normal samples for the kidney and hmg Tissue homogenates (50
µg) from paired tumor-nonnal tissues were subjected to SDS-PAGE, and the immunoblot was
incubated with the antibody against DEC I, survivin or j}-actin. (C) DEC! and s11rvivi11 mRNA
in paired 111111or-11or111al tissues for the kidney Total RNA (5 µg) of carcinoma-normal paired

samples from the colon, kidney and lung was subjected to RT-PCR analyses with a
ThennoScript I kit. For PCR amplification, a master tube containing all common reagents was
prepared and equally distributed to individual PCR reaction tubes (DEC!, survivin and j}-actin).
PCR amplification was conducted wi th cycling parameters as follows: 95°C for 30s, 52°C for
30s and 68°C for 30 or 40s for a total of 32 cycles. The PCR-amplified products were analyzed
by agarose gel electrophoresis and visualized by ethidium bromide staining.
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DECl-mediated induction ofsurvivin varies depending on serum concentrations

Solid tumors are poorly vascularized, thus hypoxic and deficient in nutrients (Vaupel et al. ,
2001).

It is likely that the levels of DEC! , serum concentrations and oxygen tension

collectively determine the overall induction ofsurvivin. We next examined the effects of serum

concentrations on the DEC 1 mediated induction of survivin. As shown in Figure 2-3A, the
expression of DEC I is markedly induced by tetracycline independently of serum
concentrations.

In contrast, the leve ls of survivin varied markedly depending on the

concentrations of serum in media. Generally, higher serum concentrations supported higher

expression of survivin, and in a given serum concentration, higher levels of DECI supported
higher expression of survivin.

Cells cultured with lower serum concentrations (0-2%)

exhibited markedly higher induction of survivin (between the presence and absence of
tetracycline in a given serum concentration) (Figure 2-3A}. Remarkably, the induction of
survivin in ce lls cultured with less serum , although profound, did not exceed the levels in cells

cultured with higher serum concentrations (e.g., 5%) (Figure 2-3A).

Two mechanisms, nan1ely increased survivin stability and/or expression, could be responsible
for increased level of survivin. To distinguish these possibilities, we perfonned a time course

study on the changes oftl1e survivin levels in reference to the levels of P-actin. Both DEC! and
DECl-M lines we re included in this study. As shown in Figure 2-3B, little changes on the
survivin levels were observed in the first 12 h-serum starvation. However, a rapid dec line was

detected after a 12 h-incubation (Figure 2-38). Such time-dependent changes occurred in both
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Figure 2-3. Time and serum-dependence of DEC l-mediated induction on survivin (A)
Effects ofserum concentrations on the induction ofsurvivin DECI stable cells were seeded in

6-well plate. After reaching -80% confluence, cells were cultured in media containing various
amounts of serum (0-5%) in tl1e presence or absence of tetracycline (1 µg/ml) for 36 h. Cell
lysates (5 µg) were analyzed for the expression of survivin, DEC 1 and P-actin.

(B)

Time-course study 011 DECJ-mediated i11ductio11 ofsurvivin DECI stab le cell s were cultured in

the presence or absence of tetracycline (1 µg/ml) for 0-36 h. Cell lysates (5 µg) were analyzed
for the expression ofsurvivin, DECl and P-actin. (C) Abundance ofsurvivin mRNA in DECl
and DEC 1-M lines DEC 1 or DEC 1-M stable lines were cultured in the presence or absence of
tetracycline (1 µg/ml) for 36 h. Total RNA (5 µg) was subjected to RT-PCR analyses with a
ThennoScript 1 kit for the levels of survivin and P-actin mRNA as described in the legend of
Figure 2-2 .
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DEC I and mutant lines, and independently of tetracycline.

In contrast, in the 24 and 36

h-cultures, markedly higher levels of survivin were detected in the presence of tetracycline, but
such increases were detected only in the DEC I but not DEC-M line.

Similarly,

tetracycline-induced expression of DEC I but not DECl-M supported higher levels ofsurvivin
mRNA (Figure 2-3C). Addition of actinomycin D, an inhibitor on RNA synthesis, completely
abolished DEC I-mediated increase on survivin mRNA (data not shown).

DECl stimulates the survivin promoter

The increase on survivin mRNA and the repressed increase by actinomycin D suggest that

DEC I-mediated induction of survivin is achieved through transcription activation. We next
determined whether DEC! directly activates the survivin promoter. Three reporters were
included in this study: pSurvivin-6270, pSurvivin-268, and pDEC2-luc. The rationale for the
reporter selection was that tl1ese reporters contain various numbers of E-box elements and
DEC I has been shown to alter reporter activity through E-box DNA elements (Figure 2-4A)
(lvanova et al., 200 I). The pSurvivin-268 reporter was derived from the 3' sequence of the
pSurvivin-6270 reporter, and both starts from nucleotide -39 (Li and Altieri, 1999). More
importantly, the pSurvivin-6270 reporter contains more than 30 E-box elements, whereas no
E-box is present in the pSurvivin-268 reporter. The pDEC2-luc reporter contains a 1,888
hp-upstream sequence from the DEC2 gene, where two E-box elements (CACGTG) are present
(Li et al., 2003). We have recently demonstrated that DEC I represses the pDEC2-luc reporter
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Figure 2-4. DEC! activates the survivin promoter but represses the DEC2 promoter
{A) Diagrammatica/ presentation ofpDEC2-luc, pSurvivin-6270 and - 268. (BJ Activation of
the survivin reporters and repression ofpDEC2-luc in full-media DEC! stable transfected cells
were cultured in 24-well plates at - 80% confluence and transfected again with a reporter
construct (100 ng) and the pRL-TK Renilla (I ng). The re-transfected cells were cultured with
media containing 10% serum in the presence or absence of tetracycline (I µg/ml} for 24 h. The
cells were collected, washed once with PBS and resuspended in passive lysis buffer. The
reporter enzyme activities were assayed with a Dual-Luciferase Reporter Assay System. The
firefly luminescence signal was normalized based on the Renilla luminescence signal.

(CJ

Activation of the survivin reporters and repression ofpDEC2-luc in senm1free media DECI
stable transfected cells were cultured in 24-well plates at - 80% confluence and transfected
again with a reporter construct (100 ng) and tl1e pRL-TK Renil/a (I ng). The re-transfected
cells were cultured with serum free media in the presence or absence of tetracycline (I µg/ml)
for 24 h. The reporter activities were determined as describe above.
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largely through the E-box in the proximal promoter region (49, 56). It should be emphasized
that altl1ough the pSurvivin-6270 reporter contains numerous E-box elements, none of them is
identical to the E-box in the pDEC2-luc reporter (Figure 2-4A).

Since DEC I-mediated induction of survivin was markedly more evident in media
supplemented with lesser serum (S 2%) (Figure 2-3A), the reporter assays were performed in

full (10% serum) or serum free media. In the presence of serum, induction of DEC! (addition
of tetracycline) modestly stimulated the activity of both pSurvivin-6270 and 268 reporters
(Figure 2-48).

In the absence of serum, however, both survivin reporters were markedly

stimulated (Figure 2-4C). The pSurvivin-268 reporter exhibited a higher activation than the
pSurvivin-6270 (Figure 2-4C). In a striking contrast, the pDEC2-luc reporter was repressed by
more than 90%, whether or not serum was supplemented (Figure 2-48 and C).

Activation of pSurvivin-268 was delayed and cycle-dependent
The activation of the survivin reporter and repression of the pDEC2-luc reporter suggest that
DECI regulates the transcription through more tl1an one mechanism.

A conceivable

explanation for such opposing activities is that DEC! is a part ofa large transcription regulatory
complex, and this complex rather than DEC! alone determines the overall transcription
activities (assumed that the complex varies among different target genes). Another possibility
is that repression of pDEC2-luc is achieved through direct mechanism, whereas activation of
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survivin reporters is through indirect mechanism or vice versa. It is expected that the direct
mechanism would have an earlier onset than the indirect mechanism. In order to test this

possibility, time-course studies were performed with pDEC2-luc and pSurvivin-268. As shown
in Figure 2-SA, activation of the pSurvivin-268 reporter was not evident during the first IO
h-incubation, and the activation was increased with prolonged incubation, particularly after I 0
h-incubation. In contrast, the pDEC2-luc reporter was markedly repressed as early as 4 h, and
the overall repression was rather steady during the entire period of incubation (Figure 2-SA).
The values from the 4 h-cultures in the absence of tetracycline were expressed as 100%.

The difference on the onset between repression and activation points to two important

possibilities: (a) pDEC2-luc is a more sensitive target (requiring less DEC!) than
pSurvivin-268; and (b) activation ofpSurvivin-268 requires the synthesis of additional factors.
Apparently, comprehensive experiments are required to definitively establish the involvement
of each possibility. However, an effort was made to gain an initial insight by testing whether
repression and activation are equally altered by cell cycle arrest. The rationale for this strategy
is that the expression of survivin is regulated in a cycle-dependent manner (Li et al., 1998), and
DEC I mouse homologue STRA 13 has been shown to delay cell cycle progression into S phase
(Seimiya et al., 2002).

DEC! stable transfected cells were transfected again with

pSurvivin-268 or pDEC2-luc and synchronized with cell cycle blockers. As shown in Figure
2-58, DEC I caused a marked repression of pDEC2-luc independently of cycle blockers. In
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Figure 2-5. Activation of the survivin promoter by DEC! is delayed a nd varies depending
on cell cycle blockers

(A) Activation of the pSurvivin-268 is delayed DECI stable transfected cells were cultured in
24-well plates at - 80% confluence and transfected again with a reporter construct (I 00 ng) and
the pRL-TK Ren ilia (1 ng). The re-transfected cells were cultured witl1 senun free media in the
presence or absence of tetracycline (1 µg/ml) for 0-36 h. The reporter enzyme activities were
determined as describe above. The values from the 4 h-cultures in the absence of tetracycline
were expressed as 100%. (B) Activation of pSurvivin-268 varies depending on cell cycle

blockers DECJ stable transfected cells were cultured in 24-well plates to -80% confluence and
transfected again with a reporter construct ( JOO ng) and the pRL-TK Renilla ( I ng). The
re-transfected cells were cultured in media containing no or a specific cycle blocker (3 mM
hydroxyurea 3 mM, 0.4 mM mimosine, 2 mM thymidine and 0.5 µg/ml nocodazole). The cells
were cultured in media supplemented with 10% serum and in the presence or absence of

tetracycline (1 µg/ml) for 24 h. The reporter enzyme activities were detem1ined as describe
above. The values from the cultures in the absence of tetracycline were expressed as 100%.
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contrast, the activation of pSurvivin-268 varied depending on tl1e blockers.

A moderate

activation was detected in cells treated with hydroxyurea, minosine and lhymidine. In contrast,

nocodazole, a cycle blocker arresting cells at G2/M, showed little effects on the
DEC I-mediated activation on the reporter. It should be emphasized that hydroxyurea repressed
but nocodazole activated the pSurvivin-268 reporter compared with vehicle controls (in the
absence of DEC I), and treatment with a blocker generally achieved a 65-80% of cells arrested
at a designated cycle as detennined by DNA content analysis (data not shown).

Requirements of functional domains in DECI to activate the survivin transcription

DEC! has several functional domains, and some of them (e.g., the orange domain) likely
interact with other proteins. To determine which functional domains are required for the
activation of survivin reporter, several DECI mutants with certain functional domains

selectively disrupted were prepared and tested for the ability to stimulate the pSurvivin-268
reporter. These mutants are diagrammatically shown in (Figure 2-6, Left). The results of the
reporter assays with the DECJ mutants on pSurvivin-268 were summarized in Figure 2-6
(Right). Deletion mutants retaining DNA binding ability (DEC 11.,.,, DECJ 1•270 , DEC 11• 197 and
DEC! 1.iso) all exhibited some transactivation activities depending on the length of a mutant.
For example, DECJ 1•347 exhibited -60% of the activity of DEC I, whereas DEC 11.iso, with a
longer C-terrninal deletion, had only - 20% of the activity of DEC I (the activity from the empty
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Figure 2-6. Requirements of functional domains in DECI to activate the pSurvivin-268

Activation of the pSurvivin-268 Cells (293T) were cultured in 24-well plates and transiently
transfected witl1 DEC I or a mutant ( 100 ng), pSurvivin-268 ( 100 ng) and the pRL-TK Renilla
( \ ng). The transfected cells were cultured in serum free media for 24 h, and lysates were
collected and analyzed for luciferase activities. Similarly firefly luminescence signal was
normalized based on the Renilla luminescence signal.
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vector was subtracted).

In contrast, the mutants with the DNA binding domain or an

N-terminal deletion (DEC 1-M, DEC 1105412 , and DEC1 237 _. 12 ) showed little activity toward the
pSurvivin-268 reporter.

These mutants were previously shown to have no DNA binding

activity (Ivanova et al., 2001). Among the substitution mutants, the DEC 1PSM mutant showed a
higher activity than DEC! in activating the pSurvivi n-268 reporter, whereas the other two
mutants (DEClRssP and DECl psoNR.SsP) showed no activation activity.
DEClRssP nor DEC1 PS6NR.SSP was shown to bind to E-box.

DEC1 P56A but not

It should be emphasized that

Western analyses detected comparable expression with all constructs (results not shown).

Both DEC 1 and Sp I bind to the proximal promoter of survivin
Motif analyses identified a clustered Sp l /CDE region (fycle gependent

~lement)

in the

proximal region of survivin promoter and has been shown to mediate its basal expression (Li
and Altieri, 1999). Some of the Sp 1 sites are slightly altered and arranged in a modified
configuration (Figure 2-7A). In order to identify DNA sequences that act as potential binding
sites for DEC 1, ten oligonucleotides were synthesized to span tl1e entire region with partial
sequences overlapped on one or botl1 ends of an oligonucleotide (Table 1). Equal amounts of
extracts from control or tetracycline-treated cells were allowed to bind to the double stranded
o ligonucleotides individually, and shifted bands were detected by non-denaturing PAGE. As
shown in Figure 2-76, one or more shifted bands were detected with seven out of ten
oligonucleotides including oligonucleotides 41-68, 55-84, 85-114, I 05-126, 115-144, 123-158,
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Table I. Sequences of Oligonucleotides for Electrophoretic Mobility Shift Assay

Oligonucleotide

Sequence

41-68

5 '-CCCCGCGGCGCGCCATIAACCGCCAGAT-3'

55-84

5' -GTGCGCTCCCGACATGCCCCGCGGCGCGCC-3'

76-105

5 '-GGGGTGGACCGCCTAAGAGGGCGTGCGCTCC-3'

85-114

5'-GGCCGCGGGGGGTGGACCGCCTAAGAGGGC-3'

105-126

5'-CTACTCCCAGAAGGCCGCGGGG-3'

11 5-144

5' -CCCCGCGCCGCCCCGCCTCTACTCCCAGAA-3'

123-158

5 '-CAACTCCCGGCACACCCCGCGCCGCCCCGCCTCTAC-3'

145-174

5' -CGCGGCGGGAGGACTACAACTCCCGGCACA-3'

175-204

5' -CTGGGTGCACCGCGACCACGGGCAGAGCCA-3'

205-234

5 '-TGTGGGCAGGGACGAGCTGGCGCGGCGTCG-3'

Note: Oligonucleotides are numbered based on the genomic sequence described previously
(27), and the sequences underlined are Sp! canonical or Spl sites.
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Figure 2-7. DEC I selectively increases DNA binding among Spl sites in the proximal
promoter of survivin
(A) Diagrammatica/ prese11tatio11 of the locatio11 of Sp/ sites (B) Expressio11 of DEC/
selectively alters DNA bi11di11g to Sp/ sites DEC! stable transfected cells were cultured in the

presence or absence of tetracycline (tel, I µg/ml) for 24 h and nuclear extracts were prepared
with a nuclear extraction kit (Active Motif). Nuclear proteins ( JO µg) were incubated with
radiolabeled double-stranded oligonucleotides in a final volume of JOµ! containing IX DNA
binding buffer. For competition experiments, nuclear extracts were first incubated with excess
cold probe (50 X in lane 1 or 10 X lane 3) and then mixed with the radiolabeled probe. The
protein-DNA complexes were resolved in 6% polyacrylamide gel electrophoresis and
visualized by autoradiography. (C) Disruption of shift bands by anti-DEC! or Sp! antibody
The gel mobility shift assays were performed as described above but in the presence of an
antibody against DEC! , Sp! or Flag tag. The protein-DNA complexes were resolved in 6%
polyacrylamide gel electrophoresis and visualized by autoradiography.
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More importantly, induction of DEC! differentially affected the binding of the

oligonucleotides.

Markedly higher binding activities were detected with oligonucleotides

115-144, 123-158 and 204-234 with cells cultured in the presence of tetracycline. In addition,
two shifted bands were detected with oligonucleotides 115-144 and 123-158, but only the upper
shifted band was intensified as a result of induced expression of DEC I, suggesting that the
detected binding was highly specific. It should be emphasized that the binding specificity with
all oligonucleotides was also established with competition assays in the presence of
corresponding unlabeled probes (data not shown).

Oligonucleotides 115-144 and 123-158 share an Sp! complex site (SPl-127), whereas
oligonucleotide 204-234 contains a typical Sp! element (Figure 2-7A), indicating that the
shifted bands with these oligonucleotides represent DNA-Sp I complexes. In order to directly
test this possibility, EMSA experiments were perfonned with an anti-Sp I antibody. As shown
in Figure 2-7C, addition of the anti-Sp I antibody caused disappearance of the shifted band with
oligonucleotide 205-234 as well as the upper shifted band with oligonucleotide 123-158. A
super-shifted band witl1 a markedly lesser intensity was also detected with each oligonucleotide.
Interestingly, a rather high background (so-called smeared bands) was observed between tl1e
original- and super-shifted bands, suggesting that many intermediated species of D A-protein
complexes are fonned as a result of the addition of the anti-Sp I antibody. Given the fact that
binding to these oligonucleotides was increased by the presence of DEC! , we next examined
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whether DEC! is part of the DNA-protein complexes. Similarly, an antibody against DEC!
was added to binding mixture.

As observed with the anti-Sp I antibody. addition of the

anti-DEC! antibody resulted in the disappearance of the originally shifted bands accompanied
by super-shifted bands with a markedly lesser intensity (Figure 2-7C).

Addition of an

anti-FLAG antibody, however, caused no changes on tl1e relative intensity of the shifted bands,
further establishing the specificity of the observed bindings.

Sp! sites-127 and 226 additively activate the survivin promoter in response to DECI
In order to determine whether binding to Sp I site-127 or 226 is responsible for the activation of

the survivin reporter, deletion and substitution mutants were prepared and tested for the
responsiveness to DEC I. Similarly, the DEC I stable line was transfected again with a reporter
mutant and cultured in the presence or absence to modulate the expression of DEC I. As shown
in Figure 2-8, deletion or mutagenic dismption of the Sp I site-226 decreased the
responsiveness to DEC! by as much as 30%. An additional 40% decrease was detected wi th
the mutant that had Sp I site-127 also disrupted in addition to Sp I site-226 (pSurvivin-154M).
TI1erefore, binding to these two Sp I sites is responsible for as much as 70% of the overall
activation mediated by DECI (Figure 2-8).
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Figure 2-8. Sp! sites 127 and 226 suppo rt DEC l -mcdiatcd ac ti vation of survivi n DEC!
stable transfected cells were cultured in 24-well plates at -80% confluence and transfected
again with a reporter mulant (100 ng) and the pRL-TK Re11illa (I ng). The re-transfecled cells
were cultured with sernm free media in the presence or absence of tetracycline (I µg/ml) for 24
h. The reporter enzyme activities were detem1ined as describe above. The values were

nom1alized based on the reading on pRL-TK Re11illa luciferase
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DISCUSSION
Recent reports from this and other laboratories have linked deregulated expression of DEC I to
oncogenic process (Li et al., 2002; 2003; lvanova et al., 2001). DEC! is abundantly expressed

in the tumor but not in the adjacent nonnal tissues. Tumorigenic environment such as hypoxia
markedly induces the expression of DEC I and the induction is abolished by von Hippel-Lindau
tumor-suppressor protein (Ivanova et al., 2001). In stable transfected cells, forced expression
of DEC I protects against apoptosis, and the overall antiapoptotic activity is well correlated
with decreased activity of several major caspases.

ln this study, we report a molecular

mechanism for the decrease on the caspase activity. DEC I transcriptionally upregulates the

expression ofsurvivin, an antiapoptotic protein that interferes with the processing and catalysis
of caspases. DEC I and survivin exhibit a paralleled expression pattern in paired tumor-nonnal
tissues.

In co-transfection experiments, DEC I stimulates the survivin promoter, and this

mechanism relies on the physical interactions with Sp! sites in the proximal promoter. These
findings collectively establish that the survivin gene is a transcription target of DEC I.

The DEC I-directed regulation likely represents an important mechanism that governs the
transcription of the survivin gene. Several lines of evidence support this notion. First, both
DEC! and survivin are abundantly expressed in the carcinomas but not the adjacent nonnal
tissues (Figure 2-2B}, providing cellular localization that supports for the regulator and target
relationship (DEC I and survivin).

Second, DEC I and survivin share an overlapping
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cycle-dependent expression. The expression of survivin is regulated in a cycle-dependent
manner with a robust expression in the G2/M phase of the cell cycle (Li et al., 1998).
Consistent with the cycle-related expression, cycle blockers hydroxyurea (S phase) and
nocodazole (G2/M phase) markedly induce DECI (Li et al., 2002), suggesting that increased
expression of DEC! is an initial event leading to the expression of survivin. Third, forced
expression of DEC I alters the cycle-dependent expression of survivin. Cells synchronized by
GI blocker mimosine express undetectable survivin (Li et al., 1998), however, transfection of
DECl in mimosine-synchronized cells causes a modest activation of the survivin promoter. As

a matter of fact, forced expression of DEC I activates the survivin promoter independently of
the cycle phase (Figure 2-4 and 5) with an exception of nocodazole.

The inability of transfected DEC I in nocodazole-synchronized cells causes additional
activation suggests that DEC I and this cycle blocker act redundantly on the induction of
survivin. However, there are several important differences on the cis-DNA elements required

for nocodazole- and DEC-mediated activation. In this study, Sp! sites-127 and 226 in the
proximal promoter of survivin are found to contribute as much as 70% to the activation of

DEC I (Figure 2-8). In contrast, nocodazole-mediated activation requires a 40 hp-proximal
sequence containing two cycle dependent elements (COE) and one cycle homology region
(CHR) (Li and Altieri, 1999). Mutagenic disruption ofone or more of these elements abolishes
the ability to respond to nocodazole. It remains to be determined whether the CDE/CHR region
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affects DEC I-mediated activation, or the Spl sites-127 and 226 affect nocodazole-mediated
activity. It should be emphasized that other Sp I sites (-151 and -171) in the survivin promoter
have been shown to support constitutive activation of survivin in HeLa cells (Li and Altieri,
1999). However, no D A binding to these sites is detected with 293T nuclear extracts (Figure
2-78, oligonucleotides 145-174 and 175-204), suggesting tlrnt these sites represent cell
type-specific regulation.

Binding to Spl sites-127 and 226 may not be the only event in DECl-mediated activation on
the survivin promoter. In DEC I stable transfectants, marked induction of survivin is observed
only in cells cultured at relatively low serum concentrations (Figure 2-3A), suggesting that the
presence of DEC! alone is not sufficient to effectively upregulate the expression of survivin.
Similarly, less serum supports higher activation of the survivin promoter reporters (Figure 2-48
and C). Even with serum free media, the activation of the survivin reporter is very minimal

during the first I 0 h-incubation, and tl1e activation continues to increase with prolonged
incubation (Figure 2-5A). In contrast, the pDEC2-luc reporter is repressed by 60% as early as
4 h. The delayed onset on the activation of the survivin reporter suggests that DEC! initiates
more than one event (e.g., binding to Sp! sites-127 and 226), and these events collectively

detem1ine the onset and magnitude of the activation.

Given the fact that the DEC I-mediated activation of the survivin reporter is largely achieved
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through Sp! sites-127 and 226, it is conceivable that increased expression of Sp! is one of the

events responsible for the delayed onset on the activation. It remains to be determined whether
DEC! actually upregulates the expression of Sp!, however, EMSA experiments have detected
marked increases on Sp I binding activity as a result of the induced expression of DEC! (Figure
2-78). In contrary to this possibility, increased Sp l binding occurs only with Sp I sites-127 and
226 but not with five others present in this region, although some of the other Sp l sites are
found to bind to Spl and related proteins (Li and Altieri, 1999; Figure 2-78). Alternatively,
Sp l interacts with other proteins and the resultant complexes collectively determine DNA
binding selectivity. In support of this possibility, mSHARP, a DEC I-related transcription factor,
has been shown to directly interact with Sp l (Azmi et al. , 2003). In this study, we have
demonstrated that addition of an anti-DEC l antibody completely disrupt the shifted bands with
Spl sites-127 and 227 (Figure 2-7C), suggesting that DEC! is part of the Sp I-DNA complex.
The disrupted binding instead of being super-shifted by the anti-DEC l or even anti-Sp I
antibody suggests that DECl-Spl complex presents a rigid steric confomiation with a high
selectivity toward a cis-DNA element. Post-translational modifications of Sp l have been
shown to alter Sp I-mediated DNA binding (Black et al., 2001; l 999; Rohl ff et al. , 1997; Su et
al., 1999). However, it remains to be determined whether post-translational modifications of
Sp! are involved in the interaction with DEC! or mSHARP.

It is interesting to notice that interactions between Sp! and DEC! result in transcription
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activation, whereas Sp 1-mSHARP complex represses the promoter of STRA 13, the mouse
homologue of DEC I (Fujimoto et al., 2001). DEC! and mSHARPI are highly identical (97%)
in the bHLH region, but rather diverse (-35%) in other regions, particularly in the C-tem1inal
half(Fujimoto et al., 2001). The high degree of sequence identity in the bHLH region suggests
that this motif mediates direct interactions with Sp I. However, it remains to be detennined

whether the regions with relatively diverse sequences are responsible for the opposing
activities on these two reporters. Apparently, the difference between the target genes (survivin
versus STRA 13) is another possibility that is likely responsible for the observed opposing
activities. Consistent with this notion, Spl , which is generally considered as a transcription
activator, has been increasingly reported to exert transcription repression depending on the

target genes, the types of cells and even the cycle phase (Black et al., 200 I).

The DECI-mediated activation of the survivin has important pathological significance.
Survivin has been shown to antagonize apoptosis and promote cell division (Li et al., 1999;
2003). The expression of survivin is cell cycle-regulated with a marked increase in the G2/M
phase (Li et al., 1998).

The dual function (antiapoptosis-cell division), along with its

cycle-dependent expression, provides an effective mechanism to ensure success of cell division.
In this study, forced expression of DEC! causes increased the activation of the survivin
promoter independently of the cycle phase (with an exception of nocodazole, see discussed
above). The DEC I-mediated alteration on the cycle dependent expression of survivin provides
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a mechanism that minimizes cell death during oncogenic process regardl ess of a cycle phase
(assumed that the deregulated expression of DECI in tumors occurs in a cycle-independent
manner).

Given the fact that DEC I has a broad tissue distribution (Shen et al., I 997),

DEC I-mediated activation may have physiological significance in cell proliferation and
differentiation as well.

In support of this possibility, STRA I 3-deficient mice develop

autoimmune disease featured by accumulation of spontaneously activated T and B cells (Sun et
al., 2001). Although these mice are genera ll y normal, but the FasL surface expression is
markedly suppressed.

Dysfunctional Fas-FasL system results in decreased apoptosis of

premature lymphocytes, leading to the development of autoimmune disease. The decreased
expression of FasL in STRA I 3-deficient mice suggests that STRA 13, like its human
homologue DEC! on the survivin, acts as a transcriptional activator.

It remains to be

determined whether Star! 3-mediated upregulation of FasL is achieved by STRA 13-Spl
complex. Interestingly, Sp I-dependent acti vation is a major pathway to support the expression
of FasL (Kavum1a et al., 2002).

DEC I-mediated activation, compared witl1 repression, has several important differences. First,
activation and repression differ on tl1e time of onset. Repression of pDEC2-luc is profound as
early as 4 h after transcription, whereas activation of pSurvivin-268 is not evident after JO

h-incubation, suggesting that activation requires one or more additional events (e.g., protein
synthesis) (Figure 2-5A).

Second, repression of pDEC2-luc is independent on serum
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concentrations and cycle blockers, whereas activation of pSurvivin-268 is altered by these
factors, suggesting that DEC! is essential but not sufficient to effectively activate this reporter.
Third, Sp !-sites support the activation of pSurvivin-268, whereas the E-box in the proximal
region supports the repression of pDEC2-luc (Li el al., 2003), suggesting that direct DNA
binding alone is sufficient to exert repression, whereas protein-protein interaction (e.g.,

DECI-Sp l) is required to support activation (although DNA binding is also involved as
discussed below). And finally, the C-terminal 65 residues are required for maximum activation
but not repression (Li el al., 2003). It is intriguing that intact DNA binding domain in DECI is

essential to transcription activation, although interaction with Sp I is an identified mechanism.
A conceivable explanation is that DNA binding mechanism and interactions with Sp I are both
involved in the activation of survivin. The DNA binding mechanism directly represses or
activates a target gene, which, in cooperation with the DEC I-Sp I complex , leads to the
activation of the survivin promoter.

The DNA binding-dependent transcription is likely

responsible for the delayed onset on the activation.

In summary, our work points to several important conclusions.

First, DEC I antagonizes

apoptosis accompanied by decreased activity of caspases, and in this study, we reports that
DECI transcriptionally upregulates the expression of the survivin, providing a molecular
explanation for its antiapoptotic activity. Second, the activation of the survivin is delayed and
varies depending on serum concentration and cycle blockers, suggesting that DECl-mediated
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activation requires more than one event and operates in cell type and cycle-related manner.

Third, DEC I activates the survivin promoter, but represses the DEC2 promoter, providing dual
transcription functionality mediated by DEC!. Given the fact that DECI has been implicated
in oncogenic process (deregulated) and is generally considered to be transcriptionally
repressive, the estab lished activation of the survivin promoter provides a molecular explanation

for its oncogenic involvement and represents the first example that DEC! and other members in
this class can act as transcription activators depending on the genomic context of a target gene.
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MANUSCRIPT lIJ

DEC! NEGATNELY REGULATES THE EXPRESSION OF DEC2
THROUGH BINDING TO THEE-BOX IN THE PROXIMAL PROMOTER

1

ABSTRACT

Human DEC, mouse STRA and rat SHARP proteins constitute a new and structurally distinct
class of the basic helix-loop-helix (bHLH) proteins.

In each species, two members are

identified with a sequence identity of>90% in the bHLH region and-40% in the total proteins,
respectively.

Recently, we have reported that DEC! is abundantly expressed in colon

carcinomas but not in the adjacent normal tissues. The present study was undertaken to extend
the expression study of DEC! and to determine whether DEC! and DEC2 had similar
expression patterns among paired cancer-nonnal tissues from the colon, lung and kidney.

Without exceptions, DEC! was markedly higher in the carcinomas, whereas the opposite was
true with DEC2. In stable transfectants, tetracycline-induced expression of DEC! caused
proportional decreases in the expression of DEC2. Co-transfection with DEC I repressed the
activity of a DEC2 promoter reporter by as much as 90%. The repression was observed witl1
wild type DEC! but not its DNA binding defective mutants.

Studies with deletion and

site-directed mutants located, in the proximal promoter, an E-box motif that supported the
DEC I-mediated repression. Disruption of this E-box markedly abolished the ability of tl1e
reporter to respond to DEC!. Our findings assign for DEC! the first target gene that is
regulated through direct DNA binding. DEC/STRA/SHARP proteins are highl y identical in
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the DNA binding domain but much more diverse in other areas. DECl-mediated repression on
the expression of DEC2 provides an important mechanism that these transcription factors
regulate the cellular function not only by modulating the expression of their target genes but
also the expression of members within the same class.
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INTRODUCTION

The basic helix-loop-helix (bHLH) proteins are intimately associated witl1 developmental
events such as cell differentiation and lineage commitment (Littlewood and Evan, 1998;
Bissonnette et al, 1994; Cromi ller et al 1998; Nikoloff et al, 1992; Hirose et al, 1996; Massari
and Murre 2000).

The HLH domain in tl1e bHLH motif is responsible for dimerization,

whereas the basic region mediates DNA binding (Littlewood and Evan, 1998). Based on
sequence alignment and domain analysis, human DEC, mouse STRA and rat SHARP
constitute a new and structurally distinct class of bHLH proteins (Boudjelal et al, 1997;
Fujimoto et al, 2001; Rossner et al, 1997; Shen et al, 1997). These proteins are distantly related
to Drosophila Hairy and E(spl) as well as the mammalian homologues (e.g., HES) with U1e
highest sequence identity (-40%) in the bHLH region (Littlewood and Evan, 1998; Dawson et
al, 1995; Kokubo et al, 1999). Like Hairy/E(spl)/Hes, DEC/STRA/SHARPs contain an orange
domain and a pro line residue in the DNA binding domain. However, the pro line is located 2
residues more toward the N-terrninus (Littlewood and Evan, 1998; Fujimoto et al, 2001).
Another major structural difference on the functional domains is that DEC/STRA/SHARPs,
unlike Hairy/E(Spl)/Hes proteins, lack the C-terrninal WRPW tetrapeptide motif (Fisher et al,
1996). Through this sequence, Hairy/E(spl)/Hes recruit corepressor Groucho to the transcriplion regulatory complex (Fisher et al, 1996). Recruitment ofGroucho is responsible for a vast
array of biological activities of Hairy/E(spl)/Hes proteins including cellular differentiation and
lineage commitment (Giebel and Campos-ortega, 1997; Poortinga et al, 1998; Chen et al, 1999;
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Hojo et al, 2000; Ohtsuka et al, 200 I).

Two members of DEC/STRA/SHARP proteins are identified in each mammalian species
studied wi th a sequence identity of >90% in the bHLH region and -40% in the total proteins,
respectively (Fujimoto et al, 2001). They exhibit an overlapping tissue distribution and their
expression is highly elevated in response to environmental stimuli (Boudjelal et al, 1997;
Fujimoto el al, 2001; Rossner et al, 1997; Shen et al, 1997). In rats that undergo seizure
induction by kainic acid, the levels of mRNA encoding SHARP I or 2 are sharply increased
within I h in the brain (Rossner et al, 1997). In cultured human cells, both DEC I and DEC2 are
markedly induced in response to hypoxia (Miyazaki et al, 2002). Co-transfection experiments
with promoter reporters have identified functional hypoxia response elements in both DEC!
and DEC2 genes. These elements show high affinity toward hypoxia inducible factor-I Cl and

p,

providing a molecular explanation on the co-regulatory phenomena of DEC I and DEC2 during
hypoxia response (Miyazaki et al, 2002). Rapid induction of these proteins in response to
environmental stimuli suggests that DEC/STRA/SHARPs are protective against detrimental
conditions.

In addition to a potential protective role against environmental stimuli, DEC/STRA/SHARPs

have been implicated in cell differentiation (Boudjelal et al, 1997; Shen el al, 1997; Shen el al,
2002), maturation of lymphocytes (Sun et al, 200 1) and regulation of molecular clock (Honma
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et al, 2002).

In a cell culture system, mouse STRAl3 promotes neuronal but represses

mesodem1al and endodermal differentiation (Boudjelal et al, 1997).

Consistent with the

inductive effect on neuronal differentiation, rat SHARP proteins are abundantly expressed in a
subset of mature neurons (Rossner et al, 1997). DEC I has recently been shown to promote
chondrocytes differentiation at the early and tenninal stages (Shen et al, 2002). STRA 13
deficient mice, although surviving to adulthood, develop antoimmune diseases accompanied
by accumulation of spontaneously activated T and B cells (Sun et al, 2001). In addition, the
mouse proteins are recently found to regulate the expression of biological clock regulator Per
(Honma et al, 2002). In addition, we and other investigators have recently demonstrated that
deregulated cell survival by DEC! may have oncogenic significance. In paired Sanlples, DEC!
is abundantly expressed in colon carcinomas but not in the adjacent nonnal tissues (Li et al,
2002). High levels of DEC! transcript are also detected in an array of cancer cell lines derived
from a wide range of organs (lvanova et al, 200 I). Cells that lack the functional tumor
suppressor VHL (von Hippel-Lindau) express higher levels of DEC! (Ivanova et al, 2001).
Forced expression of DEC I antagonizes serum deprivation-induced apoptosis and selectively
inhibits the activation of procaspases (Li et al, 2002).

These findings suggest that

overexpression of DEC I provides cells with unusual survival mechanism, thus is oncogenic.

The present study was undertaken to extend the expression study on DEC I and to determine
whether DEC I and DEC2 displayed similar expression patterns among paired tumor-nom10I
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tissues from the colon, lung and kidney. Without exceptions, DEC! was expressed markedly
higher in the carcinomas, whereas DEC2 was expressed markedly higher in the adjacent

normal tissues. Forced expression of DEC! sharply decreased the expression of DEC2 and
markedly repressed the activity of a DEC2 promoter reporter. Co-transfection experiments
with mutant reporters and EMSA located, in the proximal promoter, an E-box that supports
DECl-mediated repression. These findings provide direct evidence that DEC ! negatively
regulates the expression ofDEC2, which is largely achieved through direct DNA binding to the
E-box in the proximal promoter of DEC2.
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MATERIALS AND METHODS

Chemicals and supplies
Tri-reagent, Flag-CMV vector and anti-Flag antibody were purchased from Sigma. The goat
anti-rabbit-lgG conjugated with alkaline phosphatase or horseradish peroxidase and ECL
substrate were from Pierce. DMEM media, LipofectAMINE and ThermoScript 1 RT-PCR kit
were from ln vitrogen. Dual-Luciferase Reporter Assay System and DNA binding buffer were
from Promega. Unless otherwise indicated, all other reagents were purchased from Fisher
Scientific.

Tissue collection and processing

Samples were collected from patients who underwent surgical resection for histologically
confinned adenocarcinoma. As paired controls, specimens from the adjacent, grossly normal
tissues were harvested. The samples (12 pairs) were collected from the colon, kidney, and lung
with four pairs from each organ. The age of the patients was between 23 and 68 with seven
male and five female. The size of tumors was generally 2-5 cm in diameter, and the degree of
differentiation of tumors was moderate or poor as determined by pathological examination.

Samples were freshly processed for RNA isolation and protein extraction. Total RNA was
isolated with a Tri-reagent as described previously (Zhang et al, 1999). For the preparation of
protein extracts, tissues were homogenized in lysis buffer (20 mM Tris-HCI, pH 7.4, 1% Triton
X-100, I% sodium deoxycholate, 0.1 % SDS, 0.2 mM PMSF and I mM DTT).
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The

homogenates were centrifuged at 12,000 g for 30 min to remove any insoluble precipitates.
The protocol of using human pathological tissues was reviewed by tl1e Institutional Review
Board.

Reverse transcription coupled polymerase chain reaction (RT-PCR)
The expression of DEC I and DEC2 in human tissues and cultured cells was primarily
determined by RT-PCR experiments with a ThermoScript I kit.

Total RNA (2 µg) was

subjected to the synthesis of the first strand cDNA with an oligo(dT) primer and a
Them10Script reverse transcriptase. The reactions were incubated initially at 50°C for 30 min,
and tl1en at 60°C for 60 min after additional reverse transcriptase was added. The cDNAs were
tl1en subjected to PCR amplification with cycling parameters as follows: 95°C for 30s, 52°C for
30s and 68°C for 30 or 40s for a total of 32 cycles. The primers for DEC! amplification were:
5'-GTCTGTGAGTCACTCTTCAG-3', 5'-GAGTCTAGTTCTGTTTGAAGG-3'; the primers
for DEC2 amplification were: 5'-CGCCCATTCAGTCCGACTTGGAT-3', 5' -TGGTTGATCAGCTGGACACAC-3'; and the primers for (l-actin amplification were: 5'-GTACCCTGGCATTGCCGACAGGATG-3', 5'-CGCAACTAAGTCATAGTCCGCCTA-3'. The PCRamplified products were analyzed by agarose gel electrophoresis.

A cDNA encoding the full-length DEC! was isolated by a cDNA-trapping method (Li et al,
2002; Hu and Yan, 1999). Several DEC! mutant constructs were prepared by PCR wi th the
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full-length DEC I as the template. These mutants had a specific sequence deleted or one or
more amino acids substituted. Some of the mutant constructs were prepared with the SPORT
vector (the N-tem1inal truncated mutants), whereas others (the C-tenninal trnncated mutants)
were prepared with the Flag-vector to facilitate immuno-detection. ln some cases, a Kozak

sequence was introduced for effective translation initiation. The DEC2 promoter reporter was
prepared with the pGL3-basic luciferase vector (Promega). Human genomic DNA was isolated
from the placenta with a DNA extraction kit (Qiagen) according to the manufacturer's
instruction. A genomic fragment (-1,888to+11) was generated by PCR with 5' -AACAGATGAACTGAACGGACCG-3 ' and 5' -CCTCAGTGCAGTGTTGAAAGTG-3 ' .

This PCR

fragment was ligated to the pGL3 vector. Deletion mutants of this reporter were prepared by
endonuclease digestion followed by ligation or PCR.

Site-directed mutagenesis
The DEC2 promoter reporter had two E-box motifs that likely interact with DEC! , and the
studies with deletion mutants suggested that the E-box in the proximal region supports
DECl-mediated repression.

In order to definitively establish such a role, site-directed

mutagenesis was perfonned to substitute two of the six nucleotides. The mutant construct was
prepared with a QuickChange site-directed mutagenesis kit (Stratagene). Complementary
oligonucleotides

(5 '-GATGGTACGTTCCGAACGGGAGCTGGGTGCTGG-3 ')

were

synthesized to target this region. To perfonn the substitutions, the primers were annealed to a
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DEC2 promoter reporter and subjected to a thennocycler for a total of 15 cycles. The resultant
PCR-amplified constructs were then digested with Dpn I to remove the non-mutated parent
construct. The mutated ?CR-amplified constructs were used to transfom1 XLl-Blue. The
same approach was used to prepare three DEC! mutants that had single or double residues
substituted in the DNA binding domain (P56A, R58P or both). The general sequence for the
site-directed

mutagenic

oligonucleotides

was

5'-GAGACCTACAAATTGGCGC-

ACCCGCTCATCGAGAAAAAGAG-3' with the nucleotides in bold substituted individually
or simu ltaneously. All mutated constructs were subjected to sequencing analysis to confim1 the
desired mutation being made without secondary mutations.

Co-transfection experiment

Cells (293T) we re plated in 24-well plates in DMEM media supplemented with I 0% fetal calf
serum at a density of 1.6 x 10 5 cells per well. Transfection was conducted by lipofection with

LipofectAMJNE according to the manufacturer's instruction. Transfection mixtures contained
DEC! or a mutant construct (100 ng), reporter plasmid (100 ng) and the pRL-TK Renilla
plasmid(! ng). If DEC! stable line was used, DEC! or its mutant construct was omitted from
the transfection mixture. The transfected cells were cultured for an additional 24 h, washed
once with PBS and resuspended in passive lysis buffer (Promega). The lysed cells were
subjected to 2 cycles of freezing/thawing. The reporter enzyme activities were assayed with a
Dual-Luciferase Reporter Assay System. This system contained two substrates, which were
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used to determine the activity of two luciferases sequentiall y. The firefly luciferase activity,

which represented the reporter gene activity, was initiated by mixing an aliquot oflysates (20 µI)
with Luciferase Assay Reagent II . Then the firefly luminescence was quenched and the Renilla
luminescence was simultaneously activated by adding Stop & Glo Reagent to the sample wells.
The firefly luminescence signal was normalized based on the Ren ii/a luminescence signal. In a
case that the reading on the luciferase activity was too high, the lysates were diluted and
luciferase activities were then detennined to minimize the interference on the reading of the
Renilla luciferase activity.

Electrophoretic mobility shift assay CEMSAl
Cells (293T) were transfected with DEC I or a mutant and nuclear extracts were prepared with a
nuclear extraction kit (Active Motif). In some cases, DEC! stable transfected cells were used
but cultured in tl1e presence or absence of tetracycline to modulate the expression oftransfected
DEC!. Nuclear proteins (10

~1g)

were incubated with radiolabeled double-stranded oligonu-

cleotides (5'-CGTTCCGCACGTGAGCTGGG-3') in a final volume of JO µI containing IX
DNA binding buffer. For competition experiments, nuclear extracts were first incubated with
excess cold probe (50 or 10 X) and then mixed with the radiolabeled probe. Oligonucleotides
with a disrupted E-box were also used in the competition assays. For super-shift assays, the
anti-DEC I or an anti-Flag antibody was added either before or after tl1e nuclear extracts were
incubated with the radiolabeled probe. The protein-DNA complexes were resolved in 6%
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PAGE and visualized by autoradiography.

Western analyses were conducted as described previously (Zhu et al, 2000). The anti-DEC I
antibody against the C-tem1inal peptide was described elsewhere (Li et al, 2002). Protein
concentration was determined with BCA assay (Pierce) with bovine serum albumin as the
standard. Data are presented as mean ± SD of at least four separate experiments, except where

results of blots are shown in which case a representative experiment is depicted in the figures .
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RESULTS
DECI and DEC2 are inversely expressed in paired carcinomas and adjacent nom1al tissues
We have reported that DEC! is abundantly expressed in colon carcinoma but not in the adjacent
normal tissues (Li et al, 2002). The initial focus of the present study was to extend the
expression study on DEC! and to determine whether DEC ! and DEC2 shared similar
expression panems among paired cancer-normal tissues from the colon, kidney and lung.
RT-PCR experiments with primers specific to DEC ! and DEC2 were performed. As shown in
Figure 3-1 , without exceptions, the levels of DEC I mRNA were markedly higher in the
carcinomas, whereas the levels of DEC2 mRNA were markedly higher in the adjacent nomial
tissues.

Between paired samples, the levels of P-actin mRNA were comparable.

The

carcinoma-related increase in DEC I expression was also detected by Western blot (Top of each
depicted figure) , suggesting that mRNA levels are indicative of the overall expression of these
two genes.

Forced expression of DEC I proportionally decreases tl1e expression of DEC2
The inversed expression patterns between DEC! and DEC2 suggest that DEC! negati vely
regulates tl1e expression ofDEC2 or vice versa . In order to directly test this possibility, DEC !
stable transfected lines were used to study the expression relationship between DEC I and
DEC2. Two clonal stable lines were included: one expressing DEC! (wild type) and the other
expressing DEC!-M, which lacked the DNA binding domain. The stable lines were prepared
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Figure 3-1. Inversed ex pression patterns of DECI and DEC2 in the carcinoma a nd the
adj acent norma l tissues from the colon, kidney and lung
Total RNA (5 µg) of carcinoma-nonnal paired samples from the colon, kidney and Jung was
subjected to RT-PCR analyses with a ThermoScript I kit. For PCR amplification, a master tube
containing all common reagents was prepared and equall y distributed to individual PCR
reaction tubes (DEC!, DEC2 and J}-actin). PCR amplification was conducted with cycling
parameters as fo llows : 95°C for 30s, 52°C for 30s and 68°C for 30 or 40s for a total of32 cycles.
The PCR-amplified products were analyzed by agarose gel electrophoresis and visualized by
ethidium bromide staining. For Western blotting analysis, homogenates (I 0 µg) were subjected
to SOS-PAGE. The immunoblot was incubated with the anti body agai nst DEC!. The primary
antibody was then located by horseradish peroxidase-conjugated goat anti-rabbit lgG and

visualized with chemiluminescent substrate.
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with 293T cells and the pcDNA6ffR-pcDNA4 expression system, therefore, the expression of
DEC! and DECl-M was inducibly regulated by tetracycline as described previously (Li et al,
2002). As expected, addition of tetracycline caused a concentration-dependent increase on the
levels of DEC! as detennined by Western blots (Top, Figure 3-2A). Consistent with the
inducible increase on the levels of DEC! protein, the levels of DEC! mRNA were
proportionally increased (data not shown). In contrast to the increased expression of DEC I, the
levels of DEC2 mRNA were proportionally decreased (Figure 3-2A). However, such inversed
expression patterns were observed only in the cells expressing wi ld-type DEC! (Figure 3-2A)
but not the cells expressing the DECl mutant, even though the levels of DEC!-M were
markedly induced by tetracycline (Figure 3-28).

The E-box in the proximal promoter of DEC2 is the sequence targeted by DEC 1
The inability of DECl-M to down-regulate the expression of DEC2 suggests that
DECl-mediated repression is achieved through a DNA-binding mechanism.
directly test this possibility, reporter experiments and EMSA were conducted.

In order to
A DEC2

promoter reporter (pLuc-1888) was constructed to contain tl1e basal promoter and other
potential regulatory sequences of the DEC2 gene (- 1,888 to +1 1). This region was chosen
because it contained two E-box motifs that commonly serve as target sequences for bHLH
transcription factors (Littlewood and Evan, 1998). A series of 5' deletion mutants of this
reporter were also prepared and designed to specify the location of DNA sequence that is
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Figure 3-2. Repressed expression of DEC2 by DECI in stable transfected cells Stable
transfected cells by DEC! (A) or DECl-M (B) were seeded in 6-well plale. After reaching

-80% confluence, cells were treated with tetracycline at various concentrations (0- 1 µ g/ml) for
24 h. Total RNA and homogenates were prepared and analyzed for the expression of DEC I by
Western blots or DEC2 by RT-PCR as described in the legend for Figure 3-1. Similarly the
expression of P-actin was determined and served as controls.
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targeted by DEC! (Figure 3-3A, Left). Co-transfection experiments were conducted to test
these reporters for their ability to support DEC I-mediated activity. The stable transfected line
(wild-type DEC! only) was transfected again with a reporter construct and cultured in the
presence or absence of tetracycline to modulate the expression of DEC 1. The pRL-TK Ren ilia
plasmid was also included in the transfection mixture to normalize transfection efficiency. As
described in Figure 3-3A (Right), addition of tetracycline decreased the activity of the
pLuc-1888 reporter by as much as 90%. Similar repression was observed with the reporters
that had the sequence deleted up to the nucleotide -535. In contrast, reporter pLuc-125, which
had a further deletion from nucleotide -535 to-125, simultaneously lost the basal transcription
activity and the abi lity to respond to DEC! , suggesting the importance of this region (-535 to
-125) in both basal and regulatory transcription.

We next examined whether responsiveness to DEC! could be separated from the basal
transcription activity in the DEC2 promoter reporter. Given the fact that this region (-535 to
-125) contains a single E-box that is likely targeted by DEC! , a reporter with this E-box
disrupted was tested for the abil ity to confer basal transcription.

Reporter pLuc-535 was

subjected to site-directed mutagenesis to selecti vely disrupt the E-box (CACGTG to
AACGGG). Similarly, co-transfection experiments were perfom1ed. As shown in Figure 3-3A
(Bottom), disruption of this E-box (pLuc-535-M) caused little changes on the basal activity
(cultured without tetracycline), suggesting that this E-box contributes little to basal
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(

Figure 3-3. DEC l -mediated repression on the DEC2 promoter reporter a nd binding to
the proxima l E-box
(Al DECJ-mediated repression

011

the DEC2 promoter reporter Deletion and site-directed

mutants of the DEC2-promoter reporter (pLuc-1888) were prepared by endonuclease digestion
followed by ligation or by PCR with a QuickChange site-directed mutagenesis kit. DEC!
stable transfected cells were cultured in 24-well plates at -80% confluence and transfected
again with a reporter construct (100 ng) and the pRL-TK Renilla (I ng). The re-transfected
cells were cultured in the presence or absence of tetracycline(! µg/ml) for 24 h. The cells were
collected, washed once with PBS and resuspended in passive lysis buffer. The reporter enzyme
activities were assayed with a Dual-Luciferase Reporter Assay System.

The firefly

luminescence signal was nom1alized based on the Re11illa luminescence signal. (8) EMSA
DEC I stable transfected cells were cultured in the presence or absence of tetracycline (tet, I
µg/ml) for 24 hand nuclear extracts were prepared with a nuclear extraction kit (Active Motif).
Nuclear proteins ( 10 µg) were incubated witl1 radiolabeled double-stranded oligonucleotides
harboring the proximal E-box in a final volume of IO µI containing IX DNA binding buffer.
For competi tion experiments, nuclear extracts were first incubated with excess cold probe (50

X in lane I or I0 X lane 3) and then mixed witl1 the radiolabeled probe. Oligonucleotides (M)
with the E-box disrupted were also used in the competition assays (50 X in lane 2). For
super-shift assays, the anti-DEC I antibody (D) was added eitlier before (lane 5) or after (lane 6)
the nuclear extracts were incubated with the radio labeled probe. As a control, the anti-DEC!
antibody was rep laced by an ant i-Flag antibody (F, lane 4). The protein-DNA complexes were
resolved in 6% polyacrylamide gel electrophoresis and visualized by autoradiography.
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transcription. In contrast, the reporter mutant (pLuc-535-M) exhibited only-35% repression in
response to DECl (Figure 3-3A, lane 8), which contrasts strikingly to 90% repression observed
with the corresponding non-mutagenic reporter (Figure 3-3A, lane 5). These findings suggest
that the proximal E-box is largely responsible for DEC I-mediated repression. It should be
emphasized that similar observation was made with a substitution mutant reporter prepared

from the longest reporter pLuc-1888, and the expression levels of DEC! were comparable
among all cells as determined by Westem blots (data not shown).

We next examined whether this E-box interacted directly with DEC I. TI1e DEC I stable line
was cultured in the presence or absence of tetracycline and nuclear extracts were prepared.
Double-stranded oligonucleotides harboring this E-box were synthesized and radiolabeled.
The labeled probe was incubated with the nuclear extracts and analyzed by EMSA. As shown
in Figure 3-38 , incubation with the extracts from the cells cultured in the presence of
tetracycline yielded a shifted band (lane 8). This band was not detected when incubation was
performed with the extracts from the cell cultured without tetracycline (lane 7). The shifted
band was competed completely by 50 X (lane I) or partially by 10 X excess cold probe (lane 3).
However, the oligonucleotides (50 X) that harbored a mutated E-box (E-box-M) showed no
competitive activity (lane 2).

~1

addition, the shifted band was super-shifted by the anti-DEC I

but not the anti-Flag antibody. The super-shifted band appeared no matter if the antibody was
added before or after the DEC I-DNA complexes were fanned (lanes 5 and 6), suggesting that
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the antibody binding does not interfere with interactions between DEC I and its element (the
antibody directed against the C-tenninal sequence of DEC I).

DNA binding is required to effectively repress the DEC2 promoter reporter

Disruption of the proximal E-box caused drastic but incomplete loss of responsiveness to
DEC I (Figure 3-3A), suggesting that DNA binding is not the only mechanism involved in
DEC I-mediated repression on the DEC2 reporter or additional DEC! binding site exists in this
region. We next tested whether DEC! mutants, defective of DNA binding, had any repressive
activity. These mutants had one or more residues in the DNA binding domain substituted or
one or more structural domains deleted (Figure 3-4A).

A total of three deletion mutants

(DECI-M, DEC! 10,_. 12 and DECl 237•412 ) were prepared and all of them lacked the DNA
binding domain.

As shown in Figure 3-4A, additional sequences were also deleted in

DECllOs-412 (the HLH motif) and DECJ 237 _. 12 (the HLH motif and orange domain). The HLH
motif and the orange domain are shown in other bHLH proteins to mediate dimerization and
protein interactions, respectively (Littlewood and Evan, 1998). Similarly three substitution
mutants were prepared including DEClrs 6 A, DECI.,,, and DEClrs6 AIRS8P· The rationale for
preparing the substitution mutants was that praline 56 was assumed to be critical in DNA
binding based on studies with other bHLH proteins (Littlewood and Evan, 1998). However,
tl1ere is a major difference regarding the location of this praline. In other bHLH proteins, the
praline is located 2 residues more carboxylic terminal (corresponding to residue 58 in DEC!)
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(

Figure 3-4. Essentiality of DNA binding for DECJ to repress DEC2 promoter
activity

(A) Co-tra11s(ectio11 exeeri111e111 Cells (293T) were cultured in 24-well plates and transiently
transfected with DEC! or a DNA binding defective mutant (100 ng), DEC2 promoter reporter
(pLuc-1888, 100 ng) and the pRL-TK Renilla ( I ng). After a 24 h-incubation, cells were
collected and analyzed for luciferase activities. Similarly firefly luminescence siipial was
nomialized based on the Renilla luminescence signal, and the ratios from the cells transfected
with the vector were calculated as 100%. (BJ l1111111111ob/o//i11g analvsis The cell lysates (IO µg)
from the cells used for reporter activity were analyzed for the expression of DEC! or its
mutants by anti-DEC! antibody as described in the legend for Figure 3-1.

(CJ EMSA

Nuclear

contracts were prepared from cells transiently transfected with DECl or a mutant and incubated

with the radiolabeled proximal E-box probe. The DNA-protein complexes were resolved by
PAGE.
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8c ~ 8c

(Boudjelal et al, 1997; Fujimoto et al, 2001 ). 'Tilerefore, the mutants represented substitution of
proline 56 with an alanine (DEClrsM), arginine 58 with a praline (DECl Rssr), or both
(DEC I PS6AIRSSP).

Co-transfection experiments were conducted to test these DEC! mutants for their ability to
repress the DEC2 reporter (pLuc-1888). As shown in Figure 3-4A (Top), all deletion mutants
(DECl-M, DEC! 105412 , and DECI 237412 ) exhibited little repressive activity toward this
reporter. In contrast, all substitution mutants repressed the DEC2 reporter but the overall
repressive activity varied markedly among them. The DECl rsoA mutant showed a similar
potency as the wild-type DEC! (- 90% repression), whereas the other two mutants (DECI RssP
and DECI .,.AIRssr) caused only - 65 and - 50% repression, respectively. The expression of
DECl and its mutants was comparable with an exception ofDECl-M that was expressed to a
higher extent (Figure 3-4B), excluding the possibility that lack of expression was a contributing
factor to the observed less repression by some of the mutants (e.g., DECI .,.A/Rssr). In order to
determine whether these mutants, particularly the mutants DECI RSaP and DEClrsoAJRss r.
indeed lost DNA binding ability, nuclear extracts from the respective transfected cells were
incubated with the radiolabeled E-box oligonucleotides and the corresponding DNA-protein
complexes were analyzed by EMSA. As predicted, all deletion mutants (DEC 1-M, DEC! IOS-4l2•
and DECI 237.412 ) showed no DNA binding activity (result shown on DECl-M only) (Figure
3-4C). In contrast, DNA binding activity varied among the substitution mutants. DECl rsM
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showed a similar binding ability as DEC! , whereas DECIRssP and DECIP56NR58P had no DNA
binding activity, consistent with the fact that DEC I PS•A was the only substitution mutant that
effectively repressed the promoter activity of DEC2 (Figure 3-4A).

DNA binding is not sufficient to confer repressive activity

The studies with DNA binding defective mutants clearly demonstrated the importance of DNA
binding in repressing the DEC2 promoter. We next examined whether DNA binding was
sufficient to exert repression. In order to directly test this possibility, DEC I mutants were
prepared to keep the bHLH motif intact (DNA binding) but have sequences with various
lengths deleted from the C-tem1inus (Figure 3-5A). These C-tem1inal truncated mutants were
subcloned in the Flag-vector to faci litate immunodetection.

Similarly, co-transfection

experiments were perfom1ed with DEC! or a mutant along with the DEC2 reporter
(pLuc-1888). As shown in Figure 3-5A, deletion of the C-tenninal 65 residues (Flag-DEC l 1_347)
caused no changes on the repressive activity (Littlewood and Evan, et al, 1998). In contrast,
deletions of additional C-terminal sequence caused a partial or a complete loss of repressive
ability. As a matter of fact, Flag-DEC! 1. 150 no longer had any repressive activity. Western
analyses were performed to confirm that the mutants were actually expressed slightly higher
than the wild type DEC! (Figure 3-58).

Next, we examined whether these mutants actually retained DNA binding activity. EMSA was
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Figure 3-5. DNA binding is not sufficient for DEC ! to repress DEC2 promoter activity

(Al Co-transfection experiment Cells (293T) were cultured in 24-well plates and transiently
transfected with DECI or a C-terminal truncated mutant (100 ng), DEC2 promoter reporter
(pLuc-1888, 100 ng) and the pRL-TK Renilla (I ng). Detennination and calculation of the
luci ferase activities were described in the legend for Figure 3-4. (81 !1111111111ob/ot1ing analysis
The cell lysates ( IO µg) from tl1e cells used for reporter activity were analyzed for the
expression of DECI or its mutants by an anti-Flag antibody as described in the legend for
Figure 3-1.

(CJ EMSA

Nuclear contracts were prepared from cells transiently transfected with

DECI or a mutant and incubated with radiolabe led oligonucleotides harboring the proximal
E-box. Similarly competition experiments were performed with excess cold probe (E) or a
mutant probe (M) as described in the legend in Figure 3-3B.

For super-shift assays, an

anti-Flag (F) or the anti-DEC I (D) was added to the incubation mixtures before being analyzed
by PAGE.
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M

performed with the nuclear extracts from the cells used for reporter assays. As shown in Figure
3-SC, a shifted band was detected with all C-tem1inal truncated mutants.

The relative

electrophoretic mobility was generally associated with the size of a mutant.

For example,

Flag-DECJ 1• 150 was the shortest among the mutants and the shifted band with this mutant
exhibited the fastest mobility. More importantly, addition of an anti-Flag antibody into the
binding reactions resulted in the appearance of a super-shifted band accompanied by the
disappearance of the original shifted band, providing direct evidence that the observed
protein-DNA interactions were highly specific. These findings also suggest that DNA binding,

although essential, is not sufficient to confer repressive effect.

The HLH motif is required for dominant interfering regulation
The inability of Flag-DEC! 1. 150 to exert repression, although it bound effectively to DNA,
points to two important possibilities: the deleted region from residue 150 to 347 has intrinsic

repressive activity, or this region is responsible for recruiting protein(s) that causes repression.
Apparently comprehensive experiments are required to definitively establish the involvement
of each possibility. However, we examined the second possibility by testing mutants that
contained part or the entire sequence of this region for the ability to function as a dominant
interfering regulator. Co-transfection experiments were conducted witl1 DEC I in the presence
and absence of a mutant.

Among mutants DECl-M, DEC! 10, _. 1,, and DECl m _, 12 , only

DECl-M effectively reversed DECl-mediated repression (Figure 3-6A), although they all
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shared two important features: lacking the entire DNA binding domain and lacking repressive
activity themselves (Figure 3-4A).

Among the substitution mutants, DEC I RS BP and

DEC I rs•AJRS BP but not DEC I"" ' partially but significantly reversed DEC I-mediated
repression, consistent with the fact that DEClrssA was a potent repressor itself (as potent as
wild type DECl), whereas DEClRssP and DEClrS6A/R5SP were much less repressive (Figure
3-4A). It should be emphasized that the expression patterns in the cells co-transfected with
DECl and a mutant were consistent with what was predicted: a band with more intensified
staining was detected if a mutant co-migrated with DEC! (e.g., DEClrs•AJRSBP), otherwise, an
addi tional band (e.g., DEC 1105412 ) was detected if a mutant and DEC I were electrophoretically

distinct.

We also tested all C-tem1inal truncated mutants for the abi li ty to function as dominant
interfering_regulators. Generally, these mutants either partially or completely antagonized
DEC I-mediated repression depending on the relat ive potency to act as a repressor by its own
(Figure 3-68). Mutants with less intri nsic repressive activity exhibited a higher potency to
reverse the repression by DEC!. For exan1ple, Flag-DEC l 1. ,,0 itself had no repressive activity
(Figure 3-4A) but completely reversed DECI-mediated repression (Figure 3-6B). Among all
mutants that were less repressive than wild type DEC!, only DECl 105412 and DECI 237412 failed
to reverse tl1e repression by DECl (Figure 3-6), and they were the only mutants that did not
contain the HLH domain (Figure 3-4A and 3-SA), suggesting that the dominant interfering
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Figure 3-6. Dominant interfering regulation on DEC l-mediated repression
(Al Effects of DNA binding defective mutants on the repressive activity by DEC 1 Cells (293T)
were cultured in 24-well plates and transiently transfected with DEC 1 (50 ng) in the presence
or absence of a DNA binding defective mutant (100 ng). Vector construct was used to equalize
the amount of plasmid in each transfection. Similarly, the pRL-TK Ren ilia plasmid (I ng) was
included in the transfection mixture to normalize transfection efficiency. Cell lysates (I 0 µg)
from the cells used for reporter activity were analyzed for the expression of DEC I and its
mutants by the anti-DEC! antibody (specific to tl1e C-tenninus of DEC!). (BJ Effects o[/he

C-terminal truncated mutants on the repressive activity bv DEC/ The co-transfection and
immunodetection were performed as described in the legend for Figure 3-6A. However, both
anti-DEC! and anti-Flag antibodies were simultaneously used for tl1e inununodetection
because the C-tem1inal tnmcated constructs were prepared with the Flag-CMV vector..
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regulatory activity is achieved tluou gh the HLH domain. The HLH domain is known to
mediate dimerization (1), mutants with an intact HLH domain likely form dimers with wild
type DEC I, but the resultant dimers have no DNA binding activity or are transcriptionally
inactive. In support of the first possibility, we perfom1ed EMSA and found that DECIRssP and

DEClrsoNRSSP (DNA binding defective mutants) markedly abolished the DNA binding ability
of DEC I when cells were co-transfected together with DEC! and DECIRssP or DECl ps 6NRssr
(data not shown).
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DISCUSSION
The bHLH proteins are intimately associated with developmental events such as cell
differentiation and lineage commitment (Littlewood and Evan, 1998). Based on sequence
alignment and functional domain analyses, human DEC proteins, along with mouse STRA and
rat SHARP, constitute a new class of bHLH transcription factors (Boudjelal et al, 1997;
Fujimoto et al, 2001 ; Rossner et al, 1997; Shen et al, 1997). These proteins are shown to play
important roles in cell differentiation, regulation of molecular clock, immune response and
xenobiotic response (Boudjelal et al, 1997; Shen et al, 1997; Miyazaki et al, 2002; Shen et al,
2002 Sun et al, 2001; Honma et al, 2002 Zawel et al, 2002). Recently we have reported that

DEC I is abundantly expressed in colon carcinomas, antagonizes serum deprivation-induced
apoptosis and selectively inhibits the activation of procaspases (Li et al, 2002). In this report,
we describe inversed expression patterns between DEC 1 and DEC2 among paired
tumor-nom10l samples from the colon, lung and kidney. Experimentally forced induction of
DEC I causes proportional decreases in the expression of DEC2.

Given the fact that

DEC/STRNSHARP proteins are highly identical (>90%) in the DNA binding region, whereas
much diverse in other areas (<40%), our findings described in this report provide an important
mechanism by which the cellular function of target genes likely shared by these proteins can be
coordinately affected by members within the same class.

DNA binding is likely the primary mechanism responsible for DECl-mediated repression on
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the expression of DEC2, although members of DEC/STRA/SHARP protein family have been
shown to use non-DNA binding mechanism(s) (Sun and Taneja, 2000; Garriga-Canul et al,
2001; Yun et al, 2002). Several lines of evidence presented in this study support this notion.
First, studies with deletion and site-directed reporter mutants identify the proximal E-box that
supports the repression by DEC! , this E-box exhibits a high affinity toward DEC! and
disruption of this E-box markedly reduces its responsiveness to DEC! (Figure 3-3), suggesting
that DNA binding is involved in the DECl-mediated repression.

Second, DEC! deletion

mutants (DECl-M, DEC! 10 , 41 ,, and DEC1 237 _. 12 ) , which Jack the entire DNA binding domain,
show neither DNA binding ability nor repressive activity (Figure 3-4A), providing direct
evidence that DNA binding is required for DEC! to repress the DEC2 promoter. Finally,
among the substitution mutants, DEC1 Pl8A binds to the E-box as much as wild type DEC ! and
is equally active in repression, whereas DEC1 Rl8P and DEC1 Pl 6NRl8P show no DNA binding
ability and are much less repressive (Figure 3-4A), further supporting the notion that
DEC I-mediated repression is largely achieved through DNA binding. The precise mechanism
remains to be determined on whether DEClRssP and DEClrs•NRSSP, altl10ugh Jacking DNA
binding ability, cause some repression. It is likely that these two mutants retain some DNA
binding ability within the cells, but the conditions employed for EMSA fail to support such
interactions. Alternatively, they exert repression through non-DNA binding mechanisms (Sun
and Taneja, 2000; Garriga-Canul et al, 2001; Yun et al, 2002).
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(

DNA binding, although required to exert effective repression, is not sufficient to repress the

DEC2 promoter. Mutant Flag-DECI 1• 150, for example, binds effectively to DNA but shows no
repressive activity (Figure 3-5A). As a matter of fact, mutants, with a deletion in the region
from residue 150 to 347, all bind to DNA as effectively as wild type DEC!, but are markedly
less repressive (Figure 3-5A). In this region, several helical structures and particularly an
orange domain are located (Boudjelal et al, 1997; Fujimoto et al, 2001). These structures are
assumed to mediate protein-protein interactions based on studies with other bH LH proteins
(Littlewood and Evan, 1998; Boudjelal et al, 1997; Fujimoto et al, 2001). It is likely that this

region recruits proteins that cause repression. However, the necessity of protein recruitment to
repress DEC2 is unlikely, because mutants such as DEC! 105 ., 12 contain the entire sequence of
this region but show no dominant interfering activity against wild type DEC! (Figure 3-6A),
suggesting that this region has intrinsic repressive activity. Alternatively, proteins assumed to
be recrnited are abundantly expressed in the cells employed in this study. Although we have
not provided sufficient data to support protein recrnitment in repressing DEC2, it can not be
excluded that such events are involved in the regulation of other genes by DEC I, particularly
given the fact mouse STRA13, a highly identical protein to DEC!, has been shown to interact
directly with TFIIB through this region (Sun and Taneja, 2000).

DEC/STRNSHARPs differ significantly from other bHLH proteins in tem1s of binding to
DNA. Most bHLH proteins bind to E-box (CANNTG) or N-box (CANNAG).
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Binding

preference is specified by the sequence in the basic region. Generally, proline-containing basic
regions have higher affinity toward the N-box (Littlewood and Evan, 1998; Akazawa et al,
1992), whereas the basic regions without a proline preferentially recognize the E-box.
DEC/STRNSHARPs contain a proline, however, this proline (residue 56 based on DEC! ) is
located 2 residues more amino terminal (Fujimoto et al, 2001). Instead, DEC/STRNSHARPs
have an arginine (residue 58) that substitutes the conserved proline an1ong N-box binding
bHLH proteins. Although initial studies suggest that STRA 13 has no binding activity toward
classic E- or N-box (Boudjelal et al, 1997), PCR-based site selection experiments have recentl y
identified a class B type E-box (CACGTG) that is effectively bound by DEC I and STRA 13
(Zawel et al, 2002; St-Pierre et al, 2002).

In this study, we have demonstrated that the

contribution of Pro, 6 to DNA binding is insignificant because mutant DECl mA is equally
effective as wild type DEC! in DNA binding (Figure 3-4C). In contrast, introduction of a
proline by substituting Arg,. completely eliminates DNA binding activity (Figure 3-4C),
suggesting that residue in this location is indeed imponant for E-box binding. It would be
interesting to test whether DECIRssr and DECl., 6AIRssP show an increase in binding to an
N-box sequence.

In addition, the DEC2 reponer contains two identical E-box sequences

(proximal and distal, Figure 3-3A), however, only the proximal E-box is required for
responding to the repression by DEC!. The precise mechanism for such a difference remains to
be determined. It is likely that the genomic context rather than an E-box alone determines
intracellular DNA binding.

In suppon of this possibility, STRA 13 has been shown to
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preferably bind to an E-box flanked with certain nucleotides.

DEC! and DEC2 share the DNA binding domain with an exception of a single residue
(aspartate versus glutamate, the farthest N-tem1inal residue of this domain) (Fujimoto et al,
2001), therefore, DEC2 likely acts as an auto-regulator. This possibility is further supported by
their highly identical sequences flanking the DNA binding domain.

Immediately the

C-terminal to the DNA binding domain is the helix-loop-helix domain that is identical between
DEC I and DEC2, and the N-terminal to this domain is an acidic residue-rich stretch in both
proteins (Fujimoto et al, 2001). The DNA binding domain and its highly identical flanking
sequences suggest that DEC! and DEC2 have overlapping target genes, particularly those that
are regulated through direct DNA binding. ln support of this notion, mouse proteins (STRAl3
and DEC2) have been recently shown to repress Clock/Bmall-induced activation of the Per
promoter (Honma et al, 2002), a gene that is involved in the regulation of molecular clock.
Therefore, it is likely that DEC/STRNSHARP proteins are functionally redundant on some
target genes, and such a redundant mechanism provides a possible explanation that STRA 13
knockout mice develop to adulthood and show no discernible phenotypic differences compared
with their wild-type littermates (Sun et al, 2001). It should be emphasized, however, that DECI
and DEC2 may not necessarily exert the same biological activity on all target genes and in all
cell types, particularly given the fact that they have a minimal sequence identity (<40%) in tl1e
C-lem1inal half and exhibit several major structural differences (Fujimoto el al, 2001). Botl1
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DEC I and DEC2 have an orange domain (two helical structures spanned by - 50 residues),
however, the overall sequence identity in this domain is only moderate (- 50%). In addition, an
alanine/glycine rich region is present in DEC2 but absent in DEC!. Previous studies with
STRA 13 as well as the findings described in this study have demonstrated that the region
harboring the orange domain is required to exert effective repression by both proteins (Figure
3-5A,).

Amino acid repeats, on the other hand, are implicated in protein folding,

protein-protein interactions and degradation (Katti et al, 2000).

DEC I-mediated repression is likely responsible for the differences on cell and tissue
distributions between DEC! and DEC2. Although Northern analyses have shown that DEC!
and DEC2 have an overlapping tissue distribution (Fujimoto et al, 2001; Shen et al, 1997), it
remains to be detennined whether they are actually expressed in the same cell type and to a
similar extent (Fujimoto et al, 2001; Shen et al, 1997). Some organs with high levels of DEC!
(e.g., li ver) express lowe r levels ofDEC2 (Shen et al, 1997). Very recently, DEC! and DEC2
are found to regulate the manunalian molecular clock, but they exhibit distinct and
area-dependent expression patterns in the brain (Sun et al, 200 I). In this report, we have
demonstrated that these two proteins exhibit inversed expression patterns among the paired
tumor-normal tissues, forced expression of DEC! causes proportional decreases in the
expression ofDEC2 (Figure 3-1and2), providing direct evidence that increased expression of
DEC I is at least in part responsible for decreased expression of DEC2 in a given cell context.
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DEC I-mediated repression, although profound, may not always dictate the expression of
DEC2. For example, DEC! and DEC2 are both up-regulated in response to hypoxia induction
(Miyazaki et al, 2002). Acute hypoxia is considered severe cytotoxic stimulus, rapid induction
of both genes maximizes cellular survival mechanism based on our recent report that DECl is

antiapoptotic (Li et al, 2002), although it remains to be detennined whether DEC2 is actually
antiapoptotic as well.

In sununary, we have demonstrated that DEC! is a negative regulator on the expression of
DEC2. These two proteins exhibit inversed expression patterns among paired samples from the
colon, kidney and lung.

An inducible expression system demonstrates that increased

expression of DECJ proportionally decreases the expression of DEC2. The DEC I-mediated
repression is primarily achieved by binding to tl1e E-box in the proximal promoter of DEC2.
Site-directed mutagenesis studies show that arginine-58 in the DNA binding domain is critical
for DEC! to interact with this E-box. Given the fact that DEC/STRA/SHARP proteins are
being emerged as very important regulators in a vast array of cellular events including cell
differentiation, maturation of lymphocytes, oncogenesis, molecular clock and xenobiotic

response, our findings described in this study provide an important mechanism that these
proteins regulate the cellular function not only by modulating the expression of their target
genes but also the expression of the members within the same class.

150

REFERENCE
Akazawa C, Sasai Y, Nakanishi S, Kagemaya R (1992) Molecular characterization of a rat
negative regulator with a basic helix-loop-helix structure predominantly expressed in the
developing nervous system. J. Biol. Chem. 267, 21879-21885.
Bissonnette, R. P., McGahan, A., Mahboubi, A., and Green, D.R. (1994) Functional myc-max
heterodimer is required for activation-induced apoptosis in T cell hybridomas. J. Exp. Med. 180,
2413-2418.
Boudjelal, M., Taneja, R., Matsubara, S., Bouillet, P., Dolli:, P., and Chambon, P. (1997)
Overexpression of Strati 3, a novel retinoic acid-inducible gene of the basic helix-loop-helix
family, inhibits mesodermal and promotes neuronal differentiation of Pl9 cells. Genes Dev. II ,
2052-2065.
Chen, G., Fernandez, J., Mische, S., and Courey, A. (1999) A functional interactions betwee n
tl1e histone deacetylase Rpd3 and the corepressor Groucho in Drosophila development. Genes
Dev. 13, 2218-2230.
Cronmiller, C., Schedl, P., and Cline, T. W. ( l 988) Molecular characterization of daughterless, a
drosophila sex determination gene with multiple roles in development. Genes Dev. 2,
1666-1676.
Dawson SR, Turner DL, Weintraub H, Parkhurst SM (l 995) Specificity for the hairy/enhancer
of split basic helix-loop-helix (bHLH) proteins maps outside the bHLH domain and suggests
two separable modes of transcriptional repression. Mo/. Cell Biol. 15, 6923-693 l .
Fisher, A. L., Ohsako, S., and Caudy, M. (l 996) The WRPW motif of the hairy basis
helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and

protein-protein interaction domain. Mo/. Cell. Biol. 16, 2670-2676.
Fujimoto, K., Shen, M., Noshiro, M., Matsubara, K., Shingu, S., Honda, K., Yoshida, E.,
Suardita, K., Matsuda, Y., and Kato, Y. (200 l) Molecular cloning and characterization of DEC2,
a new member of basic helix-loop-helix proteins. Biochem. Biophys. Res. Commun. 280,
164-17!.
Garriga-Canu!, M., Roopra, A, and Buckley, N.J. (2001) The basic helix-loop-helix protein,
sharp-!, represses transcription by a histone deacetylase-dependent and a histone
deacetylase-independent mechanism. J. Biol. Chem . 276, l 4821- 14828.

151

Giebel, B., and Campos-Ortega, J.A. (1997) Functional dissection of the drosophila enhancer
of split protein, a suppressor of neurogenesis. Proc. Natl. A cad. Sci. USA 94, 6250-6254.
Hirose, K., Morita, M., Ema, M., Mimura, J., Han1ada, H., Fujii, H., Saijo, Y., Gotoh, 0.,
Sogawa, K., and Fujii-Kuriyama, Y. ( 1996) cDNA cloning and tissue-specific expression of a
novel basic helix-loop-helix/PAS factor (Amt2) with close sequence similarity to the aryl
hydrocarbon receptor nuclear translocator (Amt). Mo/. Cell Biol. 16, 1706-1713.
Hojo, M., Ohtsuka, T., Hashimoto, N., Gradwohl, G., Guillemot, F., and Hageyama, R. (2000)
Glial cell fate specification modulated by the bHLH gene HESS in mouse retina. Developmem
127, 2515-2522.
Honma, S., Kawamoto, T., Takagi, Y., Fujimoto, K., Sato, F. , Noshiro, M., Kato, Y. , and Honma,
K. (2002) Deel and Dec2 are regulators of the mammalian molecular clock.Nature 419,
84 1-844.
Hu, M., and Yan, B. (1999) Isolation of multiple distinct cDNAs by a single cDNA-trapping
procedure. Ana/y. Biochem. 266, 233-235.
Ivanova, A. V. , Ivanov, S.V., Danilkovitch-Miagkova, A., and Lerman, M.I. (2001) Regulation
of STRA 13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the
UBC9/ubiquitin proteasome degradation pathway. J. Biol. Chem. 276, 15306-15315.
Katti, M.V. , Sami-Subbu, R. , Ranjekar, P.K., Guptu, V.S. (2000) Amino acid repeat patterns in
protein sequences: their diversity and structural-functional implications. Protein Sci. 6,

1203-1209.
Kokubo H, Lun Y, Johnson RL (1999) Identification and expression of a novel fami ly ofbHLH
cDNAs related to Drosophila hairy and enhancer of split.
Biochem Biophys Res Co1111111111. 260, 459-465.

Li Y, Zhang H, Xie M, Hu M, Ge S, Yang D, Wan Y, Yan B (2002) Abundant expression of
Dec l/stra I 3/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced
apoptosis and selective inhibition ofprocaspase activation.Biochem J. 367, 413-422.
Littlewood, T. D., and Evan, G.I. (1998) Helix-loop-helix transcription factors, Oxford
University Press, pp 1-48.
Massari, M. E. , and Murre, C. (2000) Helix-loop-helix proteins: Regulators of transcription in
eucaryotic organisms. Mo/. Cell. Biol. 20, 429-440.

152

Miyazaki , K. , Kawamoto, T., Tanimoto, K. , Nishiyama, M., Honda, H., and Kato, Y. (2002)
Identification of functional hypoxia response elements in the promoter region of the DEC I and
DEC2 genes. J. Biol. Chem. 277, 47014-47021.
Nikoloff, D. M., McGraw, P., and Henry, S.A. (1992) The IN02 gene of saccharomyces
cerevisiae encodes a helix-loop-helix protein that is required for activation of phospholipid
synthesis. Nucleic Acids Res. 20, 3253-3257.
Ohtsuka, T., Sakamoto, M. , Guillemot, F. , and Kageyama, R. (2001) Roles of the bHLH genes
HES! and HESS in the ex pansion of neural stem cells of the developing brain. J. Biol. Chem.
276, 30467-30474.
Poortinga, G. , Watanabe, M. , and Parkhurst, S.M. (1998) Drosophila CtBP: a hairy-interacting
protein required for embryonic segmentation and hairy-mediated transcriptional repression.

EMBO J. 17, 2067-2078.
Rossner, M. J. , Dorr, J., Gass, P., Schwab, M.H., and Nave, K.A. ( 1997) SHARPs: mammalian
enhancer-of-split and hairy-related proteins coupled to neuronal stimulation. Mo/. Cell.
Neurosci. 9, 460-475 .

Shen, M., Kawamoto, T., Yan, W., Nakamasu, K., Tamagami, M., Koyano, Y., Noshiro, M. , and
Kato, Y. (1997) Molecular characterization of the novel basic helix-loop-helix protein DEC I

expressed in differentiated human embryo chondrocytes. Bioclzem. Biophys. Res. Comm un.
236, 294-298.
Shen, M., Yoshida, E., Yan, W., Kawamoto, T. , Suardita, K., Koyano, Y. , Fujimoto, K. , Noshiro,
M., and Kato, Y. (2002) Basic helix-loop-helix protein DEC! promotes chondrocyte
differentiation at the early and tem1inal stages. J. Biol. Chem. 277, 50112-50120.
St-Pierre, B., Flock, G., Zacksenhaus, E., and Egan, S.E. (2002) Stra!3 homodimers repress
transcription through class BE-box elements.J. Biol. Chem. 277, 46544-46551.
Sun, H. , Lu, B. , Li, R.Q. , Flavell, R.A., and Taneja, R. (2001) Defective T cell activation and
autoimmune disorder in Stra13-deficient mice. Nat lmmunol. 2, 1040-1047.
Sun, H. , and Taneja, T. (2000) Stra ! )expression is associated with growth arrest and represses
transcription through histone deacetylase (HDAC)-dependent and HDAC-independent
mechanisms. Proc. Natl. A cad. Sci. USA 97, 4058-4063.

153

Yun, Z., Maecker, H.A., Johnson, R.S., and Giaccia, A.J. (2002) Inhibition of PPAR gamma 2
gene expression by the HIF-1-regulated gene DECl/Stral3: a
mechanism for regulation of adipogenesis by hypoxia.Develop. Cell 2, 331-341.
Zawel, L., Yu, J., Torrance, C.J ., Markowitz, S., Kinzler, K.W., Vogelstein, B., and Zhou, S.
(2002) DEC! is a downstream target of TGF-beta with sequence-specific transcriptional
repressor activities. Proc Natl Acad Sci US A . 99, 2848-2853.
Zhang, H., LeCluyse, E., Liu, L., Hu, M., Maloney, L., and Yan, B. ( 1999) Rat pregnane X
receptor: molecular c loning, tissue distribution and xe nobiotic regu lation. Arch. Biocltem.

Biophys. 368, 14-22.

Zhu, W., Song, L. Matoney, L. , LeCluyse, E., and Yan, B. (2000) Dexamethasone differentiall y
regulates the expression of carboxylesterase genes in humans and rats. Drug Metab. Disp. 28,
186-191.

154

CONCLUSIONS

The purpose of this dissertation is to elucidate the oncogenic roles of DEC! and detem1ine the
molecular actions of DEC! on transcription regulation. Unique structure of DEC! indicates
that it has distinct biological functions and unique mechanism on transcription reg11lation.
Tumor-related expression pattern of DEC! suggests that DEC! is involved in oncogenesis.
Thus, the significance of the studies reported in this dissertation will contribute to our basic
understandings ofbHLH proteins as a fami ly of transcription factors involved in oncogenesis.

Expression of DEC ! is related to tumor and cell cycle progression.
In an effort to identify genes that are differentially expressed between colon carcinomas and the
adjacent normal tissues, we perfom1ed cDNA subtractive assay, a technique that identifies
genes highly expressed in one tissue over another. A cDNA wi th 98% sequence identity to
DEC! was identified. The amino acid sequence encoded by this cDNA was exactly the same as
DEC I. The initial goal of the studies described in manuscript I was to detennine if the
expression of DEC! is related to tumors. I hypothesized that DEC! is up-regulated in tumor
tissues. The rationale for this hypothesis was based on the following observations: I) DEC! is
cloned from human colon carcinoma tissues, which indicates that DEC! might be highly
expressed in tumor tissues; 2) cells that lack the functional tumor suppressor VH L express
higher levels of DEC!; 3) hypoxia induces DECI via HIF, a transcription activator which is
highly expressed in tumor.
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To examine the relationship between the expression of DEC! and tumor, human paired samples

from carcinoma tissues ru1d adjacent normal tissues were collected from colon, lung and kidney.
Both mRNA levels and protein levels of DEC! were markedly higher in all these carcinoma
san1ples, but very low levels of DEC I were detected in the paired normal samples. This result
confirmed our hypothesis that DEC! is highly expressed in tumor tissue.

Since DEC! is abundantly expressed in tumors but not in the adjacent nomial tissues, its
expression is probably related to nutrient requirement and cell confluence.

~1

DLD cells, a

colon carcinoma derived human cell line, post-confluent cells express much higher DEC I than
less confluent cells. post-confluent cells usually undergo growth arrest and fail to continue
cycle progression. Therefore, DEC! expression is probably linked to cell cycle states. To test
this possibility, DLD cells were treated with different cell cycle blockers to arrest cells at GO,
GI, Sand G2 phases. Protein level of DEC! demonstrated that S blocker hydroxyurea and G2
blocker nocodazole markedly induced DEC!. The induction was observed as early as 6 hours
after treatment. Cell cycle synchronization nom1ally needs 24 hours. This rapid induction of
DEC! suggests Urnt the induction of DEC! occurs prior to cell arrest rather than as a result of
this effect.

Therefore, DEC!

may slow down cell cycle progression and has

proliferation-inhibitory effects.

In order to test the possibility that DEC I inhibits cell proliferation, stable transfectants were

156

prepared. Sense, mutant and anti-sense DEC I constructs were stably transfected into T-Rex
293 cells, in which the inserted genes can be inducibly regulated by tetracycline. As expected,
proliferation studies revealed that sense cells with tetracycline showed much lower growth
rates than the same cells cultured without tetracycline. The mutant cells, which encode a
mutant DEC l lacking the DNA binding domain, had no effects on proliferation. The
requirement for DNA binding domain implied that DEC! inhibits cell proliferation through
regulating other protein expressions. It is interesting to note that DEC! has proliferation
inhibiting activity. Cancer cells always have high proliferation rate. However, in some

conditions such as in short of blood supply, high proliferation is not good fo r cell survival. Cells
with lower growth rate may have higher survival ability and are resistant to death. Thus, DEC l
might help cells against apoptosis, an event occurs when cells are in short of nutrients.

DEC! antagonizes serum deprivation-induced apoptosis.
Tumor related expression of DEC I and its anti-proliferation activity suggests it may protect
cells against apoptosis. Therefore, another goal of the studies described in manuscript l was to
test the hypothesis that DEC! has antiapopototic activity, an effect that favors tumor survival.
The rationale for this hypothesis included: l) DEC! is highly expressed in over-confluent cells
which usually undergo apoptosis due to nutrient depletion; 2) DEC! is rapidly induced by
detrimental stimuli like hypoxia and treatment with cytotoxic chemicals like hydroxyurea and
nocodawle, indicating that DEC 1 has cytoprotective functions and prevents cells from death; 3)
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DEC! is up-regulated by H!F-la, an transcription factor that has been show to have
anti-apoptotic effects.

To test this hypothesis, the DEC! stable transfectants were cultured in serum free media in the
presence or absence of tetracycline to imitate nutrients depletion conditions and to induce

apoptosis. After 48 hours, cells cultured without tetracycline showed typical apoptotic changes
while cells cultured with tetracycline displayed normal appearances. This anti-apoptotic effect
was also confim1ed by DNA fragmentation, a hallmark of cell apoptosis. Like anti-proliferation
effects, this antiapoptotic effect also required DNA binding domain because DEC I mutant cell
lines failed to prevent serum deprivation induced apoptosis.

Caspases are a family of cysteine proteases that play central roles in regulating apoptotic
process. Pro-apoptotic signals, like FasL, TNF and DNA damages activate initiator caspase 8.
Cytochrome C released from mitochondria is coupled to the activation of caspase 9, another
key initiator caspase. Activation of both caspase 8 and 9 results in the activation of downstream
effector caspases 3 and 7, which in tum cleaves cytoskeletal and nuclear proteins and induces
apoptosis. To test whether DEC! has any effects on these caspases activation, cell lysates from
serum deprived stable transfectants were prepared and assayed for the activities of caspase 3/7,
8 and 9. The activities of caspase 3/7 and 9, but not 8, were markedly decreased by DEC!. The
expression levels of these procaspases have no changes, which implied that DEC I inhibits tl1e
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activation process ofprocaspases rather than represses the expression level ofprocaspases.

DEC! upregualtes the antiapoptotic protein, survivin.

The goal of the studies reported in manuscript II was to extend the apoptotic study ofDEC l and
detennine the signaling pathways leading to apoptotic inhibition. Several classes of proteins,
notabl y the inhibitor of apoptosis protein (!AP) family, have been shown to inhibit procaspase
activation and the catalytic activity of several caspases. To test whether DECl has any effects
on lAP protein regulations, we examined the expression levels of several IAP proteins

including c!AP-1, clAP-2, XIAP and survivin in DEC! stable transfectants treated with semm
deprivation. Among these IAP proteins, only survivin was markedly increased in

tetracycline-treated cells, suggesting that DEC! selectively increases the expression of !AP
proteins. The induction ofsurvivin by DEC! was consistent to the following observations: 1)
Both survivin and DEC! are upregulated in tumors; 2) The expressions ofsurvivin and DEC!
are cell cycle dependent and upregualted by cell cycle blocker nocodazole; 3) Survivin has
been shown to inhibit the activation ofprocaspase 3 and 9, but not 8, consistent to the activities
of DEC!. Moreover, paralleled expression pattem between DEC! and survivin in paired
tumor-nonnal tissues also supported the notion that DEC I regulates the expression of survivin.

It should be noted that the upregulation of survivin by DEC I only occured in semm deprived

cells and was time-dependent. Time course studies showed that survivin expression declined
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after 24 hours of serum deprivation, but little changes were observed before 24 hours
incubation. However, the expression of DECI prevented the decrease of survivin expression

and kept survivin to a relative high level, thus protected cells from death.

Two mechanisms, namely increased survivin stab ility and/or exprssion, are likely responsible
for such a relatively higher steady level of survivin. Same increase patterns were observed in

both survivin mR.NA and protein levels, suggesting that DEC! mediated induction ofsurvivin
is achieved through transcription acti vation. To test this possibility, transfection studies were

conducted with survivin promoter reporters pSurvivin-6270 and pSurivivin-268. Both these
two reporters showed 5 fold induction of survivin by DEC I in serum deprived stable
transfectants. Similar induction fold on reporter pSurvivi n-6270 and pSurvivin-268 indicated
that the responsible sequences for DEC ! are located downstream of site -268 in survivin
promoter.

Multiple Spl binding sites are responsible for the survivin induction by DECI
Sequences analysis reveals that a clustered Spl /CDE region (cycle dependent element) is
located in the proximal region of surviv in promoter and has been shown to mediate basal
transcription. However, no E-box is identified in this region. In order to identify DNA
sequences that act as potential binding sites for DEC I, ten oligonucleotides were synthesized to
span the entire promoter region of reporter pSurvivin-268. EMSA studies with these
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oligonucleotides identified Spl-127 and Spl-226 as two Sp! binding sites whose DNA-protein
bindings were dramatically increased in the presence of DEC!. Deletion and substitution
mutation assays on pSurvivin-268 reporters showed that Sp! sites-127 and 226 additively
activated the survivin promoter reporter in response to DEC!. Super-shift studies using
an ti-Sp I and anti-DEC ! antibodies found that both DEC! and Sp! bond to the Sp! sites- 127
and 226. The DEC! mutant lacking the DNA-binding domain failed to induce survivin,
suggesting the DNA binding requirement of this activity. The delayed induction on survivin
implied that the induction was through regu lating otl1er transcription factors. However, the
direct binding of DEC I to Sp I-protein complex indicated that DEC! was directly involved in
this transcription activation. Therefore, DEC! up-regulates survivin probably through more
than one mechanism. It remains to be detemuned whether the interaction between Sp I-binding
site and DEC I requires basic domain and whether DEC I binds to Sp I-binding site directly or
through other proteins.

DECI negatively regulates the expression of DEC2
Soon after DECl /STRA13/SHARP2 was reported, Fujimoto et al (2001) identifies human,
mouse and rat DEC2, a novel member of the DEC subfannly. DEC2 has high (97%) similarity
with DECI in the bHLH region but has a quite different c-terminal part. These two proteins
show different tissue distributions. To determine if DEC2 has similar expression patterns in
tumors like DECI, mRNA levels ofDEC2 were tested in paired tumor-normal tissues from the
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colon, Jung and kidney. In contrast to DECI which was highly expressed in tumors, DEC2 was

expressed markedly higher in the adjacent normal tissues and had reverse expression patterns
with DECI in all the samples tested. Searching of the DEC2 promoter sequence identified two
classical E-box sequence CACGTG at position-1684 and-169. Zawel et al (2000) reports that
DECJ bind to E-box and mediates transcription repression. But Boudjelal et al (1997) shows
that DEC I failes to bind either E-box or N-box. To solve this controversy, the goal of the
studies described in manuscript II was to detem1ine whether DEC! binds directly to E-box
sequence in the promoter region of DEC2 and represses its transcription.

In DEC! stable cell lines, forced expression of DEC! proportionally decreased the expression

of DEC2 . This result strongly supported our hypothesis that DEC I repressed the expression of
DEC2. However, tl1e repression on DEC2 was only observed in DEC I sense Jines, but not in
DEC! mutant lines, cells that express a mutant DEC! lacking the DNA binding domain. The
requirement of DNA binding domain suggestes that the repression on DEC2 is through a DNA
binding mechanism. To test this possibility, a DEC2 promoter reporter (pLuc-1888) was
constructed to contain the promoter region (-1888 to +11) of DEC2 gene. Co-transfection and
Juciferase assays showed that DEC! repressed the transcription of pLuc-1888 reporter by as
much as 90%.

A 5' deletion mutant reporter pLuc-535 gave the same result as pLuc-1888,

which indicated that the repression was achieved through E-box - 169 rather than E-box - 1684.
Disruption of E-box - 169 by site-directed mutagenesis in pLuc-535 abrogated the repression
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by 60%. EMSA studies gave direct evidence that DEC! bond to the E-box -169 and the
specificity of this binding was confinned by super-shift experiment. Taken together, these
results suggests that DEC! represses the transcription of DEC2 and the repression is primary
achieved through direct DNA binding to the E-box in the proximal promoter of DEC2.

To further expand our studies on molecular mechanisms of DEC I-mediated transcription
repression, many DEC! mutants were included in the reporter assay. Substitution mutation of
arginine 58 to proline totally abrogated the E-box binding ability of DEC! and reduced the
transcription repression by 60%, which pointed out the importance of this residue in DNA
binding. C-tem1inal deletion mutants of DEC! showed various transcription repression and
indicated that deleted region from residue 150 to 347 were important for the repressive activity
of DEC!. The 150-347 region either has intrinsic repressive activity, or is responsible for
recruiting transcription co-repressors. The exact mechanisms still need to be clarified.

In conclusion, the studies reported in this dissertation demonstrate that DEC I is highly
expressed in tumor and inhibits cell proliferation. Expression of DEC I protects cells against
serum deprivation induced apoptosis through upregulation of anti-apoptotic protein survivin.
The upregulation of survivin is regulated by two Sp I binding sites in the proximal promoter of
survivin. Both DEC I and Sp I are involved in the binding of these Sp I sites. In contrast to
transcription activation, DEC! negatively reguates the expression ofDEC2 through binding to
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the E-box in the proximal promoter. These findings establish the oncogenic roles of DEC I and
e lu cidate the signaling pathway that leads to antiapopto tic activity. The studies on transcription

regulations provide molecular mechanisms that DEC! regulates the transcription as an
activator as well as a repressor depending on the genomic context of a target gene.
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APPENDICES
ABBREVIATION
ARNT: Ah receptor nuclear translocation protein

bHLH: basic helix-loop-helix
CHAPS: 3-[C3-cholamidopropyl)dimethylammonio ]-1-propanesulfonic acid
DEC: differentially expressed in chondrocytes
DMEM: Dulbecco's modified Eagle's medium
DIT: dithiothreitol
E-box: Ephrussi box
EMC : extramacrochaetae protein
EMSA: Electrophoretic mobility shift assay
E(spl): enhancer of split protein
HAT: histone acetyltransferase
HES: hairy and enhancer of split-related mammalian proteins
HLH: helix-loop-helix
!AP: inhibitor of apoptosis protein
MAD: Max-associated dimer protein
Mash: mammalian Achaete-Scute homologue protein
MAX: Myc-associated x protein
MyoD: myogenic detem1ination factor
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PCR: polymerase chain reaction
PBS: phosphate-buffered saline
PMSF: phenylmethysulfonyl nuoride

RT-PCR: reverse transcription-polymerase chain reaction
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SHARP: split and hairy related protein
STRA: stimulated with retinoic acid
TAL: T cell acute leukemia protein
TBP: TATA-binding protein
TFll: transcription factor II
TGF-Jl: transforming growth factor Jl
VHL: Von H ippel-Lindau

166

BIBLIOGRAPHY
Akazawa, C., Sasai, Y., Nakanishi, S., and Kagemaya, R. (1992). Molecular characterization of
a rat negative regu lator with a basic helix-loop-he lix structure predominantly expressed in the
developing nervous system. Journal of Biological Chemistry, 267, 21879-21885.
Alland L., Muhle R. , Hou H., Jr., Potes J., Chin L., Schreiber-Agus N., and DePinho R.A.
(1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional rep ression.

Nature, 387, 49-55.
Amati B. , Brooks M.W., Levy N., Lin lewood T.D., Evan G.1., and Land H. (1993). Oncogenic
activity of the c-Myc protein requires dimerization with Max. Cell, 72, 233-245.
Aronheim A, Shiran R. , Rosen A., and Walker M.D. (1993). The E2A gene product co ntains
two separable and functionally distinct transcription activation domains. Proceedings of the

National Academy ofSciences of USA, 90, 8063-8067.
Ashkenazi A, Dixit VM (1999). Death receptors: signaling and modulation. Science, 28 1,
1305-1308.
Atchley, W.R., and Fitch, W.M. (1997). A natural classification of the basic helix-loop-helix
class of transcription factors. Proceedings of the National Academy of Sciences of USA, 94,
5172-5176.
Ayer D.E., Kretzner L., and Eisenman R.N. (1993). Mad : a heterodimeric partner for Max that
antagonizes Myc transcr iptional activity. Cell, 72, 211-222.
Ayer D.E. , Lawrence Q., and Eisenman R.N. ( 1995). Mad-Max transcriptional repression is
mediated by ternary complex formation with mammalian homologs of yeast represso r Sin3.

Cell 80, 767-776.
Azmi S, Sun H, Ozog A, Taneja R (2003). mSharp/DEC2, a basic helix-loop-heli x protein
functions as a transcriptional repressor of E-box activity and Stral 3 expression. Journal of

Biological Chemistry, 278. 20098-20109.
Bacs i, S.G., Rei sz Porszasz, S., and Hankinson, 0., (1995). Orientation of the heterodimeric
aryl hydrocarbon (dioxin) receptor complex on its asymmetric DNA recogn ition sequence.

Molecular Pharmacology, 47, 432-438.
Bannister A., and Kouzarides T. (1996). The CBP co-activatior is a histone acetyltransfe rase.

167

Nature, 384, 641-643.
Beckmann, H., Su, L.K., and Kadesch, T. (1990). TFE3: a heli x-loop-helix protein that
activates transcription through the immunoglobulin enhancer muE3 motif. Genes &
Development, 4, 167-179.
Benezra R., Davis R.L., Lockshon D., Turner D.L., and Weintraub H. ( 1990). The protein Id: a
negative regulator of helix-loop-helix DNA binding proteins. Cell, 61, 49-59.
Benton, B.K., Reid, M.S., and Okayama, H. (1993). A schi zosaccharomyces pombe gene that
promotes sexual differentiation encodes a helix-loop-helix protein with homology to myo D.
EMBOJournal, 12, 135-143.
Bissonnene, R.P., McGahan, A., Mahboubi, A., and Green, D.R. ( 1994). Functional myc- max
heterodimer is required for activation-induced apoptosis in T cell hybridomas. Journal of
Experimental Medicine, 180, 2413-2418.
Black AR, Black JD, Azizkhan JC (200 1). Sp! and KrUppel-like factor family of transcription
factors in cell growth regulation and cancer. Journal of Cellular Physiology, 188, 143-160.
Black AR, Jensen D, Lin SY, Azizkhan JC (1999). Growth/cell cycle regulation of Sp!
phosphorylation. Journal of Biological Chemistry, 274, 1207-1215.
Boudjelal, M., Taneja, R., Matsubara, S. , Bouillet, P. , Dolle, P., and Chambon, P. ( 1997).
Overexpress ion of Strat 13, a novel retinoic acid-inducible gene of the basic heli x-loo p-helix
family, inhibits mesodermal and promotes neuronal differentiation of P 19 cells. Genes &
Development, 11, 2052-2065.
Brivanlou A.H., Darnell J.E. (2002). Signal transduction and the control of gene expression.
Science, 295, 813-818.
Budihardjo I, Oliver H, Lutter M, Luo X, Wang X ( 1999). Biochemical pathways of caspase
activation during apoptosis. Annual Review of Cell and Developmental Biology, I 5, 269-290.
Burbach, K., Poland, A., and Bradfield, C.A. ( 1992). Cloning of the Ah-receptor cDNA reveals
a distincti ve ligand-activated transcription factor. Proceedings of the National Academy of
Sciences of USA, 89, 8185-8189.

168

Caudy, M., Vassin, H., Brand, M., Tuma, R., Jan, L.Y. , and Jan. Y.N. (1988). Daughterless, a
drosophila gene essential for both neurogenesis and sex determination, has seq uence
similarities to myc and the achaete-scute complex. Cell, 55, I 061-1067.
Chen G. , Fernandez J., Mische S., and Courey A. (1999). A functional interaction between the
histone deacetylase Rpd3 and the corepressor Groucho in Drosophila development. Genes &

Development, 13, 2218-2230.
Chen Q., Cheng J.T. , Tasi L.H., Schneider N., Buchanan g., Carroll A., Crist W., Ozanne B.,
Siciliano M.J., and Baer R. (1990). The ta l gene undergoes chromosone translocatioin in Tcell
leukemia and potentially encodes a helix-loop-helix protein. EMBO Journal, 9, 415-424.
Cheng S.W., Davies K.P. , Yung E., Beltran R.J ., Yu J., and Ka lpana G.V. (1999). c-MYC
interacts with INll/hSNF5 and requires the SWl/ SNF complex for transactivation function.

Nature Genetics, 22, 102-105.
Condorelli, G. L., Tocci, A., Botta, F., Facchiano, F., Testa, U., Vitelli, L., Valtieri, M., Croce,
C.M., and Peschle, C. (1997). Ectopic TALl/SCL expression in phenotypically normal or
leukemic myeloid precursors: proliferation and antiapoptotic effects coupled with a
differentiation blockade. Molecular and Cellular Biology, 17, 2954-2969.
Cronm iller, C., Schedl , P. , and Cline, T. W. ( 1988). Molecular characterization of daughte rless,
a drosophila sex determination gene with multiple roles in development. Genes & Developme/1/,
2, 1666-1676.
Cryns, V. , and Yuan, J. ( 1998). Proteases to die for. Genes & Developme/1/, 12, 155 1-1570.
Dawson SR, Turner DL, Weintraub H, Parkhurst SM (1995). Specificity for the hairy/enhancer
of split basic he lix-loop-helix (bHLH) proteins maps outside the bHLH domain and suggests
two separable modes of transcriptional repression. Molecular and Cellular Biology, 15,
6923-6931.
Eckner R., Yao T.P., Oldread E. , and Livingston D. ( 1996). interaction and functional
collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes &

Development, 10, 2478-2490
Ellenberger, T. (1994). Getting a grip on DNA recognition: stuctures of the bas ic reg ion leucine
zipper, and the basic region heli x- loop-helix DNA-binding domains. Current Opinion in Cell

Biology. 4, 12-21.

169

Ellis H.M., Spann D.R., and Posakony J.W. (1990). Extramacrochaetae, a negative regulator of
sensory organ development in Drosophila, defines a new class of helix-loop-helix proteins.

Cell, 61, 27-38.
Evan G.I. and Littlewood T.D. (1993). The role of c-myc in cell growth. Current Opinion in

Genetics & Development, 3, 44-49.
Ferre D.A., Pognonec P., Roeder R.G. and Burley S.K. ( 1994). Structure and function of the
b/HLH/Z domain of USF. EMBO Journal, 13, 180-189.
Ferre D.A., Prendergast G.C., Ziff E.B. and Burley S.K. ( 1993). Recognition by Max of its
cognate DNA through a dimeric b/HLH/Z domain. Nalure, 363, 38-45.
Fisher A.L., and Caudy M. (1998). Groucho proteins: transcriptional co-repressors for specific
subsets of DNA -binding transcription factors in vertebrates and invertebrates. Genes &

Developmenl, 12, 193 1-1940.
Fisher, A.L., Ohsako, S. And Caudy, M. (1996). The WRPW motif of the hairy basis
helix-loop-helix repressor proteins acts as a 4-amino-acid tran scription repression and

protein-protein interaction domain. Molecular and Cellular Biology, 16, 2670-2676.
Fujimoto, K., Shen, M., Noshiro, M., Matsubara, K., Shingu, S., Honda, K., Yoshida, E.,
Suardita, K., Matsuda, Y., and Kato, Y. (2001). Molecular cloning and characteri zation of
DEC2, a new member of basic helix-loop-helix proteins. Biochemical and

Biophysical

Research Communications, 280, 164-171.
Garriga-Canul, M., Roopra, A, and Buckley, N.J. (2001). The basic helix-loop-helix protein,
sharp-I, represses transc ription by a histone deacetylase-dependent and a histone
deacetylase- independent mechanism. Journal of Biological Chemistry, 276, 14821-14828.
Giebel, B., and Campos-Ortega, J.A. (1997). Functional dissection of the drosophila enhancer
of split protein, a suppressor ofneurogenesis. Proceedings ofthe National Academy of Sciences

of USA, 94, 6250-6254.
Goodrich, J., Carpenter, R., and Cohen, E.S. (1992). A common gene regulates pigmentation
pattern in diverse plant species. Cell, 68, 955-964.
Grant P., Schieltz D., Pray-Grant M., Steger D., Reese J., Yates 111, and Workman J. (1998). a
subset of TA Flis are integral components of the SAGA complex reauired for nucleosornal
acetylation and transcription stimulation. Cell, 94, 45-53.

170

Grant P., Schieltz D. , Pray-Grant M., Yates Il l, and Workman J. (1998). The ATM-related
cofactor Tra I is a component of the purified SAGA complex. Molecular Cell, 2, 863-867.
Green DR, Reed JC ( 1999). Mitochondria and apoptosis. Science, 281, 1309-131 2.
Henthorn P., Kiledjian M., and Kadesch T. (1990). Two distinct transcripti on factors that bind
the immunoglobulin enhancer ftE5hcE2 motif. Science, 247, 467-470.
Hirose, K., Morita, M., Ema, M., Mimura, J., Hamada, H., Fuj ii, H., Saijo, Y., Gotoh, 0.,
Sogawa, K., and Fujii-Kuriyama, Y. ( 1996). cDNA cloning and tissue-specific expression of a
novel basic helix-loop-he lix/PAS factor (Arnt2) with close sequence simi larity to the ary l
hydrocarbon receptor nuclear translocator (Amt). Molecular and Cellular Biology. 16,
1706-1713.
Hojo, M. , Ohtsuka, T., Hash imoto, N., Gradwohl , G., Gui llemot, F., and Hageyama, R. (2000).
Glial cell fate specification modulated by the bHLH gene HESS in mouse retina. Development,
127, 25 15-2522.
Honma S., Kawamoto T., Takagi Y., Fujimoto K. , Sato F., Noshiro M., Kato Y., and Honma K.
DEC I and DEC2 are regulators of the mammalian molecular clock. Nature, 419, 841-844.
Hu, M., and Yan, B. ( 1999). Isolation of multiple distinct cDNAs by a single cDNA-trapping
procedure. Analytical Biochemisty, 266, 233-235.
lnuzuka H, Nanbu-Wakao R, Masuho Y, Muramatsu M, Tojo H, Wakao H (1999). Differential
regu lation of immediate early gene expression in preadipocyte cells through multiple signaling
pathways. Biochemical and Biophysical Research Communications, 265, 664-668.
lvanova, A. V., Ivanov, S. V., Danilkovitch-Miagkova, A., and Lerman, M.I. (200 I). Regul ation
of STRA 13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the
UBC9/ubiquitin proteasome degradation pathway. Journal of Biological Chem istry, 276,
15306- 15315 .
Kasof GM, Gomes BC (200 I). Livin, a nove l inhibitor of apoptosis protein family member.

Journot of Biological Chemistry, 276, 3238-3246.
Katti , M.V., Sami-Subbu, R., Ranjekar, P.K., Guptu, V.S. (2000). Amino acid repeat patterns in
protein sequences: their di ve rsity and structural-functional implications. Protein Science, 6,
1203-1209.

171

Kavurma MM , Bobryshev Y and Khachigian LM (2002). Ets-1 positively regulates Fas ligand
transcription via cooperative interactions with Spl. Journal of Biological Chemist1y, 277,
36244-36252.
Kee, B., and Murre C. (1998). Induction of early B cell factor (EBF) and multiple Bl ineage
genes by the basic helix-loop-helix transcription factor E 12. Journal of

Experimental

Medicine, 188, 699-713.
Kim, D., Peng, X.C., and Sun, X.H. (1999). Massive apoptosis ofthmocytes in Teel! deficient
Id I transgenic mice. Molecular and Cellular Biology, 19, 8240-8253.
Kokubo H, Lun Y, Johnson RL(l 999). Identification and exp ression ofa novel family ofbHLH
cDNAs related to Drosophila hairy and enhancer of split. Biochemical and Biophysical

Research Communications, 260, 459-465.
Koskinen P.J ., Ayer D.E., and Eisenman R.N. (1995). Repression of Myc-Ras cotransformation
by Mad is mediated by multiple protein-protein interactions. Cell Growth & Differentiation, 6,
623-629.
Kretzner L., Blackwood E.M., and Eisenman R.N . (1992). Myc and Max proteins possess
distinct transcriptional act ivities. Nature, 359, 426-429.
LaCasse EC, Baird S, Kome luk RG, MacKenzie AE ( 1998). The inhibitors of apoptosis (IAPs)
and their emerging role in cancer. Oncogene, 17, 3247-3259.
Lahoz E.G., Xu L., Schreiber-Agus N., and DePinho R.A. (1994). Suppression of Myc, but not
EI a, transformation acitivity by Max-associated proteins, Mad and Mxil . Proceedings of the

National Academy ofSciences o/USA, 91, 5503-5507.
Langlands K., Yin X., Anand G., and Prochownik E.V. (1997). Differential interactioins of Id
proteins with basic-heli x-loop-helix transcriptioin factors. Journal of Biological Chemist1y,
272, 19785-19793.
Li F (2003). Survivin study: what is the next wave? Journal of Cellular Physiology, 197, 8-29.
Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Togn in S, Villa A, Marchisio PC,
Altieri DC ( 1999). Pleiotropic cell-division defects and apoptosis induced by interference with
survivin function. Nature Cell Biology, l, 461-466.
Li F, Altieri DC (1999). Transcriptional analysis of human survi vin gene expression.

172

Biochemical Journal, 344 Pt 2, 305-3 I I.
Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998). Control of
apo ptosis and mitotic sp indle checkpoint by survivin . Nature, 396, 580-584.
Li Y., Xie M., Song X., Gregan S., Sachdeva K., Wan Y., and Yan B. (2003). DECJ negatively
regulates the expression of DEC2 through the E-box in the proximal promoter. Journal of

Biological Chemistry, 278, 16899-16907.
Li Y, Zhang H, Xie M, Hu M, Ge S, Yang D, Wan Y, Yan B (2002). Abundant expression of
Decl /stral3/s harp2 in colon carcinoma: its antagonizing role in serum deprivation-induced
apoptosis and selecti ve in hibition of procaspase activation. Biochemical Journal, 367,
413-422.
Linlewood, T.D., and Evan, G. I. ( 1998). Helix-loop-helix transcription factors, Oxford
Uni versity Press, pp 1-48.
Luscher, B., and Eisenman, R.N. ( 1990). New light on myc and myb, part I, myc. Genes &

Development, 4, 2025-2035.
Ma P.C.M., Rould M.A., Weintraub H., and Pabo C.O. ( 1994). Crystal structure of MyoD
bHLH domain DNA complex: perspectives on DNA recognition and implications for
transcriptional activation. Cell, 77, 451-459.
Maestro, R., Tos, A.P.D., Hamamori , Y., Krasnokutsky, S., Sartorelli, V., Kedes, L., Doglioni ,
C., Beach, D. H., and Hannon, G.J. ( 1999). Twist is a potential oncogene that inhibits apo ptosis.

Genes & Development, 13, 2207-22 17.
Massari, M. E., and Murre C. (2000). Helix-loop-heli x proteins: Regulators of transcription in
eucaryotic organisms. Molecular and Cellular Biology, 20, 429-440.
Massari M., Grant P., Pray-Grant M., Berger S., Workman J., and Murre C. ( I 999). A conserved
motif present in a class of helix-loop-helix proteins activates transcripti on by di rect rec ruitment
of the SAGA complex. Molecular Cell, 4, 63-73.
Massari M., Jennings P., and Murre C. (1996). The ADI transactivation domain of E2A
contains a highl y conserved heli x which is required for its activity in both saccharomyces

cerevisiae and mammalian cells. Molecular and Cellular Biology, 16, I 2 I- I 29.
McMahon S.B ., Van Buskirk H.A., Dugan K.A., Copeland T.D., and Cole M.D. ( 1998). The

I 73

novel ATM-related protein TRRAP is essential cofactor for the c-Myc and E2F oncoproteins.

Cell, 94, 363-374.
Mil ler LK (1999). An exegesis of IAPs: salvation and surpri ses from BIR motifs. Trends in Cell

Biology, 9, 323-328.
Miyazaki K., Kawamoto T., Tanimoto K. , Nishiyama M., Hond a H., and Kato Y. (2002).
Identification of functiona l hypoxia response elements in the promoter region of the DECJ and
DEC2 genes. Journal of Biological Chemistry, 277, 47014-47021.
Morgenbesse r, S.D., Schreiber Agus, N., Bidder, M., Mahon ., K.A. , Overbeek, P.A ., Horner, J. ,
and DePinho, R.A. (1995). Contrasting roles for c-myc and 1-myc in the regulation of cellular
growt h and diffe rentiation in vivo. EMBOJournal, 14, 743-756.
Murre, C., Bain, G, Dijk, M.A.V., Engel, I., Furnari, B.A., Massari, M.E., Matthews, J.K.,
Quong, M.W., Rivera, R.R., and Stuiver, M.H. ( 1994). Structure and function of
hel ix- Joop-hel ix proteins. Biochimica et Biophysica Acta, 1218, 129-135.
Murre, C., and Baltimore, D. (1992). The helix-loop-helix motif: structure and function, Cold
Spring Harbor Laboratory Press, Plainview, N.Y.
Naek, J. H. , Jang, J.E., Kang, C.M., Chung, H.Y., Kim, N.D., and Kim, K. W. (2000).
Hypoxia-ind uced

VEGF

enhances

tumor

survivability

via

suppression

of se rum

deprivation-induced apoptosis. Oncogene, 19, 4621-4631.
Neuhold L.A., and Wold b. (1993). HLH forced dimers: tethering MyoD to E47 generates a
dominant positive myogenic factor insulated from negative regu lation by Id. Cell, 74,
1033-1042.
Nikoloff, D. M., McGraw, P., and Henry, S.A. (1992). The IN02 gene of saccharomyces
cerevisiae encodes a helix-loop-heli x protein that is required for activation of phospholipid
synthesis. Nucleic Acids Research, 20, 3253.
Norton, J.D. (2000). ID helix-loop-helix proteins in cell growth, different iation and
tumorigenesis. Journal of Cell Science, 113, 3897-3905.
Ogryzko V., Kotani T., Zhang X., Schlitz R., Howard T., Yang X., Howard B., Qin J., and
Nakatani Y. (1998). Histone-Jike TAFs within the PCAF histone acety lase complex. Cell, 87,
953-959.

174

Ohtsuka, T., Sakamoto, M., Guillemot, F., and Kageyama, R. (200 1). Roles of the bHLH genes
HES I and HESS in the ex pansion of neural stem cell s of the developing brain. Journal of

Biological Chemistry. 276, 30467-30474.
Packham, G., and Cleveland, J.L. ( 1995). The role of omithine decarboxylase in
c-Myc- induced apoptosis. Current Topics in Microbiology and Imm unology, 194, 283-290.
Penn, L.J.Z., Laufer, E.M ., and Land, H. ( 1990). C-myc: evidence for multiple regul atory
function s. Seminars in Cancer Biology, I, 69-80.
Parkhurst S.M. (1998). Groucho: making its Marx as a transcriptional co-repressor. Trends in

Genetics, 14, 130-1 32 .
Poortinga, G., Watanabe, M., and Parkhurst, S.M. (1998). Drosophila CtBP: a hai ry- interacting
protein required for embryonic segmentation and hairy-mediated transc ripti onal repression.

EMBO Journal, 17, 2067-2078.
Reed JC (200 I). The Survivin saga goes in vivo. Journal of Clinical In vestigation, 108,
965-969.
RohlffC , Ahmad S, Borellini F, Lei J, G lazer RI (1997). Modulation of transcription factor Spl
by cA MP-dependent protein kinase. Journal of Biological Chemist1y, 272, 2 113 7-2 1141
Rossner, M.J., Dorr, J., Gass, P., Schwab, M.H., and Nave, K.A. ( 1997). SHARPs: mammalian
enhancer-of-split and hairy- rel ated proteins co upled to neuronal stimulation. Molecular and

Cellular Neuroscience, 9, 460-475.
Seimiya M., Bahar R., Wang Y., Kawamura K., Tada Y., Okada S., Hatano M., Tokuhisa T. ,
Saisho H., Watanabe T., Tagawa M .. , and 0 -Wang J. (2002). Clast5/Stra 13 is a negative
regulator of B lym phocyte activation. Biochemical and Biophysical Research Communications,
292, 121-127.
Shen M .. , Kawamoto T., Teramoto M. , Makihira S., Fujimoto K., Yan W., Noshiro M., and
Kato Y. (200 1). Induction of basic helix-loop-helix protein DEC! (B HLHB2)/Stral3/Sharp2 in
response to the cyclic adenosine monophosphate pathway. European Journal of Cell Biology,
80, 329-334.

Shen, M., Kawamoto, T. , Yan, W., Nakamasu, K., Tamagami , M., Koyano, Y., Noshiro, M.. and
Kato, Y. ( 1997). Molecular characterization of the novel bas ic hel ix-loop-helix protein DEC!
expressed in differentiated human embryo chondrocytes. Biochemical and

Research Communication, 236, 294-298.

175

Biophysical

Shen M., Yoshida E., Yan W., Kawamoto t. , Suardita K., Koyano Y., Fujimoto K., Noshiro M.,
and Kato Y. (2002). Basic helix-loop-helix protein DEC I promotes chondrocyte differentiation
at the early and terminal stages. Journot of Biological Chemistry, 277, 50 11 2-50 120.
St-Pierre B., Flock G., Zacksenhaus E., and Egan S.E. (2002). Stra\3 homodimers repress
transcription through class B E-box elements. Journal of Biological Chemislly, 277,
46544-46551.
Su K, Roos MD, Yang X, Han I, Paterson AJ, Kud\ow JE (1999). An N-term inal region of Sp I
targets its proteasome-dependent degradation in vitro. Journal of Biological Chemistry, 274,
15194-15202.
Sun H., Lu B., Li R., Flavell R.A ., and Taneja R. (2001). Defective T cel l activation and
autoimmune disorder in Stra\3-deficient mice. Nature Immunology, 2,1040-1047.
Sun, H., and Taneja R. (2000). Stra\3expression is associated with growth arrest and represses
transcription through histone deacetylase (HDAC)-dependent and HDAC-independent
mechanisms. Proceedings ofthe National Academy ofSciences of USA , 97, 4058-4063 .
Teramoto M, Nakamasu K, Noshiro M, Matsuda Y, Gotoh 0 , Shen M, Tsutsumi S, Kawamoto
T, Iwamoto Y, Kato Y. (2001). Gene structure and chromosomal location of a human bHLH
transcriptional factor DEC I x Stra\3 x SHARP-2/BHLHB2. Journal of Biochemistry (Tokyo),
29, 391-396.
Vaupel, P., Kelleher, D.K ., and Hocke\, M. (200 1). Oxygen status of malignant tumors:
pathogenesis of hypoxia and significance for tumor therapy. Seminars in Oncology, 28, 29-35.
Villares, R., and Cabrera, C.V. ( 1987). The achaet-scute gene complex of D. Melanogaster:
conserved domains in a subset of genes required for neurogenesis and their homology to myc.
Cell, 50, 415-424.
Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R. Blackwell , T.K.,
Turner, D., Rupp, R., Hollenberg, S., Zhuang, Y., and Lassar, A. (1991). The Myo D gene fami ly:
nodal point during specification of the muscle cell lineage. Science, 251, 761-766.
Wice, 8.M ., and Dardon, J.1. ( 1998). Forced expression of Id I in the adult mouse small
intestinal epithelium is associated with development of adenomas. Journal of Biological
Chemistry, 273, 25310-25319.

176

Wu, L., and Whitlock, J.P.J. (1993). Mechanism of dioxin action: receptor-enhancer
interactions in intact cells. Nucleic Acids Research, 21, 119-125.
Xie M, Yang D, Liu L, Xue B, Yan B (2003). Mouse carboxylesterase M-LK rapidly
hydrolyzes antitumor prodrug CPT-11 and the N-terminal three quarter sequence determines
substrate select ivity. Drug Metabolism and Disposition, 31: 21-27.
Xie M, Yang D, Liu L, Xue B, Yan B (2002). Rodent and human carboxylesterases:
immuno-relatedness, overlapping substrate specificity, differential sensitivity to serine
inhibitors, and tumor-related expression. Drug Metabolism and Disposition, 30: 541-547.
Yan, B., Yang, D., Bullock, P., and Parkinson, A. (1995). Rat serum carboxylesterase: cloning,
expression, regulation and evidence of secretion from liver. Journal of Biological Chemistry,
270, 19128-19134.
Yang YL, Li XM (2000). The IAP family: endogenous caspase inhibitors with multiple
biological activities. Cell Research, I 0, 169-177
Yoon DY, Buchler P, Saarikoski ST, Hines OJ, Reber HA , Hankinson 0 (2001). Identification
of genes differentially induced by hypoxia in pancreatic cancer cells. Biochemical and
Biophysical Research Communications, 288, 882-886.
Yu, J.L., Rak, J.W., Carmeliet, P., Nagy, A., Kerbel, R.S ., and Coomber, B.L. (2001).
Heterogeneous vascular dependence of tumor cell populations. American Journal ofPathology,

158, 1325-1334.
Yun Z., Maecker H.L., Johnson R.S., and Giaccia A.J. (2002). Inhibition of PPARy2 gene
expression by the HIF-1-regualted gene DECI /Strl3: a mechanism for regulation of
adipogenesis by hypoxia. Development Cell, 2, 331-341.
Zawel L., Yu J., Torrance C.J., Markowitz S., Kinzler K. W., Vogelstein B., and Zhou S. (2002).
DEC I is a downstream target of TGF-P with sequence-specific transcriptional repressor
activities. Proceedings of the National Academy a/Sciences of USA, 99, 2848-2853.
Zhang, H., LeC luyse, E., Liu, L., Hu, M., Matoney, L., and Yan, B. ( 1999). Rat pregnane X
receptor: molecular cloning, tissue distribution and xenobiotic regulation. Archives of
Biochemistry and Biophysics, 368, 14-22.

177

Zhao, G.Q., Zhao, Q., Zhou, X., Mattei, M.G., and de Crornbrugghe, B. ( 1993). TFEC, a basic
heli x-loop-heli x protein, fo rms heterodimers wi th TFE3 and inh ibits TFE3-dependent
transcription activation. Molecular and Cellular Biology, 13, 4505-4512.
Zhu, W., Song, L. Maloney, L., LeCluyse, E., and Yan, B. (2000). Dexarnethaso ne differentia ll y
regulates the express ion of carboxylesterase genes in hum ans and rats. Drug Metabolism and

Disposition, 28, 186-191.
Zhuang, Y., Soriano, P., and Weintraub, H. ( 1994). The helix- loop- helix E2A is required for B
cell fo rm ation. Cell, 79, 875-884.

178

